<SEC-DOCUMENT>0001213900-25-080878.txt : 20250827
<SEC-HEADER>0001213900-25-080878.hdr.sgml : 20250827
<ACCEPTANCE-DATETIME>20250826191731
ACCESSION NUMBER:		0001213900-25-080878
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20251008
FILED AS OF DATE:		20250827
DATE AS OF CHANGE:		20250826

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			60 DEGREES PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001946563
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				452406880
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41719
		FILM NUMBER:		251259248

	BUSINESS ADDRESS:	
		STREET 1:		1025 CONNECTICUT AVENUE NW
		STREET 2:		SUITE 1000
		CITY:			WASHINGTON
		STATE:			DC
		ZIP:			20036
		BUSINESS PHONE:		202-327-5422

	MAIL ADDRESS:	
		STREET 1:		1025 CONNECTICUT AVENUE NW
		STREET 2:		SUITE 1000
		CITY:			WASHINGTON
		STATE:			DC
		ZIP:			20036
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>ea0254708-def14a_60degrees.htm
<DESCRIPTION>DEFINITIVE PROXY STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Schedule 14A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Proxy Statement Pursuant to Section 14(a) of<BR>
the Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 85%"><FONT STYLE="font-size: 10pt">Filed by the Registrant</FONT></TD>
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Filed by a party other than the Registrant</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Check the appropriate box:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Preliminary Proxy Statement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Definitive Proxy Statement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Definitive Additional Materials</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Soliciting Material under &sect; 240.14a-12</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_001.jpg" ALT=""></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B><U>60 DEGREES PHARMACEUTICALS, INC.</U></B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(Name of Registrant as Specified In Its Charter)</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B><U>N/A</U></B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Payment of Filing Fee (Check all boxes that apply): </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">No fee required</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Fee paid previously with preliminary materials.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a- 6(i)(1) and 0-11</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_002.jpg" ALT=""></P>



<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>60 DEGREES PHARMACEUTICALS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>1025 Connecticut Avenue NW Suite 1000<BR>
Washington, D.C. 20036</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>https://60degreespharma.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">August 26, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Fellow Stockholders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On behalf of your Board of Directors, we cordially
invite you to attend the 2025 Annual Meeting of Stockholders of 60 Degrees Pharmaceuticals, Inc. (the &ldquo;Annual Meeting&rdquo;). The
Annual Meeting will be held on October 8, 2025, at 12:00 p.m. Eastern Time, in a virtual meeting format only and conducted via live audio
webcast over the telephone to enable our stockholders to participate from locations around the world. Stockholders will <B>NOT</B> be
able to attend the Annual Meeting in person. The Annual Meeting will be accessible only over the telephone. Please see &ldquo;Attending
the Virtual Annual Meeting&rdquo; in the proxy statement (&ldquo;Proxy Statement&rdquo;) accompanying this letter for information on how
to obtain the proxy materials, attend, ask questions at the Annual Meeting and vote at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are making available to you the accompanying
Notice of Annual Meeting of Stockholders (&ldquo;Notice&rdquo;), Proxy Statement and form of proxy card or voting instruction form on
or about August 26, 2025. We are pleased to furnish proxy materials to stockholders primarily over the internet. We believe that this
process expedites stockholders&rsquo; receipt of proxy materials, lowers the costs of our Annual Meeting and conserves natural resources.
On or about September 3, 2025, we mailed to our stockholders a Notice of Internet Availability of Proxy Materials (the &ldquo;Internet
Availability Notice&rdquo;) that includes instructions on how to access our Proxy Statement and 2024 Annual Report and how to vote over
the telephone. The Internet Availability Notice also includes instructions on how you can receive a paper copy of your Annual Meeting
materials, including the Notice, Proxy Statement and proxy card or voting instruction form. If you elected to receive your Annual Meeting
materials by mail, the Notice, Proxy Statement and proxy card or voting instruction form were enclosed. If you elected to receive your
Annual Meeting materials via e-mail, the e-mail contains voting instructions and links to the 2024 Annual Report and the Proxy Statement,
both of which are available on our website at <I>https://60degreespharma.com</I>. Additional details regarding admission to, and the business
to be conducted at, the Annual Meeting are described in the accompanying Notice and Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Only stockholders of record at the close of business
on August 26, 2025 are entitled to notice of, and to vote at, the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Your vote is important.</B> Regardless of whether
you plan to attend the Annual Meeting, we hope that you will vote as soon as possible. You may vote over by telephone or by mailing in
a proxy card. Please review the instructions on the proxy card or voting instruction form regarding each of these voting options. Voting
will ensure your representation at the Annual Meeting regardless of whether you attend the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you for your on-going support of 60 Degrees
Pharmaceuticals, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 40%"><FONT STYLE="font-size: 10pt"><I>/s/ Geoffrey Dow</I></FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Geoffrey Dow</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer and President</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>60 DEGREES PHARMACEUTICALS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>1025 Connecticut Avenue NW Suite 1000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20036</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>https://60degreespharma.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>To Be Held Virtually at 12:00 p.m. (Eastern
Time) on October 8, 2025</U></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notice is hereby given that the 2025 Annual Meeting
of Stockholders (the &ldquo;Annual Meeting&rdquo;) of 60 Degrees Pharmaceuticals, Inc., a Delaware corporation (&ldquo;Company,&rdquo;
&ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo;), will be held on October 8, 2025 at 12:00 p.m. (Eastern Time) via a live audio
webcast over the telephone. You will be able to virtually attend the Annual Meeting over the telephone and ask questions during the Annual
Meeting. We are holding the Annual Meeting for the following purposes, which are more fully described in the accompanying proxy statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">to elect five (5) directors to serve until the 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified (the &ldquo;Director Election Proposal&rdquo;);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">to approve an amendment to the 60 Degrees Pharmaceuticals, Inc. 2022 Equity Incentive Plan (the &ldquo;2022 Plan&rdquo;) to increase the number of shares of common stock available for issuance by 250,000 shares (the &ldquo;2022 Plan Amendment Proposal&rdquo;);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">to approve an amendment to our certificate of incorporation, as corrected (&ldquo;Certificate of Incorporation&rdquo;), to effect a reverse stock split of our common stock at a reverse stock split ratio ranging from 1:3 to 1:10 inclusive, as determined by our Board of Directors in its sole discretion (the &ldquo;Certificate of Incorporation Amendment Proposal&rdquo;);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">to ratify the selection by our Board of Directors of RBSM LLP as our <FONT STYLE="background-color: white">independent auditor </FONT>for the fiscal year ending December 31, 2025 (the &ldquo;Auditor Proposal&rdquo;);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt; background-color: white">to approve adjourning the Annual Meeting, if necessary, to solicit additional proxies in the event there are not sufficient votes in favor of the Director Election Proposal, the 2022 Plan Amendment Proposal and the Certificate of Incorporation Amendment Proposal at the time of the Annual Meeting (the &ldquo;Adjournment Proposal&rdquo;); and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">to transact such other business as may properly come before the meeting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These items of business are more fully described
in the proxy statement (&ldquo;Proxy Statement&rdquo;) accompanying this Notice of Annual Meeting of Stockholders (the &ldquo;Notice&rdquo;).
We are not aware of any other business to come before the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After careful consideration, the Board has determined
that each proposal listed above is in the best interests of the Company and its stockholders and has approved each proposal. <B>The Board
recommends a vote &ldquo;FOR&rdquo; the Election of each director nominee (Proposal 1), &ldquo;FOR&rdquo; the approval of an amendment
to the 2022 Plan (Proposal 2), &ldquo;FOR&rdquo; the approval of an amendment to our Certificate of Incorporation (Proposal 3), &ldquo;
&ldquo;FOR&rdquo; the ratification of our independent auditor (Proposal 4) and &ldquo;FOR&rdquo; the approval of the Adjournment Proposal
(Proposal 5).</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All stockholders are invited to attend the Annual
Meeting virtually and no stockholder will be able to attend the Annual Meeting in person. The Annual Meeting will be accessible via the
telephone in accordance with the instructions contained in the Proxy Statement. Please see &ldquo;<I>Questions and Answers About the Meeting
and Voting&mdash;How Do I Vote At The Annual Meeting?</I>&rdquo; in the Proxy Statement accompanying this Notice for information on how
to attend, ask questions during the Annual Meeting and vote at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>WHO CAN VOTE?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You can vote at the Annual Meeting if you were
a stockholder of record as of the close of business on August 26, 2025 (the &ldquo;Record Date&rdquo;). Only stockholders of record on
the Record Date are entitled to receive this Notice and to vote at the Annual Meeting or at any postponement(s) or, continuations(s) or
adjournment(s) of the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ANNUAL REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A copy of our Form 10-K (the &ldquo;2024 Annual
Report&rdquo;) accompanies the Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>REVIEW THE PROXY MATERIALS AND ANNUAL REPORT
ON OUR WEBSITE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may also read the 2024 Annual Report, this
Notice and Proxy Statement on our website at <I>https://investors.60degreespharma.com</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>AVAILABLE DATE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Notice, the Proxy Statement and the form
of proxy are first being made available to stockholders on or about August 26, 2025 at <I>www.SXTP.vote</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">YOUR VOTE IS IMPORTANT. YOU MAY VOTE BY TELEPHONE
OR BY MAILING BACK A PROXY CARD. PLEASE REVIEW THE INSTRUCTIONS IN THE PROXY STATEMENT OR ON THE PROXY CARD OR VOTING INSTRUCTION FORM
REGARDING EACH OF THESE VOTING OPTIONS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hope you are able to attend the Annual Meeting
virtually via the telephone. Whether or not you attend, it is important that your stock be represented and voted at the meeting. I urge
you to please complete, date and return the proxy card in the enclosed envelope, vote your shares electronically or vote by telephone
using the information provided in the attached Proxy Statement prior to the Annual Meeting date. The vote of each stockholder is very
important. You may revoke your written proxy at any time before it is voted at the Annual Meeting by giving written notice to the Company&rsquo;s
Chief Financial Officer, by submitting a properly executed paper proxy bearing a later date or by attending the Annual Meeting virtually
and voting online during the meeting. Stockholders may also revoke their proxies by entering a new vote by telephone.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By Order of the Board of Directors,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 40%"><FONT STYLE="font-size: 10pt"><I>/s/ Geoffrey Dow</I></FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Geoffrey Dow</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Director, Chief Executive Officer and President</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Washington, D.C.</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">August 26, 2025</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt; width: 94%"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING</FONT></A></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 5%"><FONT STYLE="font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt"><A HREF="#a_002"><FONT STYLE="font-size: 10pt">PROPOSAL 1: ELECTION OF DIRECTORS</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt"><A HREF="#a_003"><FONT STYLE="font-size: 10pt">DIRECTORS AND EXECUTIVE OFFICERS</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt"><A HREF="#a_004"><FONT STYLE="font-size: 10pt">CORPORATE GOVERNANCE</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt"><A HREF="#a_005"><FONT STYLE="font-size: 10pt">AUDIT COMMITTEE REPORT</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt"><A HREF="#a_006"><FONT STYLE="font-size: 10pt">DIRECTOR COMPENSATION</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt"><A HREF="#a_007"><FONT STYLE="font-size: 10pt">EXECUTIVE COMPENSATION</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt"><A HREF="#a_008"><FONT STYLE="font-size: 10pt">DELINQUENT SECTION 16(A) REPORTS</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt"><A HREF="#a_009"><FONT STYLE="font-size: 10pt">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt"><A HREF="#a_010"><FONT STYLE="font-size: 10pt">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt"><A HREF="#a_011"><FONT STYLE="font-size: 10pt">PROPOSAL 2: APPROVAL OF AMENDMENT TO THE 2022 EQUITY INCENTIVE PLAN TO INCREASE TOTAL NUMBER OF AUTHORIZED SHARES BY 250,000 SHARES</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt"><A HREF="#a_012"><FONT STYLE="font-size: 10pt">PROPOSAL 3: APPROVAL OF AMENDMENT OF CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT AT A SPLIT RATIO OF 1:3 TO 1:10, INCLUSIVE, AS DETERMINED BY THE BOARD OF DIRECTORS IN ITS SOLE DISCRETION </FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">30</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt"><A HREF="#a_013"><FONT STYLE="font-size: 10pt">PROPOSAL 4: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 0.125in; text-align: justify; text-indent: -0.125in"><A HREF="#a_014"><FONT STYLE="font-size: 10pt">PROPOSAL 5: APPROVAL OF THE ADJOURNMENT OF THE ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IN THE EVENT THERE ARE NOT SUFFICIENT VOTES IN FAVOR OF THE DIRECTOR ELCTION PROPOSAL, THE 2022 PLAN AMENDMENT PROPOSAL AND THE CERTIFICATE OF INCORPORATION AMENDMENT PROPOSAL</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">36</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9.5pt; text-align: justify; text-indent: -9pt"><A HREF="#a_015"><FONT STYLE="font-size: 10pt">ADDITIONAL INFORMATION</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">37</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>60 DEGREES PHARMACEUTICALS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>1025 Connecticut Avenue NW Suite 1000<BR>
Washington, D.C. 20036</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROXY STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For Annual Meeting of Stockholders to Be Held
on October 8, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors (the &ldquo;Board&rdquo;)
of 60 Degrees Pharmaceuticals, Inc., a Delaware corporation (&ldquo;60 Degrees Pharmaceuticals,&rdquo; &ldquo;60P,&rdquo; &ldquo;Company,&rdquo;
&ldquo;we,&rdquo; &ldquo;us&rdquo; or &ldquo;our&rdquo;), solicits the enclosed proxy for use at the 2024 Annual Meeting of Stockholders
of the Company (&ldquo;Annual Meeting&rdquo;) to be held on October 8, 2025, only via live audio webcast over the telephone by following
the instructions set forth here at &ldquo;<I>Questions and Answers About the Meeting And Voting</I>&mdash;<I>How Do I Vote at the Annual
Meeting?</I>&rdquo; This proxy statement (&ldquo;Proxy Statement&rdquo;) and the accompanying Notice of Annual Meeting of Stockholders
(the &ldquo;Notice&rdquo;) and form of proxy are first being made available to stockholders on or about August 26, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are furnishing proxy materials to our stockholders
primarily via the internet. On or about September 3, 2025, we mailed to our stockholders a Notice of Internet Availability of Proxy Materials
(the &ldquo;Internet Availability Notice&rdquo;) containing instructions on how to access our proxy materials, including our Proxy Statement
and our 2024 Annual Report to Stockholders (the &ldquo;2024 Annual Report&rdquo;). The Internet Availability Notice also provides information
on how to access your voting instructions to be able to vote by telephone. Other stockholders, in accordance with their prior requests,
have received e-mail notification of how to access our proxy materials and vote via telephone, or have been mailed paper copies of our
proxy materials and a proxy card or voting instruction form. Internet distribution of our proxy materials helps to expedite receipt by
our stockholders, lowers the cost of the Annual Meeting and conserves natural resources. If you have previously elected to receive our
proxy materials electronically, you will continue to receive these materials via e-mail unless you elect otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The executive offices of the Company are located
at, and the mailing address of the Company is 1025 Connecticut Avenue NW Suite 1000, Washington, D.C. 20036.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Proxy Statement contains information about
the matters to be voted on at the Annual Meeting and the voting process, as well as information about our directors and executive officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Under Securities and Exchange Commission (&ldquo;SEC&rdquo;)
rules that allow companies to furnish proxy materials to stockholders over the Internet, we have elected to deliver our proxy materials
to the majority of our stockholders over the Internet. This delivery process allows us to provide stockholders with the information they
need, while at the same time conserving natural resources and lowering the cost of delivery. On or about September 3, 2025, we will begin
sending to our stockholders the Internet Availability Notice containing instructions on how to access our Proxy Statement for our Annual
Meeting and our 2024 Annual Report. The Internet Availability Notice also provides instructions on how to vote and access the virtual
Annual Meeting by telephone and how to receive a paper copy of the proxy materials by mail. The Notice and Proxy Statement are also available
at <I>www.SXTP.vote.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>QUESTIONS AND ANSWERS ABOUT THE MEETING AND
VOTING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: What is a proxy?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>A proxy is another person that you legally
designate to vote your stock. If you designate someone as your proxy in a written document, that document is also called a &ldquo;proxy&rdquo;
or a &ldquo;proxy card.&rdquo; By using the methods discussed below, you will be appointing Geoffrey Dow, the Chief Executive Officer,
President and a director of the Company, and Tyrone Miller, the Chief Financial Officer of the Company, as your proxy. The proxy agent
will vote on your behalf, and will have the authority to appoint a substitute to act as proxy. If you are unable to attend the Annual
Meeting, please vote by proxy so that your shares may be voted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: What is a proxy statement?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>A proxy statement is a document that
regulations of the SEC require that we give to you when we ask you to sign a proxy card to vote your stock at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: What is the purpose of the Annual Meeting?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>At our Annual Meeting, stockholders
will vote on: (i) the election of five (5) directors; (ii) to approve an amendment to the 60 Degrees Pharmaceuticals, Inc. 2022 Equity
Incentive Plan (the &ldquo;2022 Plan&rdquo;) to increase the number of shares of common stock available for issuance by 250,000 shares;
(iii) to approve an amendment to our certificate of incorporation, as corrected (&ldquo;Certificate of Incorporation&rdquo;), to effect
a reverse stock split of our common stock at a reverse stock split ratio ranging from 1:3 to 1:10 inclusive, as determined by our Board
in its sole discretion; (iv) the ratification of the selection by our Board of RBSM LLP as our <FONT STYLE="background-color: white">independent
auditor </FONT>for the fiscal year ending December 31, 2025<FONT STYLE="background-color: white">; and </FONT>(v) such other matters as
may come before the meeting. We are not currently aware of any such matters. In addition, following the meeting our management will report
on the Company&rsquo;s performance over the last fiscal year and respond to questions from stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: Why am I receiving these materials?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>The Board has made these materials available
to you over the internet at www.SXTP.vote, or has delivered printed versions of these materials to you by mail, in connection with the
Board&rsquo;s solicitation of proxies for use at the Annual Meeting. The Annual Meeting is scheduled to be held on Tuesday, October 8,
2025, at 12:00 p.m. Eastern Time, via live audio webcast via telephone. This solicitation by the Board is for proxies for use at the Annual
Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: Why did I receive a one-page notice in the
mail regarding the Internet availability of proxy materials this year instead of a full set of proxy materials?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>As permitted by SEC rules, we are making
this Proxy Statement and our Annual Report available to our stockholders electronically via the internet. On or about September 3, 2025,
we mailed to our stockholders the Internet Availability Notice containing instructions on how to access this proxy statement and our Annual
Report and vote online. If you received the Internet Availability Notice by mail you will not receive a printed copy of the proxy materials
in the mail unless you request a copy. The Internet Availability Notice instructs you on how to access and review all of the important
information contained in the Proxy Statement and Annual Report. The Internet Availability Notice also instructs you on how you may submit
your proxy by telephone. If you received the Internet Availability Notice by mail and would like to receive a printed copy of our proxy
materials, you should follow the instructions for requesting such materials contained on the Internet Availability Notice and note that
any requests to receive printed proxy materials must be requested no later than September 5, 2025. We encourage you to take advantage
of the availability of the proxy materials on the internet in order to help lower the costs of delivery and reduce the Company&rsquo;s
environmental impact.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: How do I obtain the materials for the Annual
Meeting?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>You should have received the Internet
Availability Notice in the mail of how to obtain materials for the Annual Meeting. Please follow the instructions on the Internet Availability
Notice to obtain the materials either via the internet, by telephone or by e-mail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may also view the following proxy materials
on the Company&rsquo;s website at <I>https://60degreespharma.com</I>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the Company&rsquo;s 2024 Annual Report; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the Company&rsquo;s 2025 Proxy Statement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may not vote on the Company&rsquo;s website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company urges you to request your materials
before September 5, 2025 so that you will receive them in a timely manner in order to vote at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: Who may attend the Annual Meeting?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>The Annual Meeting is open to all stockholders
of record as of close of business on August 26, 2025 (the &ldquo;Record Date&rdquo;), or their duly appointed proxies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: What will I need in order to attend the
Annual Meeting Online?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>You may attend the Annual Meeting via
the telephone, vote your shares and, after the meeting adjourns, ask a question during the Annual Meeting. On the day of the Annual Meeting,
you may attend the Annual Meeting by calling the telephone number provided and following the instructions to vote your shares. Please
have your Virtual Control Number with you while calling into the Annual Meeting. Further instructions on how to vote are set forth below
in the question &ldquo;<I>How do I vote at the Annual Meeting?</I>&rdquo; If you do not comply with the procedures outlined in this Proxy
Statement, you will not be admitted to the virtual Annual Meeting. Online access will begin on or around 11:45 A.m. Eastern Time on October
8, 2025, and we encourage you to access the meeting prior to the start time. The meeting audio webcast will begin promptly at 12:00 p.m.
Eastern Time on October 8, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: May stockholders ask questions?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>Yes. Representatives of the Company
will answer stockholders&rsquo; questions of general interest after the adjournment of the Annual Meeting. Depending upon the number of
persons asking questions, the Chairman of the meeting may limit the number of questions one person may ask in order to give a greater
number of stockholders an opportunity to ask questions. If you choose to attend the meeting over the telephone, you may request to ask
a question during the Annual Meeting. Questions will be answered as time allows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: Who may vote?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>You may vote if you owned 60 Degrees
Pharmaceuticals common stock as of the close of business on August 26, 2025. Each share of 60 Degrees Pharmaceuticals common stock is
entitled to one vote. As of the Record Date, the Company had 4,104,469&nbsp; shares of common stock outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: What am I voting on?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>You will be voting on the following
items of business at the Annual Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the election of five (5) directors to serve until the 2026 Annual Meeting of stockholders and until their respective successors are duly elected and qualified;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">to approve an amendment to the 2022 Plan to increase the number of shares of common stock available for issuance by 250,000 shares;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">to approve an amendment to our Certificate of Incorporation to effect a reverse stock split of our common stock at a reverse stock split ratio ranging from 1:3 to 1:10 inclusive, as determined by our Board in its sole discretion;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the ratification of the selection by our Board of RBSM LLP as our independent <FONT STYLE="background-color: white">auditor </FONT>for the fiscal year ending December 31, 2025;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; background-color: white">to approve adjourning the Annual Meeting, if necessary, to solicit additional proxies in the event there are not sufficient votes in favor of the Director Election Proposal, 2022 Plan Amendment Proposal, the Certificate of Incorporation Amendment Proposal at the time of the Annual Meeting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any other business that properly comes before the meeting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: How does the Board recommend that I vote?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>Our Board recommends that you vote your
shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;<B>FOR</B>&rdquo;<B>&nbsp;</B>each of the nominees named in this Proxy Statement for election to the Board;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;<B>FOR</B>&rdquo; the approval of an amendment to the 2022 Plan;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;<B>FOR</B>&rdquo; the approval of an amendment to our Certificate of Incorporation;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;<B>FOR</B>&rdquo;<B>&nbsp;</B>the ratification of the selection by our Board of RBSM LLP as our independent <FONT STYLE="background-color: white">auditor </FONT>for the fiscal year ending December 31, 2025;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;<B>FOR</B>&rdquo;<B>&nbsp;</B>the approval of the Adjournment Proposal; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">to provide authority for the persons named as proxies to vote on other matters that may come before the Annual Meeting in their discretion. The Board has made no recommendation as to how the proxies will vote with respect to other matters that may come before the meeting. Such proxies will vote on any other matter in their sole discretion.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: How do I vote at the Annual Meeting?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>You should have received the Internet
Availability Notice in the mail that described the methods of voting at the virtual Annual Meeting. Please refer to that notice to vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you received a paper proxy card, you may vote
by mail by returning the proxy card to the address on the enclosed envelope.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you wish to vote your shares electronically
at the Annual Meeting, you will need to call into the Annual Meeting while the polls are open (you will need the Virtual Control Number
included on your proxy card that was included with the proxy materials).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Record holders may cast their vote during the
meeting by calling to the virtual meeting with the Virtual Control Number, which is included in the Internet Availability Notice and then,
following the instructions while the polls are open during the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Beneficial holders will need to submit a legal
proxy no later than 5:00 p.m. Eastern Time on October 7, 2025 to Proxy@equitystock.com. The beneficial holder will then be issued a Virtual
Control Number, which can be used to enter the Annual Meeting and cast their vote while the polls are open during the annual meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, a record or beneficial shareholder
may call the number listed in the Notice of Internet Availability for the Annual Meeting without a Virtual Control Number if the shareholder
identifies themselves as a shareholder on the phone. The shareholder will not be able to cast a vote nor ask questions during the Q&amp;A
section using this method to join the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>If you encounter technical difficulties</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will have technicians ready to assist you with
any technical difficulties you may have in accessing the Annual Meeting live audio webcast. Please be sure to check in by 11:45 A.m. Eastern
time, on October 8, 2025, the day of the Annual Meeting, so that we may address any technical difficulties before the Annual Meeting live
audio webcast begins. If you encounter any difficulties accessing the Annual Meeting live audio webcast during the check-in or meeting
time, please email proxy@equitystock.com or call (877) 804-2062 (toll free).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company urges you to vote before October 7,
2025 to ensure that your vote is timely received and counted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: Can I change my mind after I vote?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>You may change your vote at any time
before the polls close at the Annual Meeting. You may do this by:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">signing another proxy card with a later date and returning it to us prior to the Annual Meeting; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">voting again by telephone during the virtual Annual Meeting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Your attendance at the Annual Meeting will not
have the effect of revoking a proxy unless you take any of the actions noted above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: Who will count the votes?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>Equity Stock Transfer, an independent
inspector who is not affiliated with the Company or any director, director nominee or officer of the Company, will count the votes and
will serve as the inspector of election.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: What if I return my proxy card but do not
provide voting instructions?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>If you vote by proxy card, your shares
will be voted as you instruct by the individuals named as proxies on the proxy card. If you sign and return a proxy card but do not specify
how your shares are to be voted, the persons named as proxies on the proxy card will vote your shares in accordance with the recommendations
of the Board. These recommendations are:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>FOR</B> the election of the five (5) nominees for director named in this Proxy Statement (Proposal 1);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>FOR </B>the approval of an amendment to the 2022 Plan (Proposal 2);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>FOR </B>the approval of an amendment to our Certificate of Incorporation (Proposal 3);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>FOR </B>the ratification of the selection by our Board of RBSM LLP as our independent auditor for the fiscal year ending December 31, 2025 (Proposal 4); </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>FOR</B> the <FONT STYLE="background-color: white">approval of the adjournment of the Annual Meeting, if necessary, to solicit additional proxies in the event there are not sufficient votes in favor of the Director Election Proposal, the 2022 Plan Amendment Proposal and the Certificate of Incorporation Amendment Proposal at the time of the Annual Meeting </FONT>(Proposal 5); and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">to provide authority for the persons named as proxies to vote on other matters that may come before the Annual Meeting in their discretion. The Board has made no recommendation as to how the proxies will vote with respect to other matters that may come before the meeting.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: What does it mean if I receive more than
one proxy card?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>It means that you have multiple accounts
with brokers and/or our transfer agent. Please vote all of these shares. We recommend that you contact your broker and/or our transfer
agent to consolidate as many accounts as possible under the same name and address. Our transfer agent is Equity Stock Transfer, LLC, which
may be reached at (212) 575-5757.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: Will my shares be voted if I do not provide
my proxy?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>Your shares may be voted if they are
held in the name of a brokerage firm, even if you do not provide the brokerage firm with voting instructions. Brokerage firms have the
authority under the rules of Nasdaq to vote shares for which their customers do not provide voting instructions on certain &ldquo;routine&rdquo;
matters. The proposal to ratify the selection of RBSM LLP as our independent auditor for fiscal year 2025 is considered a routine matter
for which brokerage firms may vote shares for which they have not received voting instructions. The other proposals to be voted on at
our Annual Meeting are not considered &ldquo;routine&rdquo; under applicable rules. When a proposal is not a routine matter and the brokerage
firm has not received voting instructions from the beneficial owner of the shares with respect to that proposal, the brokerage firm cannot
vote the shares on that proposal. This is called a &ldquo;broker non-vote.&rdquo; Abstentions and broker non-votes will have no effect
on the outcome of the vote on these proposals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: How many votes must be present to hold the
Annual Meeting?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>Your shares are counted as present at
the Annual Meeting if you attend the Annual Meeting online or if you properly return a proxy by telephone or mail. In order for us to
conduct our Annual Meeting, at least thirty-three and 34/100ths of the outstanding shares of stock, as of the Record Date, entitled to
vote must be present or represented by proxy at the Annual Meeting. This is referred to as a quorum. Abstentions and broker non-votes
will be counted for purposes of establishing a quorum at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: How many votes are needed to elect directors?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>You may vote &ldquo;FOR&rdquo; each
nominee or &ldquo;WITHHOLD&rdquo; to vote for each nominee. Unless you mark &ldquo;WITHHOLD&rdquo; with respect to a particular nominee
or nominees, your proxy will be voted &ldquo;FOR&rdquo; each of the director nominees named in this proxy statement. In an uncontested
election, a nominee will be elected as a director if the number of &ldquo;FOR&rdquo; votes exceeds the number of votes withholding authority.
In a contested election, a nominee will be elected director if he receives more votes than another nominee. Thus, the five (5) directors
with the most votes &ldquo;FOR&rdquo; will be elected to the Board. Broker non-votes and withheld votes will not affect the outcome of
the vote on directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: How many votes are needed to approve the
other proposals?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>The affirmative vote of a majority of
the voting power of the shares present in person or represented by proxy at the meeting and entitled to vote is required to approve the
election of the Board of Directors, an amendment to the Certificate of Incorporation, an amendment to the 2022 Plan, and ratify the appointment
of our independent registered public accounting firm and approve the adjournment of the Annual Meeting. Abstentions will be treated as
votes against these proposals. Brokerage firms have authority to vote customers&rsquo; unvoted shares held by the firms in street name
on the ratification of the appointment of our independent registered public accounting firm and approval of the adjournment of the Annual
Meeting. If a broker does not exercise this authority, such broker non-votes will have no effect on the results of this vote. Brokerage
firms do not have authority to vote customers&rsquo; unvoted shares held by the firms in street name on the approval of the election of
directors of the current Board of Directors, approval of an amendment to the 2022 Plan, approval of the amendment to the Certificate of
Incorporation and approval to obtain the approval of our stockholders to appoint our independent registered public accounting firm. However,
if our stockholders do not ratify the appointment of RBSM LLP as our independent registered public accounting firm for the fiscal year
ending December 31, 2025, the audit committee of our Board will reconsider its appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: Is voting confidential?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>We will keep all the proxies, ballots
and voting tabulations private. We only let our Inspectors of Election, representatives of Equity Stock Transfer, examine these documents.
Management will not know how you voted on a specific proposal unless it is necessary to meet legal requirements. We will, however, forward
to management any written comments you make on the proxy card or that you otherwise provide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: When will the Company announce the voting
results?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>The Company may announce preliminary
voting results after the adjournment of the Annual Meeting and will announce the final voting results of the Annual Meeting on a Current
Report on Form 8-K filed with the SEC within four business days after the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: Do any directors or officers of the Company
have a personal interest in the matter to be acted upon at the Annual Meeting?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>Except for those directors who are nominated
for election at the Annual Meeting, no officer or director has any substantial interest, direct or indirect, by security holdings or otherwise
in all proposals voted on in Proposal 2, Proposal 3 and Proposal 4 that is not shared by all other stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: What if other matters are presented for
consideration at the Annual Meeting?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>The Company knows of no other matters
to be submitted to the stockholders at the Annual Meeting, other than those described herein. If other matters do arise, the Board has
made no recommendation as to how the proxies will vote on such other matters. If any other matters properly come before the stockholders
at the Annual Meeting, it is the intention of the persons named on the proxy card as proxies to vote the shares represented thereby on
such matters in their discretion and in accordance with their best judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: Whom do I call if I have questions?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A: </B>If you have any questions, need additional
material, or need assistance in voting your shares, please feel free to contact InvestorComLLC at (877) 972-0090.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_002"></A><B>MATTERS REQUIRING STOCKHOLDER ACTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROPOSAL 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ELECTION OF DIRECTORS (Item 1 on the Proxy Card)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Nominees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are five (5) nominees recommended by the
Nominating and Corporate Governance Committee of the Board (the &ldquo;Nominating and Corporate Governance Committee&rdquo;) for election
this year to hold office until the 2025 Annual Meeting of the Stockholders and until their respective successors are elected and qualified.
Our Board has nominated: (i) Geoffrey Dow; (ii) Charles Allen; (iii) Cheryl Xu; (vi) Stephen Toovey; and (v) Paul Field and our management
has no reason to believe that any nominee will be unable to serve. Their biographies are provided at pages 9 to 10. The biographies of
each of the nominees contains information regarding the person&rsquo;s service as a director, business experience, public-company director
positions held currently or at any time during the last five years, information regarding involvement in certain legal or administrative
proceedings, if applicable, and the experiences, qualifications, attributes or skills that caused the Nominating and Corporate Governance
Committee and the Board to determine that the person should serve as a director for the Company. In addition to the information presented
above regarding each nominee&rsquo;s specific experience, qualifications, attributes and skills that led our Board to the conclusion that
he or she should serve as a director, we also believe that all of our director nominees have a reputation for integrity, honesty and adherence
to high ethical standards. They each have demonstrated business acumen and an ability to exercise sound judgment, as well as a commitment
of service to 60 Degrees Pharmaceuticals and our Board. Finally, we value their significant experience on other public company boards
of directors and board committees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A nominee will be elected as a director if he
receives a plurality of the votes cast, in person or by proxy, at the Annual Meeting. This means that the nominees for election as director
who receive the highest number of affirmative votes at the Annual Meeting will be elected as director. Withheld votes and broker non-votes
will have no effect on the outcome of the vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise instructed, the proxy holders
will vote the proxies received by them &ldquo;<B>FOR</B>&rdquo; each of the nominees named above. If any nominee becomes unavailable for
election as a result of an unexpected occurrence, shares that would have been voted for that nominee will instead be voted for the election
of a substitute nominee proposed by our Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The Board recommends that you vote &ldquo;FOR&rdquo;
the election of all of these nominees.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_003"></A><B>DIRECTORS AND EXECUTIVE OFFICERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth certain information
regarding our directors and executive officers:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 20%"><FONT STYLE="font-size: 10pt"><B>Name<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; width: 5%"><FONT STYLE="font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; width: 20%"><FONT STYLE="font-size: 10pt"><B>Position</B></FONT></TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; width: 11%"><FONT STYLE="font-size: 10pt"><B>Director<BR>
Since</B></FONT></TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; width: 40%"><FONT STYLE="font-size: 10pt"><B>Board Committee</B></FONT></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Geoffrey Dow</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">52</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Chief Executive Officer, President and Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">June 1, 2022</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">None</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Tyrone Miller</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">51</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">N/A</FONT></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Kristen Landon</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">58</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Chief Commercial Officer</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">N/A</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Charles Allen</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">49</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">July 12, 2023</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Audit &ndash; Chairman; Compensation; Nominating and Corporate Governance.</FONT></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Cheryl Xu</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">57</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">July 12, 2023</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">None</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Stephen Toovey</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">71</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">July 12, 2023</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Nominating and Corporate Governance &ndash; Chairman; Compensation; Audit. </FONT></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Paul Field</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">62</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">July 12, 2023</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Compensation &ndash; Chairman; Audit; Nominating and Corporate Governance.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Geoffrey Dow </I></B>is our Chief Executive
Officer, President, and is also one of our directors. Dr. Dow has over 20 years of product development experience in tropical diseases
and has an extensive publication and patent history. His decades of hands-on experience include 13 years in key leadership and advisory
roles in the antimalarial drug development program at the Walter Reed Army Institute of Research and at the U.S. Army Medical Materiel
Development Activity. Dr. Dow co-founded 60P in 2010. Since then, he has been involved in various projects, including leading the project
development team in securing FDA-regulatory approval for Tafenoquine (as Arakoda) for malaria prophylaxis, securing a supply chain and
access relating to Arakoda, managing post-marketing regulatory commitments, ensuring the successful prosecution of supporting patents
on which Dr. Dow was an inventor, and ensuring the company adheres to GMP, quality, and pharmacovigilance requirements. Dr. Dow has also
published a number of important safety reviews, clinical trials, non-clinical studies, on which he was a thought leader or contributor,
which dispelled many of the myths about 8-aminoquinolines. As a scientist, experienced industry project manager and inventor, Dr. Dow&rsquo;s
ultimate goal is to develop and secure the regulatory approval and commercial success of products, old and new, for new indications in
infectious disease. Dr. Dow received a B.Sc. (Hons) in Veterinary and Biomedical Science from Murdoch University, Perth, Western Australia
(&ldquo;Murdoch&rdquo;) in 1994, a Ph.D. in Veterinary and Biomedical Science from Murdoch in 2000 and an MBA from the University of Maryland
at College Park in 2012. We believe that Mr. Dow is well qualified to serve as a Director given his product development experience in
tropical diseases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Tyrone Miller </I></B>is our Chief Financial
Officer. Mr. Miller joined us in 2014 and has held a number of roles since then, including Treasurer. He worked with the founder and Chief
Executive Officer of 60P and raised over $6 million in external financing. Mr. Miller also established a multinational financial reporting
system and worked with consultants in designing tax and credit strategies. He also provides key strategic advice in areas of financing
and business planning to 60P. In addition, he is the founder and Principal of Tax &amp; Accounting Practice at Miller Tax &amp; Advisory
since 2011. In that role, Mr. Miller advises owners of closely held businesses on accounting, financial and tax matters and has designed
accounting systems for private sector businesses. From 2002 to 2011, he was a Senior Accountant at Sachs Figurelli, LLC, where he prepared
and processed corporate and individual tax returns, consulted on reengineering accounting processes for construction, restaurant and professional
services businesses and managed staff in preparation and processing of payroll and personal property returns. Mr. Miller is currently
a Certified Public Accountant. He received a Bachelor&rsquo;s of Business Administration with a concentration in International Business
from Emory University in 1996.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Kristen Landon </I></B>is our Chief Commercial
Officer. Ms. Landon joined us in 2024 and brings over 26 years&rsquo; experience building and transforming pharmaceutical brands in both
start-up and large multinational companies. Ms. Landon has launched and relaunched over a dozen brands, many with peak revenues in excess
of $100 million across therapeutic categories including women&rsquo;s health, infectious disease, dermatology, nephrology, and hematology/oncology.
Most recently, Ms. Landon served as Senior Vice President of Marketing and Communications at TherapeuticsMD with responsibility for the
branded portfolio, marketing insights, and corporate communications. Prior commercial leadership roles include VP Marketing at Radius
Health, VP Marketing at Sprout Pharmaceuticals (acquired by Valeant), Executive Director Women&rsquo;s Health at Actavis Plc, and positions
of increasing responsibility in sales and marketing at Forest Labs, Abbott Labs, and Novartis. Ms. Landon holds an MBA from Silberman
College of Business at Fairleigh Dickinson University, and a Bachelor&rsquo;s degree from Kean University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Charles Allen </I></B>is one of our directors
since July 11, 2023 and since February 5, 2014 has served as the Chief Executive Officer of BTCS Inc. (&ldquo;BTCS&rdquo;) and the Chairman
of the Board of BTCS since September 11, 2014. Mr. Allen is responsible for BTCS&rsquo; overall corporate strategy and direction. Since
December 2, 2022, Mr. Allen has been a director of Innovation1 Biotech Inc. Since January 12, 2018, Mr. Allen has been the Chief Executive
Officer of Global Bit Ventures Inc. (&ldquo;GBV&rdquo;). Since October 10, 2017, Mr. Allen has been a director of GBV. Mr. Allen has extensive
experience in business strategy and structuring and executing a variety of investment banking and capital markets transactions, including
financings, initial public offerings, and mergers and acquisitions. Prior to his work in the blockchain industry at BTCS, he worked domestically
and internationally on projects in technology, media, natural resources, logistics, medical services, and financial services. He has served
as a managing director at numerous boutique investment banks focused on advising and raising capital for small and mid-size companies.
Mr. Allen received a Bachelor of Science in Mechanical Engineering from Lehigh University and a Master of Business Administration from
the Mason School of Business at the College of William &amp; Mary. The Board concluded that Mr. Allen&rsquo;s background and leadership
experiences in the financial industry qualify him to be a member of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Cheryl Xu</I></B> is one of our directors
since July 11, 2023 and until recently served as Biogen&rsquo;s Vice President, Public Policy &amp; Government Affairs since 2020. Ms.
Xu was PhRMA&rsquo;s first Representative to China. Subsequently she started a consulting business in 2005, advising well-known multinational
companies such as Pfizer, J&amp;J and UnitedHealth Group on their market access and expansion strategies in China. Cheryl has provided
consultations to both the U.S. and Chinese governments on pharmaceutical policies including strengthening of IP protection and monitoring
system for China&rsquo;s API exports. Prior to that, she was the Director of International Finance at Pharmacia based in New Jersey from
1998 to 2003. Ms. Xu received her Bachelor of Science degree in Physics from Peking University, and Master of Business Administration
in Finance from Washington University in St. Louis. The Board concluded that Ms. Xu&rsquo;s background and leadership experiences in the
pharmaceutical industry qualify her to be a member of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Dr. Stephen Toovey</I></B> is one of our
directors since July 11, 2023 and is an infectious and tropical disease physician. Dr. Toovey has worked in the pharmaceutical industry
and academia in both developed and developing countries, and currently specializes in the research of influenza and other respiratory
viruses, malaria, rabies and the neurological aspects of infectious diseases. He is currently the Chief Executive Officer of Pegasus,
a medical and scientific services company and has held that position since 2008. Dr. Toovey also advises a number of pharmaceutical companies
and biotech organizations on infection and immunology related matters, from translation through Phase IV, and founded numerous pharmaceutical
and pharma-related companies, with the most recent being the co-founding of Ark Biosciences in 2014. Dr. Toovey served as Chief Medical
Officer of Ark Biosciences from 2014 until 2020. In addition, he held a teaching and clinical post at the Royal Free and University College
Medical School in London, United Kingdom, Academic Centre for Travel Medicine and Vaccines, World Health Organization Collaborating Center,
appointed in 2008. He has been editor of the journal Travel Medicine and Infectious Disease since its foundation in 2003. Dr. Toovey has
authored over 100 publications in peer reviewed medical journals, contributed to a number of textbooks and has presented at over 50 scientific
meetings. Dr. Toovey received his PhD from the University of Ghent. The Board concluded that Dr. Toovey&rsquo;s background and leadership
experiences in the pharmaceutical industry and academia qualify him to be a member of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Paul Field</I></B> is one of our directors
since July 11, 2023. Paul has over 30 years of business development experience across a range of disease areas, and a deep network in
the global biopharmaceutical industry. He is currently a corporate advisor at Imunexus since 2020, Marinova since 2018, and GARDP (Switzerland)
since 2018. He was until recently the Australian representative of FIND (Switzerland) from 2018 to 2021 and a business development advisor
to the drug discovery company Biocurate from 2018 to 2020. Paul was previously the life sciences specialist at Austrade from 2014 to 2018,
the Australian Government&rsquo;s investment promotion agency, where he facilitated foreign direct investment into Australian research
in neglected tropical diseases, infectious diseases, autoimmune diseases, cancer and other therapeutic areas. Paul was the founder and
Executive Chairman of Bio-Link from 2005 to 2014, a privately owned biotechnology business development company. His work at Bio-Link involved
the commercialization of discovery, pre-clinical and early-stage clinical programs undertaken by Australian biotech companies and medical
research institutions. Paul has served on a number of Boards of Directors, and he is a Fellow of the Australian Institute of Company Directors.
The Board concluded that Mr. Field&rsquo;s background and leadership experiences in the biotechnology industry qualify him to be a member
of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Family Relationships</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no family relationships among any of
our executive officers or directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Legal Proceedings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the best of our knowledge, none of our directors
or executive officers have, during the past ten years, been involved in any legal proceedings described in subparagraph (f) of Item 401
of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_004"></A>CORPORATE GOVERNANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The business and affairs of 60 Degrees Pharmaceuticals
are managed under the direction of the Board. The Board believes that good corporate governance is a critical factor in achieving business
success and in fulfilling the Board&rsquo;s responsibilities to the Company&rsquo;s stockholders. The Board believes that its practices
align management and stockholder interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Governance section of the Company website
makes available the Company&rsquo;s corporate governance materials, including the Certificate of Incorporation, as corrected, as of the
date of this Proxy Statement, and bylaws, the charters for each Board committee, the Company&rsquo;s Code of Conduct and information about
how to report concerns about the Company. To access these documents on the Company&rsquo;s website, please visit <I>https://60degreespharma.com</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Board Composition/Election </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board presently consists of five (5) directors
whose terms expire at this Annual Meeting. Our directors are elected annually. All of the current directors have served on the Board since
the effective date of the Company&rsquo;s registration statement for its initial public offering in July 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board has fixed the number of directors at
five (5).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As discussed in more detail later in this section,
the Board has determined that three (3) of the five (5) individuals standing for election are independent under the rules of Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Board Meetings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board met a total of five times during fiscal
year 2024 in person or via video or teleconference and acted by unanimous written consent on fourteen occasions. Each of the directors
who served fiscal year 2024 attended all meetings of the Board. Attendance for meetings of the Board committees was at least 67% during
fiscal year 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Selection of Nominees for The Board of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nominating and Corporate Governance Committee
considers candidates for Board membership suggested by its members and other Board members, as well as management and stockholders. The
Nominating and Corporate Governance Committee&rsquo;s charter provides that it may retain a third-party executive search firm to identify
candidates from time to time. Our Board seeks members from diverse professional backgrounds who combine a broad spectrum of experience
and expertise with a reputation for integrity. Directors should have experience in positions with a high degree of responsibility, be
leaders in the companies or institutions with which they are affiliated and are selected based upon contributions they can make to the
Board and management. The Nominating and Corporate Governance Committee&rsquo;s assessment of a proposed candidate may include a review
of the person&rsquo;s judgment, experience, independence, understanding of the Company&rsquo;s business or other related industries and
such other factors as the Nominating and Corporate Governance Committee determines are relevant in light of the needs of the Board. The
Nominating and Corporate Governance Committee believes that its nominees should reflect a diversity of experience, gender, race, ethnicity
and age. The Board does not have a specific policy regarding director diversity. The Nominating and Corporate Governance Committee also
considers such other relevant factors as it deems appropriate, including the current composition of the Board, the balance of management
and independent directors, and the evaluations of other prospective nominees, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with this evaluation, it is expected
that each member of the Nominating and Corporate Governance Committee will interview the prospective nominee before the prospective nominee
is presented to the full Board for consideration. After completing this evaluation and interview process, the Nominating and Corporate
Governance Committee will make a recommendation to the full Board as to the person(s) who should be nominated by the Board, and the Board
determines the nominee(s) after considering the recommendation and report of the Nominating and Corporate Governance Committee. We look
for director candidates who have the skills and experience necessary to help us achieve success within our industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that each of our directors has the
necessary qualifications to be a value-added member of our Board. As noted in the director biographies, our directors have experience,
qualifications and skills across a wide range of public and private companies, possessing a broad spectrum of experience both individually
and collectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no arrangements or understanding between
any of the directors or the director nominee or officers of our Company or any other person pursuant to which any officer or director
or director nominee was or is to be selected as an officer or director or director nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Stockholder Nominations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For nominations or other business to be properly
brought before an annual meeting by a stockholder, the stockholder must have given timely notice thereof in writing to the Nominating
and Corporate Governance Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To be timely, a stockholder&rsquo;s notice shall
be delivered to the Chief Financial Officer at the principal executive offices of the Company not later than the close of business on
the ninetieth (90<SUP>th</SUP>) day nor earlier than the close of business on the one hundred twentieth (120<SUP>th</SUP>) day prior to
the first anniversary of the preceding year&rsquo;s annual meeting; provided, however, that in the event that the date of the annual meeting
is advanced more than thirty (30) days prior to or delayed by more than thirty (30) days after the anniversary of the preceding year&rsquo;s
annual meeting, notice by the stockholder to be timely must be so delivered not earlier than the close of business on the one hundred
twentieth (120<SUP>th</SUP>) day prior to such annual meeting and not later than the close of business on the later of the ninetieth (90<SUP>th</SUP>)
day prior to such annual meeting or the tenth (10<SUP>th</SUP>) day following the day on which public announcement of the date of such
meeting is first made. In no event shall the public announcement of an adjournment of an annual meeting commence a new time period for
the giving of a stockholder&rsquo;s notice as described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Such stockholder&rsquo;s notice shall set forth:
(A) as to each person whom the stockholder proposed to nominate for election or reelection as a director all information relating to such
person that is required to be disclosed in solicitations of proxies for election of directors in an election contest, or is otherwise
required, in each case pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;),
and Rule 14a-4(d) thereunder (including such person&rsquo;s written consent to being named in the proxy statement as a nominee and to
serving as a director if elected); (B) as to the stockholder giving the notice and the beneficial owner, if any, on whose behalf the nomination
is made: (i) the name and address of such stockholder, as they appear on the Company&rsquo;s books, and of such beneficial owner, (ii)
the class and number of shares of the Company that are owned beneficially and of record by such stockholder and such beneficial owner
and (iii) whether either such stockholder or beneficial owner intends to deliver a proxy statement and form of proxy to holders of, in
the case of the proposal, at least the percentage of the Company&rsquo;s voting shares required under applicable law to carry the proposal
or, in the case of a nomination or nominations, a sufficient number of holders of the Company&rsquo;s voting shares to elect such nominee
or nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nominations and the solicitation notice should
be sent to the Nominating and Corporate Governance Committee, 60 Degrees Pharmaceuticals, Inc., 1025 Connecticut Avenue NW Suite 1000,
Washington, D.C. 20036.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date of this Proxy Statement, we have
not received timely notice of any nomination by a stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Nominees for Director</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nominating and Corporate Governance Committee
recommended to the Board and the Board nominated Mr. Dow, Mr. Allen, Ms. Xu, Mr. Toovey and Mr. Field to stand for election for the five
(5) Board seats. Each such individual has consented to serve if elected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If elected, we expect that all of the aforementioned
nominees will serve as directors and hold office until the 2026 Annual Meeting of Stockholders and until their respective successors have
been elected and qualified or until their death, retirement or resignation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Ethical Guidelines</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">60 Degrees Pharmaceuticals&rsquo; code of business
conduct and ethics (&ldquo;Code&rdquo;) was adopted to emphasize the Company&rsquo;s commitment to the highest standards of business conduct.
The Code applies to our directors, officers and employees, including our principal executive officer, principal financial officer and
principal accounting officer or controller, or persons performing similar functions. The Code is available on our corporate website at
<I>https://investors.60degreespharma.com/corporate-governance/governance-overview</I>. The Code requires compliance with applicable law,
discusses how conflicts of interest are handled, requires familiarity with the Company&rsquo;s disclosure requirements and provides for
waivers under certain circumstances. We intend to disclose any amendments to our code of business conduct and ethics, or waivers of its
requirements, on our website or in filings under the Exchange Act to the extent required by applicable rules and exchange requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Board Leadership</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nominating and Corporate Governance Committee
annually reviews the Board&rsquo;s leadership structure and evaluates the performance and effectiveness of the Board. The Board retains
the authority to modify its leadership structure in order to stay current with our Company&rsquo;s circumstances and advance the best
interests of the Company and its stockholders as and when appropriate. The Board&rsquo;s annual self-evaluation includes questions regarding
the Board&rsquo;s opportunities for open communication and the effectiveness of executive sessions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Corporate Governance Policies and Practices</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Director Independence</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board undertakes an annual review of director
independence. During this review, the Board considers transactions and relationships between each director or any member of his or her
immediate family and the Company and its subsidiaries and affiliates. The purpose of this review is to determine whether any such relationships
or transactions were inconsistent with a determination that the director is independent. As a result of this review, the Board affirmatively
determined that three (3) of the five (5) of the directors are independent of the Company and its management under Nasdaq rules. Geoffrey
Dow and Cheryl Xu are not considered independent because of their employment by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In determining that the other directors did not
have a material relationship with the Company, the Board concluded that Messrs. Allen, Toovey and Field had no other relationship with
the Company other than their relationship as a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Board Committee Charters</U>. The Audit Committee,
the Compensation Committee and the Nominating and Corporate Governance Committee of the Board operate pursuant to written charters. These
charters were approved by the Board and reflect certain best practices in corporate governance. These charters comply with the requirements
of the Nasdaq. Each charter is available on the Company&rsquo;s website at: <I>https://investors.60degreespharma.com/corporate-governance/governance-overview</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Private Executive Sessions</U>. Our non-management
directors meet in executive session at each regular Board meeting. The executive sessions are attended only by the non-management directors.
Our independent directors meet in executive sessions at least once per year and met once in 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Advance Materials</U>. Information and data
important to the directors&rsquo; understanding of the business or matters to be considered at a Board or Board committee meeting are,
to the extent practical, distributed to the directors sufficiently in advance of the meeting to allow careful review prior to the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Board Access</U>. The Board has access to management
and outside advisers as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><I><U>Access to Management and Employees</U></I>. Directors have full and unrestricted access to the management and employees of the Company. Additionally, key members of management attend Board meetings to present information about the results, plans and operations of the business within their areas of responsibility.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><I><U>Access to Outside Advisors</U></I>. The Board and its committees may retain counsel or consultants without obtaining the approval of any officer of the Company in advance or otherwise. The Audit Committee has the sole authority to retain and terminate the independent auditor. The Nominating and Corporate Governance Committee has the sole authority to retain search firms to be used to identify director candidates.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>The Board&rsquo;s Role In Risk Oversight</U>.
The Board maintains overall responsibility for overseeing the Company&rsquo;s risk management, including succession planning, product
safety and information and digital security. In furtherance of its responsibility, the Board has delegated specific risk-related responsibilities
to the Audit Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee engages in substantive discussions
of risk management at its regular committee meetings held during the year. At these meetings, it receives functional risk review reports
covering significant areas of risk from the employees responsible for these functional areas, as well as receiving reports from the Chief
Financial Officer who reports directly to the Chairperson of the Audit Committee. The Audit Committee also receives reports at each meeting
regarding legal and regulatory risks from management and meets in separate executive sessions with our independent auditors and our Chief
Financial Officer. The Audit Committee provides a summary to the full Board at certain Board meetings of the risk area reviewed together
with any other risk related subjects discussed at the Audit Committee meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>The Board&rsquo;s Role In Information Security</U>.
Information security and privacy has been and remains of the utmost importance to the Company in light of the value we place on maintaining
the trust and confidence of our customers, employees and other stakeholders. Accordingly, our Chief Executive Officer and President advises
the Audit Committee and the full Board at least once per year on our program for managing information security risks, including data privacy
and data protection risks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Access To The Board By Stockholders</U>. Stockholders
and other parties interested in communicating directly with individual directors, the non-management directors as a group or the entire
Board may do so by writing to the Nominating and Corporate Governance Committee, c/o Nominating and Corporate Governance Committee Chairman,
60 Degrees Pharmaceuticals, Inc., 1025 Connecticut Avenue NW Suite 1000, Washington, D.C. 20036.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nominating and Corporate Governance Committee
has approved a process for handling letters received by the Company and addressed to individual directors, non-management members of the
Board or the Board. Under that process, the Chief Executive Officer and President of the Company reviews all such correspondence and regularly
forwards to a designated individual member of the Nominating and Corporate Governance Committee copies of all such correspondence (although
we do not forward commercial correspondence and correspondence duplicative in nature; however, we will retain duplicate correspondence
and all duplicate correspondence will be available for directors&rsquo; review upon their request) and a summary of all such correspondence.
The Chairman of the Nominating and Corporate Governance Committee will forward correspondence directed to individual directors as he deems
appropriate. Written correspondence from stockholders relating to accounting, internal controls or auditing matters are immediately brought
to the attention of the Company&rsquo;s Audit Committee Chairman and handled in accordance with procedures established by the Audit Committee
with respect to such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Board Committees</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors has a standing Audit Committee,
Compensation Committee and Nominating and Corporate Governance Committee. The following table summarizes the members and functions of
the Board&rsquo;s committees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">Stephen Toovey</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 5%"><FONT STYLE="font-size: 10pt">71</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 20%"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 11%"><FONT STYLE="font-size: 10pt">2021</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 40%"><FONT STYLE="font-size: 10pt">Nominating and Governance &ndash; Chairman; Audit; Nominating and Corporate Governance.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Charles Allen</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">49</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">2021</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Audit &ndash; Chairman; Compensation; Nominating and Corporate Governance.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Paul Field</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">62</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">2021</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Compensation &ndash; Chairman; Compensation; Audit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 10pt"><B>Name of Committee and<BR> Its Members</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Functions of the Committee</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="24" STYLE="width: 30%"><I>Audit Committee:</I><BR> <BR> Charles Allen,<BR> Chairman; <BR> Stephen Toovey; <BR> Paul Field.</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 3%"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify; width: 65%"><FONT STYLE="font-size: 10pt">reviewing and discussing with management and the independent auditor the annual audited financial statements, and recommending to the Board whether the audited financial statements should be included in our annual disclosure report;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">discussing with management and the independent auditor significant financial reporting issues and judgments made in connection with the preparation of our financial statements;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">discussing with management major risk assessment and risk management policies;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">monitoring the independence of the independent auditor;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">reviewing and approving all related-party transactions;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">inquiring and discussing with management our compliance with applicable laws and regulations;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">pre-approving all audit services and permitted non-audit services to be performed by our independent auditor, including the fees and terms of the services to be performed;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">appointing or replacing the independent auditor;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">determining the compensation and oversight of the work of the independent auditor (including resolution of disagreements between management and the independent auditor regarding financial reporting) for the purpose of preparing or issuing an audit report or related work;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">approving reimbursement of expenses incurred by our management team in identifying potential target businesses.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="7"><I>Compensation Committee:</I><BR> <BR> Paul Field,<BR> Chairman; <BR> Charles Allen; <BR> Stephen Toovey</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">reviewing, approving and determining or making recommendations to our Board regarding the compensation of our executive officers;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">administering our equity compensation plans;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">reviewing and approving, or makings recommendations to our Board regarding incentive compensation and equity compensation plans; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">establishing and reviewing general policies relating to compensation and benefits of our employees.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="7"><I>Nominating and Corporate Governance Committee</I><BR> <BR> Stephen Toovey,<BR> Chairman;<BR> Charles Allen;<BR> Paul Field</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">identifying, reviewing and evaluating candidates to serve on our Board consistent with criteria approved by our Board;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">evaluating director performance on our Board and applicable committees of our Board and determining whether continued service on our Board is appropriate;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">evaluating nominations by stockholders of candidates for election to our Board; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">corporate governance matters.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_005"></A>AUDIT COMMITTEE REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The Audit Committee: </I>The members of the
Audit Committee (for purposes of this report, the &ldquo;Committee&rdquo;) are Messrs. Charles Allen, who serves as Chairman, Stephen
Toovey and Paul Field. The Board has determined that all of the members of the Committee are independent within the meaning of applicable
SEC regulations and the listing standards of the Nasdaq and that Mr. Allen, the Chair of the Committee, is qualified as an audit committee
financial expert within the meaning of SEC regulations. The Board has also determined that Mr. Allen has accounting and related financial
management expertise within the meaning of the listing standards of the Nasdaq and that each member of the Committee is financially literate
within the meaning of the Nasdaq listing standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Audit Committee Charter:</I> The Audit Committee
operates under a written charter adopted by the Board. The charter is reviewed by management at least annually, and any recommended changes
are presented to the Committee for review and approval. The charter is available on our website at: <I>https://investors.60degreespharma.com/corporate-governance/governance-overview</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Audit Committee Responsibilities: </I>The Committee
assists the Board in fulfilling its responsibilities for general oversight of the integrity of the Company&rsquo;s financial statements,
the adequacy of the Company&rsquo;s system of internal controls and procedures and disclosure controls and procedures, the Company&rsquo;s
risk management, the Company&rsquo;s compliance with legal and regulatory requirements, the independent auditors&rsquo; qualifications
and independence and the performance of the Company&rsquo;s internal audit function and independent auditors. The Committee has the authority
to obtain advice and assistance from outside legal, accounting or other advisors as the Committee deems necessary to carry out its duties
and receive appropriate funding, as determined by the Committee, from the Company for such advice and assistance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Committee has sole authority over the selection
of the Company&rsquo;s independent auditors and manages the Company&rsquo;s relationship with its independent auditors (who report directly
to the Committee). Each year, the Committee evaluates the performance, qualifications and independence of the independent auditors. The
Committee is also involved in the selection of the lead audit partner. In evaluating the Company&rsquo;s independent auditors, the Committee
considers the quality of the services provided, as well as the independent auditors&rsquo; and lead partner&rsquo;s capabilities and technical
expertise and knowledge of the Company&rsquo;s operations and industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Committee met four times during the fiscal
year ended 2024. The Committee schedules its meetings with a view to ensuring that it devotes appropriate attention to all of its tasks.
The Committee&rsquo;s meetings generally include private sessions with the Company&rsquo;s independent auditors and with the Company&rsquo;s
internal auditors, in each case without the presence of the Company&rsquo;s management, as well as executive sessions consisting of only
Committee members. In addition to the scheduled meetings, senior management confers with the Committee or its Chair from time to time,
as senior management deems advisable or appropriate, in connection with issues or concerns that arise throughout the year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management is responsible for the Company&rsquo;s
financial reporting process, including its system of internal control over financial reporting, and for the preparation of consolidated
financial statements in accordance with accounting principles generally accepted in the United States. The Company&rsquo;s independent
auditors are responsible for auditing those financial statements in accordance with professional standards and expressing an opinion as
to their material conformity with U.S. generally accepted accounting principles and for auditing the effectiveness of the Company&rsquo;s
internal control over financial reporting. The Committee&rsquo;s responsibility is to monitor and review the Company&rsquo;s financial
reporting process and discuss management&rsquo;s report on the Company&rsquo;s internal control over financial reporting. It is not the
Committee&rsquo;s duty or responsibility to conduct audits or accounting reviews or procedures. The Committee has relied, without independent
verification, on management&rsquo;s representations that the financial statements have been prepared with integrity and objectivity and
in conformity with accounting principles generally accepted in the U.S. and that the Company&rsquo;s internal control over financial reporting
is effective. The Committee has also relied, without independent verification, on the opinion of the independent auditors included in
their report regarding the Company&rsquo;s financial statements and effectiveness of internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Oversight Matters: </I>As part of its oversight
of the Company&rsquo;s financial statements, the Committee reviews and discusses with both management and the Company&rsquo;s independent
auditors all annual and quarterly financial statements prior to their issuance. With respect to each 2024 fiscal reporting period, management
advised the Committee that each set of financial statements reviewed had been prepared in accordance with accounting principles generally
accepted in the U.S., and reviewed significant accounting and disclosure issues with the Committee. These reviews included discussions
with the independent auditors of matters required to be discussed pursuant to Public Company Accounting Oversight Board (&ldquo;PCAOB&rdquo;)
Auditing Standard No. 1301 (Communication with Audit Committees), including the quality (not merely the acceptability) of the Company&rsquo;s
accounting principles, the reasonableness of significant judgments, the clarity of disclosures in the financial statements and disclosures
related to critical accounting practices. The Committee has also discussed with RBSM matters relating to their respective independence,
including a review of audit and non-audit fees and the written disclosures and letter received from RBSM required by applicable requirements
of the Public Company Accounting Oversight Board (&ldquo;PCAOB&rdquo;) regarding their respective communications with the Committee concerning
independence. The Committee also considered whether non-audit services provided by the independent auditors are compatible with the independent
auditors&rsquo; independence. The Committee also received regular updates, and written summaries as required by the PCAOB rules (for tax
and other services), on the amount of fees and scope of audit, audit-related, tax and other services provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Committee reviewed key initiatives
and programs aimed at strengthening the effectiveness of the Company&rsquo;s internal and disclosure control structure. As part of this
process, the Committee continued to monitor the scope and adequacy of the Company&rsquo;s internal auditing program, reviewing staffing
levels and steps taken to implement recommended improvements in internal procedures and controls. The Committee also reviews and discusses
legal and compliance matters with management, and, as necessary or advisable, the Company&rsquo;s independent auditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Audit Committee Recommendation</I>: Based on
the Committee&rsquo;s discussions with management and the independent auditors and the Committee&rsquo;s review of the representations
of management and the report of the independent auditors to the Board and stockholders, and subject to the limitations on the Committee&rsquo;s
role and responsibilities referred to above and in the Audit Committee Charter, the Committee recommended to the Board that it include
the audited consolidated financial statements in the Company&rsquo;s Annual Report on Form 10-K for the fiscal year ended December 31,
2024 for filing with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>This report has been furnished by the members
of the Audit Committee:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Charles Allen, Chairman</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stephen Toovey</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Paul Field</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_006"></A><B>DIRECTOR COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee establishes and reevaluates
if it deems necessary or prudent in its discretion, the cash and equity awards (amount and manner or method of payment) to be made to
non-employee directors for such fiscal year. In making this determination, the Compensation Committee may utilize such market standard
metrics as it deems appropriate, including, without limitation, an analysis of cash compensation paid to our peer group&rsquo;s independent
directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee has the power and discretion
to determine in the future whether non-employee directors should receive annual or other grants of options to purchase shares of common
stock or other equity incentive awards in such amounts and under such policies as the Compensation Committee may determine utilizing such
market standard metrics as it deems appropriate, including, without limitation, an analysis of equity awards granted to independent directors
of our peer group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table illustrates the compensation
paid by the Company to its directors. The disclosure is provided for the fiscal year ended December 31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Director Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>As of December 31,
2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fees Earned or Paid in Cash<BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock <BR> Awards<BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Option Awards<BR> ($)<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-Equity Incentive Plan Compensation ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">All Other Compensation ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; text-align: left">Charles Allen</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">73,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">912</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">73,912</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: left">Cheryl Xu</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">912</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,912</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stephen Toovey</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">70,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">912</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">70,912</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: left">Paul Field</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">70,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">912</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">70,912</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Represents the aggregate grant date fair value of options granted during the fiscal year, computed in accordance with FASB ASC Topic 718.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_007"></A>EXECUTIVE COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table illustrates the compensation
packages of the Company&rsquo;s executive officers. The disclosure is provided for the fiscal years ended December 31, 2024 and 2023.
We refer to these individuals as our &ldquo;named executive officers&rdquo;:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Summary Compensation
Table</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name and Principal Position</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Base Salary<BR> ($)<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cash Bonus <BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock Bonus <BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Option Award<BR> ($)<SUP>(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Total</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($)</B></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 32%; text-align: left">Geoffrey Dow</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 7%; text-align: center">2024</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">228,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">20,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">24,175</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">51,250</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">323,425</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9.25pt">President and Chief Executive Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125,555</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125,555</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9.25pt">(Principal Executive Officer)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">54,510</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">54,510</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Tyrone Miller</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">204,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">19,525</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">41,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">284,525</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; padding-left: 9.25pt">Chief Financial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">135,632</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">135,632</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; padding-left: 9.25pt">(Principal Financial and Accounting Officer)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">148,672</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">148,672</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Kristen Landon</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">300,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">113,570</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">38,125</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">19,167</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">470,862</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9.25pt">Chief Commercial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">We periodically review, and may increase, base salaries in accordance with our normal annual compensation review for each of our named executive officers.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><U>Equity Awards</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On July 12, 2023, Dr.
Dow was granted a five-year option to purchase a total of 250 shares of our common stock on the last day of each quarter in each calendar
year (for a cumulative total or no more than 5,000 shares over five years) and (ii) Mr. Miller was granted a five-year option to purchase
a total of 200 shares of our common stock on the last day of each quarter in each calendar year (for a cumulative total or no more than
4,000 shares over five years). The per share exercise price of the options were initially equal to the per share closing price of our
common stock on the date of grant and had a cashless exercise provision. In November 2023, the Board reset the exercise price of the options
to be equal to $60.00 and modified the vesting provisions of the option to vest annually over five years, rather than quarterly, with
the first vesting date being December 31, 2024. The initial grant and subsequent&#8239;amendment of these options was contingent upon
the stockholders of the Company approving the amendment to the exercise price of the options and approving the amendment to the 2022 Plan
to increase the number of shares available under the 2022 Plan in order to comply with Listing Rule 5635(c) of The Nasdaq Stock Market
LLC. On July 16, 2024, the Company&rsquo;s stockholders approved the proposal to increase the number of shares available under the 2022
Plan. As of that date, Dr. Dow and Mr. Miller&rsquo;s option grants, as subsequently amended, were considered effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In February 2024, subject
to and contingent upon the stockholders of the Company approving the amendment to the 2022 Plan to increase the number of shares available
under the 2022 Plan, we granted Ms. Landon a five-year option to purchase a total of 4,167 shares of our common stock with a per share
exercise price to be determined by the Board on the date of grant. The options had a cashless exercise price and vest annually over five
years, with the first vesting date being December 31, 3024. On September 26, 2024, the Board approved the grant of the options to Ms.
Landon at a per share exercise price of $6.85.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In December 2024, the
Board approved the grant of 105,000 options to Dr. Dow and 15,000 options to Mr. Miller as equity-based long-term incentive awards, which
vest in five equal tranches on the last date of each fiscal year over five years, with the first vesting date being December 31, 2024.
The options were granted on January 2, 2025 with a per share exercise price of $6.55, the closing stock price on the grant date, and have
a seven-year term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><U>Employment Agreements</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Dow Employment
Agreement.</I></B> We entered into an Employment Agreement dated as of January 12, 2023, with Geoffrey Dow (the &ldquo;Dow Employment
Agreement&rdquo;), our Chief Executive Officer and Chairman of our Board. The term of the Dow Employment Agreement began on January 12,
2023 for an initial period of two years, with subsequent automatic renewals unless either party thereto provides notice to terminate at
least 90 days prior to the applicable renewal date. The Dow Employment Agreement provides Dr. Dow an annual base salary of $228,000, bonuses
to the extent certain events occur or if applicable performance goals are met and employee benefits that are generally given to our senior
executives. In December 2024, the Board approved an increase to Dr. Dow&rsquo;s base salary to $250,000 beginning in fiscal year 2025.
Contingent on the receipt of shareholder approval to increase the number of shares available under the 2022 Plan, Dr. Dow was granted
a five-year option to purchase a total of 250 shares of our common stock that vest on the last day of each quarter in each calendar year
(for a cumulative total or no more than 5,000 shares over five years). The per share exercise price of the option was initially equal
to the per share closing price of our common stock on the date of the initial public offering and shall have a cashless exercise provision.<B><I>&nbsp;</I></B>In
November 2023, the Board reset the exercise price of the option to be equal to $60.00 and modified the vesting provisions of the option
to vest annually over five years, rather than quarterly, with the first vesting date being December 31, 2024. The initial grant and subsequent
amendment of Dr. Dow&rsquo;s options was contingent upon the stockholders of the Company approving the amendment to the exercise price
of the options and approving the amendment to the 2022 Plan to increase the number of shares available under the 2022 Plan in order to
comply with Listing Rule 5635(c) of The Nasdaq Stock Market LLC. On July 16, 2024, the Company&rsquo;s stockholders approved the proposal
to increase the number of shares available under the 2022 Plan. As of that date, Dr. Dow&rsquo;s option grant, as subsequently amended,
was considered effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We may terminate Dr.
Dow&rsquo;s employment for Cause, as defined in the Dow Employment Agreement, at any time upon notice to Dr. Dow setting forth in reasonable
detail the nature of such Cause. We also may terminate Dr. Dow&rsquo;s employment other than for Cause at any time upon thirty (30) days&rsquo;
written notice to him. Dr. Dow may terminate his employment for Good Reason, as defined in the Dow Employment Agreement, at any time upon
thirty (30) days&rsquo; written notice to us. In the event that Dr. Dow&rsquo;s employment is terminated other than for Cause or for Good
Reason, Dr. Dow will be entitled to, among other things, a continuation of his annual salary plus health insurance benefits for a period
not exceeding 18 months. In addition, in the event of a Change in Control, as defined in the Dow Employment Agreement, on, or at any time
during the 24 months following, the Change in Control, (i) we terminate Dr. Dow&rsquo;s employment for any reason other than Cause or
Disability, as defined in the Dow Employment Agreement, or (ii) Dr. Dow terminates his employment for Good Reason, Dr. Dow will be entitled
to Change in Control severance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Dr. Dow is subject to
non-competition and non-solicitation during the term of his employment and for a period of 24 months after termination of his employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Miller Employment
Agreement</I></B>. We entered into an Employment Agreement dated as of January 12, 2023 with Tyrone Miller (the &ldquo;Miller Employment
Agreement&rdquo;), our Chief Financial Officer. The term of the Miller Employment Agreement began on January 12, 2023 and will continue
for a period of two years, with subsequent automatic renewals unless either party thereto provides notice to terminate at least 90 days
prior to the applicable renewal date. The Miller Employment Agreement provides Mr. Miller an annual base salary of $204,000, bonuses to
the extent certain events occur or if applicable performance goals are met and employee benefits that are generally given to our senior
executives. In December 2024, the Board approved an increase to Mr. Miller&rsquo;s base salary to $215,000 for fiscal year 2025. Contingent
on the receipt of shareholder approval to increase the number of shares available under the 2022 Plan, Mr. Miller was granted a five-year
option to purchase a total of 200 shares of our common stock that vest on the last day of each quarter in each calendar year (for a cumulative
total or no more than 4,000 shares over five years). The per share exercise price of the option was initially equal to the per share closing
price of our common stock on the date of the initial public offering and shall have a cashless exercise provision. In November 2023, the
Board reset the exercise price of the option to be equal to $60.00 and modified the vesting provisions of the option to vest annually
over five years, rather than quarterly, with the first vesting date being December 31, 2024. The initial grant and subsequent amendment
of Mr. Miller&rsquo;s options was contingent upon the stockholders of the Company approving the amendment to the exercise price of the
options and approving the amendment to the 2022 Plan to increase the number of shares available under the 2022 Plan in order to comply
with Listing Rule 5635(c) of The Nasdaq Stock Market LLC. On July 16, 2024, the Company&rsquo;s stockholders approved the proposal to
increase the number of shares available under the 2022 Plan. As of that date, Mr. Miller&rsquo;s option grant, as subsequently amended,
was considered effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We may terminate Mr.
Miller&rsquo;s employment hereunder for Cause, as defined in the Miller Employment Agreement, at any time upon notice to Mr. Miller setting
forth in reasonable detail the nature of such Cause. We also may terminate Mr. Miller&rsquo;s employment other than for Cause at any time
upon thirty (30) days&rsquo; written notice to him. Mr. Miller may terminate his employment for Good Reason, as defined in the Miller
Employment Agreement, at any time upon thirty (30) days&rsquo; written notice to us. In the event that Mr. Miller&rsquo;s employment is
terminated other than for Cause or for Good Reason, Mr. Miller will be entitled to, among other things, a continuation of his annual salary
plus health insurance benefits for a period not exceeding 18 months. In addition, in the event of a Change in Control, as defined in the
Miller Employment Agreement, on, or at any time during the 24 months following, the Change in Control, (i) we terminate Mr. Miller&rsquo;s
employment for any reason other than Cause or Disability, as defined in the Miller Employment Agreement, or (ii) Mr. Miller terminates
his employment for Good Reason, Mr. Miller will be entitled to Change in Control severance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Mr. Miller is subject
to non-competition and non-solicitation during the term of his employment and for a period of 24 months after termination of his employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Landon Employment
Agreement</I></B>. We entered into an Employment Agreement dated as of February 7, 2024 with Kristen Landon (the &ldquo;Landon Employment
Agreement&rdquo;), our Chief Commercial Officer. The term of the Landon Employment Agreement began on February 12, 2024 and will continue
at will, meaning that Ms. Landon or the Company may terminate the employment relationship at any time, with or without cause, and with
or without notice and for any reason or no particular reason. The Landon Employment Agreement provides Ms. Landon an annual base salary
of $300,000, sales bonuses and bonuses to the extent certain events occur or if applicable performance goals are met and employee benefits
that are generally given to our senior executives. Contingent on the receipt of shareholder approval to increase the number of shares
available under the 2022 Plan, Ms. Landon was granted a five-year option to purchase a total of 4,167 shares of our common stock with
a per share exercise price to be determined by the Board on the date of grant. The options had a cashless exercise price and vest annually
over five years, with the first vesting date being December 31, 3024. On September 26, 2024, after the receipt of stockholder approval
to increase the number of shares available under the 2022 Plan, the Board approved the grant of the options to Ms. Landon at a per share
exercise price of $6.85.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OUTSTANDING EQUITY AWARDS AT DECEMBER 31, 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="16" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Option Awards</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="8" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Stock Awards</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid; font-weight: bold">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of securities underlying unexercised options, exercisable (#)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of securities underlying unexercised options unexercisable (#)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Equity incentive plan awards: Number of securities underlying unexercised unearned options <BR> (#)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option exercise price<BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option <BR> expiration<BR> date</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of shares or units of stock that have not vested (#)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Market value of shares or units of stock that have not vested ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 29%; text-align: left"><FONT STYLE="font-size: 10pt">Geoffrey Dow,<BR> President and Chief Executive Officer (Principal Executive Officer)<SUP>(1)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">1,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">4,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">60.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 10%; text-align: center">July 16, 2034</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-size: 10pt">Tyrone Miller,<BR> Chief Financial Officer (Principal Financial and Accounting Officer)&nbsp;<SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">800</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,200</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">60.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">July 16, 2034</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-size: 10pt">Kristen Landon,<BR> Chief Commercial Officer<SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">6.85</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">September 26, 2034</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Dr. Dow&rsquo;s options to purchase a total of 5,000 shares of our common stock vest annually on the last date of each fiscal year in five equal tranches, with the first vesting date being December 31, 2024.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Mr. Miller&rsquo;s options to purchase a total of 4,000 shares of our common stock vest annually on the last date of each fiscal year in five equal tranches, with the first vesting date being December 31, 2024.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Ms. Landon&rsquo;s options to purchase a total of 4,167 shares of our common stock vest annually on the last date of each fiscal year in five equal tranches, with the first vesting date being December 31, 2024.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_008"></A><B>DELINQUENT SECTION 16(a) REPORTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 16(a) of the Securities Exchange Act of
1934, as amended, requires our directors, executive officers and persons who own more than 10% of the outstanding shares of common stock
of the Company to file with the SEC reports of their ownership and changes in their ownership of common stock of the Company. Directors,
executive officers and greater-than-ten percent shareholders are also required to furnish the Company with copies of all ownership reports
they file with the SEC. To our knowledge, based solely on a review of the copies of such reports furnished to the Company, Cheryl Xu failed
to file a timely Form 4 with regard to the purchase of common shares on 27 August, 2024, December 12, 2024, and December 13, 2024, and
Kristen Landon failed to file a Form 4 with respect to Options issued on September 26, 2024 and January 17, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B></B></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B><A NAME="a_009"></A>SECURITY OWNERSHIP
OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information with
respect to the beneficial ownership of our common stock, our only outstanding class of voting stock, known by us as of the Record Date,
by:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">each person or entity known by us to be the beneficial owner of more than 5% of our common stock;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">each of our directors;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">each of our executive officers; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">all of our directors and executive officers as a group.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Beneficial ownership is determined in accordance
with the rules of the SEC and, thus, represents voting or investment power with respect to our securities as of the Record Date. In computing
the number and percentage of shares beneficially owned by a person, shares that may be acquired by such person within 60 days of the Record
Date are counted as outstanding, while these shares are not counted as outstanding for computing the percentage ownership of any other
person. Except as otherwise indicated, the persons listed below have sole voting and investment power with respect to all shares of our
common stock owned by them, except to the extent such power may be shared with a spouse. Unless otherwise noted, the address of each person
below is c/o 60 Degrees Pharmaceuticals, Inc., 1025 Connecticut Avenue NW Suite 1000, Washington, D.C. 20036.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Officers and Directors</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Title</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<BR>
 Shares Beneficially<BR>
 Owned</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percent of<BR>
 Class</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Geoffrey Dow</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: center">President, Chief Executive Officer and Director</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">37,766</TD><TD STYLE="width: 1%; text-align: left"><SUP>(2)</SUP></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: left">Tyrone Miller</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Chief Financial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,074</TD><TD STYLE="text-align: left"><SUP>(3)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Kristen Landon</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Chief Commercial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,374</TD><TD STYLE="text-align: left"><SUP>(4)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: left">Charles Allen</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">518</TD><TD STYLE="text-align: left"><SUP>(5)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Cheryl Xu</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,100</TD><TD STYLE="text-align: left"><SUP>(6)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: left">Stephen Toovey</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">518</TD><TD STYLE="text-align: left"><SUP>(7)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Paul Field</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">518</TD><TD STYLE="text-align: left"><SUP>(8)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Officers and Directors as a Group (total of 7 persons)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">69,868</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.69</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Less than 1%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Percentages based on 4,104,469 shares of common stock issued and outstanding as of August 14, 2025 plus shares of common stock the person has the right to acquire within 60 days thereafter. Unless otherwise indicated, the principal address of the named executives and directors is c/o 1025 Connecticut Avenue NW Suite 1000, Washington, D.C. 20036. On February 24, 2025, the Company effectuated a 1-for-5 Reverse Stock Split of its outstanding common stock. Accordingly, all share numbers presented in this table have been adjusted to reflect the Reverse Stock Split.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Includes (i) 4,471 shares of our common stock held in the name of Geoffrey Dow, (ii) 11,120 shares of common stock held by the Geoffrey S. Dow Revocable Trust (the &ldquo;Dow Trust&rdquo;), of which Geoffrey Dow is the trustee and has control over the voting and disposition of the shares of common stock held by the Dow Trust, (iii) 175 shares of common stock issuable upon exercise of warrants issued to the Geoffrey S. Dow Revocable Trust, (iv) 1,000 shares underlying fully vested options exercisable into common stock at a per share exercise price of $60.00, and (v) 21,000 shares underlying fully vested options exercisable into common stock at a per share exercise price of $6.55.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Includes (i) 5,274 shares of our common stock held in the name of Tyrone Miller, (ii) 800 shares underlying fully vested options exercisable into common stock at a per share exercise price of $60.00, and (iii) 3,000 shares underlying fully vested options exercisable into common stock at a per share exercise price of $6.55.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Ms. Landon beneficially owns a total of 5,374 shares of common stock, of which includes (i) 4,540 shares of common stock held in the name of Ms. Landon, and (ii) 834 shares underlying fully vested options exercisable into common stock at a per share exercise price of $6.85.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Mr. Allen beneficially owns a total of 518 shares of common stock, of which includes (i) 234 shares of common stock held in the name of Mr. Allen, and (ii) 284 shares underlying fully vested options exercisable into common stock at a per share exercise price of $318.00.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Ms. Xu beneficially owns a total of 16,100 shares of common stock, of which includes (i) 15,816 shares of common stock held in the name of Ms. Xu, and (ii) 284 shares underlying fully vested options exercisable into common stock at a per share exercise price of $318.00.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Mr. Toovey beneficially owns a total of 518 shares of common stock, of which includes (i) 234 shares of common stock held in the name of Mr. Toovey, and (ii) 284 shares underlying fully vested options exercisable into common stock at a per share exercise price of $318.00.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Mr. Field beneficially owns a total of 518 shares of common stock, of which includes (i) 167 shares of common stock held by the Field Family Trust, of which Mr. Field is a trustee and has control over the voting and disposition of the shares of common stock held by the Field Family Trust, (ii) 67 shares of common stock held in the name of Mr. Field, and (iii) 284 shares underlying fully vested options exercisable into common stock at a per share exercise price of $318.00.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_010"></A>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Company&rsquo;s policies and procedures
for the review of related person transactions the Audit Committee reviews related person transactions in which we are or will be a participant
to determine if they are in the best interests of our stockholders and the Company. Transactions, arrangements or relationships or any
series of similar transactions, arrangements or relationships in which a related person had or will have a material interest and that
exceed $120,000 are subject to the Audit Committee&rsquo;s review. Any member of the Audit Committee who is a related person with respect
to a transaction under review may not participate in the deliberation or vote respecting approval or ratification of the transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Related persons are directors, director nominees,
executive officers, holders of 5% or more of our voting stock and their immediate family members. Immediate family members are spouses,
parents, stepparents, children, stepchildren, siblings, daughters-in-law, sons-in-law and any person, other than a tenant or domestic
employee, who resides in the household of a director, director nominee, executive officer or holder of 5% or more of our voting stock.
After its review, the Audit Committee may approve or ratify the transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other than as disclosed below, and except for
the regular salary and bonus payments made to our directors and officers in the ordinary course of business as described in the section
&ldquo;<I>Executive Compensation</I>,&rdquo; there have been no transactions since January 1, 2023 or any currently proposed transaction
or series of similar transactions to which the Company was or is to be a party, in which the amount involved exceeds USD$120,000 and in
which any current or former director or officer of the Company, any 5% or greater stockholder of the Company or any member of the immediate
family of any such persons had or will have a direct or indirect material interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_011"></A><B>PROPOSAL 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>APPROVAL OF AN AMENDMENT TO INCREASE THE NUMBER
OF AUTHORIZED SHARES UNDER THE 2022 EQUITY INCENTIVE PLAN BY 250,000 SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has adopted a resolution declaring it
advisable and in the best interests of the Company and its stockholders that the shares of common stock authorized for issuance under
the 2022 Plan be increased by 250,000 (the &ldquo;Plan Amendment&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On November 22, 2022,
our Board and our stockholders approved the 60 Degrees Pharmaceuticals, Inc. 2022 Equity Incentive Plan. The 2022 Plan governs equity
awards to our employees, directors, officers, consultants and other eligible participants. Initially, the maximum number of shares of
our common stock that may be subject to awards under the 2022 Plan was equal to 3,977. The 2022 Plan provides for an annual automatic
increase in the number of shares available for issuance beginning on January 1, 2023, and each January 1 thereafter, by four percent (4%)
of the number of outstanding shares of common stock on the immediately preceding December 31, or such lesser number of shares as determined
by our Board. As of the Record Date, the maximum shares of our common stock that may be subject to awards under the 2022 Plan is equal
to 215,452.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The purpose of the 2022
Plan is to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive
to employees, directors and consultants, and to promote the success of our business. The administrator of the 2022 Plan may, in its sole
discretion, amend, alter, suspend or terminate the 2022 Plan, or any part thereof, at any time and for any reason. Unless earlier terminated
by the administrator, the 2022 Plan will terminate ten years from the date it is adopted by our Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Overview and Purpose of the Stockholder Approval</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to give the Company the flexibility to
responsibly address its future equity compensation needs, the Company is requesting that stockholders approve the Plan Amendment, which
will authorize an additional 250,000 shares for issuance under the 2022 Plan, so that an overall total of 465,452 shares will be reserved
under the 2022 Plan. Having a sufficient number of shares under the 2022 Plan is critical to our ability to continue to attract, retain,
engage and focus highly motivated and qualified employees, particularly in the competitive labor market that exists today in our industry.
A copy of the Plan Amendment is attached to this proxy statement as <U>Annex A</U> and a copy of the 2022 Plan is attached to this proxy
statement as <U>Annex B</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>No Appraisal Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stockholders have no rights under the DGCL or
under our Certificate of Incorporation to exercise dissenters&rsquo; rights of appraisal with respect to the approval of the Plan Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Description of the 2022 Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The principal features of the 2022 Plan are summarized
below, but the below summary is qualified in its entirety by reference to the full text of the plan document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Authorized Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Initially, the maximum
number of shares of our common stock that may be subject to awards under the 2022 Plan was equal to 3,977. The 2022 Plan provides for
an annual automatic increase in the number of shares available for issuance beginning on January 1, 2023, and each January 1 thereafter,
by four percent (4%) of the number of outstanding shares of common stock on the immediately preceding December 31, or such lesser number
of shares as determined by our Board. On July 16, 2024 and November 6, 2024, our stockholders approved an increase to the number of shares
available under the 2022 Plan by 83,334 shares and 100,000 shares, respectively, which increases were previously approved by the Board.
As of the Record Date, the maximum shares of our common stock that may be subject to awards under the 2022 Plan is equal to 215,452.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Plan Administration</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">One or more committees
appointed by our Board will administer the 2022 Plan. Initially, the Compensation Committee shall administer the 2022 Plan. In addition,
if we determine it is desirable to qualify transactions under the 2022 Plan as exempt under Rule 16b-3 of the Exchange Act, such transactions
will be structured with the intent that they satisfy the requirements for exemption under Rule 16b-3. Subject to the provisions of the
2022 Plan, the administrator has the power to administer the 2022 Plan and make all determinations deemed necessary or advisable for administering
the 2022 Plan, including the power to determine the fair market value of our common stock, select the service providers to whom awards
may be granted, determine the number of shares covered by each award, approve forms of award agreements for use under the 2022 Plan, determine
the terms and conditions of awards (including the exercise price, the time or times at which the awards may be exercised, any vesting
acceleration or waiver or forfeiture restrictions and any restriction or limitation regarding any award or the shares relating thereto),
construe and interpret the terms of the 2022 Plan and awards granted under it, prescribe, amend and rescind rules relating to the 2022
Plan, rules and regulations relating to sub-plans established for the purpose of facilitating compliance with applicable non-U.S. laws,
easing the administration of the 2022 Plan and/or for qualifying for favorable tax treatment under applicable non-U.S. laws, in each case
as the administrator may deem necessary or advisable and modify or amend each award (subject to the provisions of the 2022 Plan), including
the discretionary authority to extend the post-termination exercisability period of awards and to extend the maximum term of an option
or stock appreciation right (subject to the provisions of the 2022 Plan), to allow Participants to satisfy withholding tax obligations
in a manner permissible under the 2022 Plan, to authorize any person to execute on behalf of us any instrument required to effect the
grant of an award previously granted by the administrator and to allow a participant to defer the receipt of payment of cash or the delivery
of shares that would otherwise be due to such participant under an award. The administrator also has the authority to allow participants
the opportunity to transfer outstanding awards to a financial institution or other person or entity selected by the administrator and
to institute an exchange program by which outstanding awards may be surrendered or cancelled in exchange for awards of the same type which
may have a higher or lower exercise price or different terms, awards of a different type or cash, or by which the exercise price of an
outstanding award is increased or reduced. The administrator&rsquo;s decisions, interpretations and other actions are final and binding
on all participants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Eligibility</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Awards under the 2022
Plan, other than incentive stock options, may be granted to our employees (including our officers and directors) or a parent or subsidiary,
members of our Board, or consultants engaged to render bona fide services to us or a parent or subsidiary. Incentive stock options may
be granted only to our employees or a subsidiary, provided the services (i) are not in connection with the offer or sale of securities
in a capital-raising transaction, and (ii) do not directly promote or maintain a market for our securities, in each case, within the meaning
of Form S-8 promulgated under the Securities Act, and provided further, that a consultant will include only those persons to whom the
issuance of shares may be registered under Form S-8 promulgated under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Stock Options</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Stock options may be
granted under the 2022 Plan. The exercise price of options granted under the 2022 Plan generally must at least be equal to the fair market
value of our common stock on the date of grant. The term of each option will be as stated in the applicable award agreement; provided,
however, that the term may be no more than 10 years from the date of grant. The administrator will determine the methods of payment of
the exercise price of an option, which may include cash, shares or other property acceptable to the administrator, as well as other types
of consideration permitted by applicable law. After the termination of service of an employee, director or consultant, they may exercise
their option for the period of time stated in their option agreement. In the absence of a specified time in an award agreement, if termination
is due to death or disability, the option will remain exercisable for six months. In all other cases, in the absence of a specified time
in an award agreement, the option will remain exercisable for three months following the termination of service. An option may not be
exercised later than the expiration of its term. Subject to the provisions of the 2022 Plan, the administrator determines the other terms
of options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Stock Appreciation
Rights</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Stock appreciation rights
may be granted under the 2022 Plan. Stock appreciation rights allow the recipient to receive the appreciation in the fair market value
of our common stock between the exercise date and the date of grant. Stock appreciation rights may not have a term exceeding 10 years.
After the termination of service of an employee, director or consultant, they may exercise their stock appreciation right for the period
of time stated in their stock appreciation right agreement. In the absence of a specified time in an award agreement, if termination is
due to death or disability, the stock appreciation rights will remain exercisable for six months. In all other cases, in the absence of
a specified time in an award agreement, the stock appreciation rights will remain exercisable for three months following the termination
of service. However, in no event may a stock appreciation right be exercised later than the expiration of its term. Subject to the provisions
of the 2022 Plan, the administrator determines the other terms of stock appreciation rights, including when such rights become exercisable
and whether to pay any increased appreciation in cash or with shares of our common stock, or a combination thereof, except that the per
share exercise price for the shares to be issued pursuant to the exercise of a stock appreciation right will be no less than 100% of the
fair market value per share on the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Restricted Stock</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Restricted stock may
be granted under the 2022 Plan. Restricted stock awards are grants of shares of our common stock that vest in accordance with terms and
conditions established by the administrator. The administrator will determine the number of shares of restricted stock granted to any
employee, director or consultant and, subject to the provisions of the 2022 Plan, will determine the terms and conditions of such awards.
The administrator may impose whatever conditions to vesting it determines to be appropriate (for example, the administrator may set restrictions
based on the achievement of specific performance goals or continued service to us); provided, however, that the administrator, in its
sole discretion, may accelerate the time at which any restrictions will lapse or be removed. Recipients of restricted stock awards generally
will have voting and dividend rights with respect to such shares upon grant without regard to vesting, unless the administrator provides
otherwise. Shares of restricted stock that do not vest are subject to our right of repurchase or forfeiture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Restricted Stock
Units</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">RSUs may be granted under
the 2022 Plan. RSUs are bookkeeping entries representing an amount equal to the fair market value of one share of our common stock. Subject
to the provisions of the 2022 Plan, the administrator determines the terms and conditions of RSUs, including the vesting criteria and
the form and timing of payment. The administrator may set vesting criteria based upon the achievement of Company-wide, divisional, business
unit or individual goals (including continued employment or service), applicable federal or state securities laws or any other basis determined
by the administrator in its discretion. The administrator, in its sole discretion, may pay earned RSUs in the form of cash, in shares
of our common stock or in some combination thereof. Notwithstanding the foregoing, the administrator, in its sole discretion, may accelerate
the time at which any vesting requirements will be deemed satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Performance Awards</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Performance awards may
be granted under the 2022 Plan. Performance awards are awards that will result in a payment to a participant only if performance goals
established by the administrator are achieved or the awards otherwise vest. The administrator will set objectives or vesting provisions,
that, depending on the extent to which they are met, will determine the value of the payout for the performance awards. The administrator
may set vesting criteria based on the achievement of Company-wide, divisional, business unit, or individual goals (including, but not
limited to, continued employment or service), or any other basis determined by the administrator in its discretion. Each performance award&rsquo;s
threshold, target, and maximum payout values are established by the administrator on or before the grant date. After the grant of a performance
award, the administrator, in its sole discretion, may reduce or waive any performance objectives or other vesting provisions for such
performance award. The administrator, in its sole discretion, may pay earned performance awards in the form of cash, in shares, or in
some combination thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Non-transferability
of Awards</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Unless the administrator
provides otherwise, the 2022 Plan generally does not allow for the transfer of awards other than by will or by the laws of descent and
distribution and only the recipient of an award may exercise an award during their lifetime. If the administrator makes an award transferrable,
such award will contain such additional terms and conditions as the administrator deems appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Certain Adjustments</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In the event of certain
changes in our capitalization, to prevent diminution or enlargement of the benefits or potential benefits available under the 2022 Plan,
the administrator will adjust the number and class of shares that may be delivered under the 2022 Plan or the number, and price of shares
covered by each outstanding award and the numerical share limits set forth in the 2022 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Dissolution or
Liquidation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In the event of our proposed
liquidation or dissolution, the administrator will notify participants as soon as practicable and all awards will terminate immediately
prior to the consummation of such proposed transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Merger or Change
in Control</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The 2022 Plan provides
that in the event of our merger with or into another corporation or entity or a &ldquo;change in control&rdquo; (as defined in the 2022
Plan), each outstanding award will be treated as the administrator determines, including, without limitation, that (i) awards will be
assumed, or substantially equivalent awards will be substituted, by the acquiring or succeeding corporation (or an affiliate thereof)
with appropriate adjustments as to the number and kind of shares and prices; (ii) upon written notice to a participant, that the participant&rsquo;s
awards will terminate upon or immediately prior to the consummation of such merger or change in control; (iii) outstanding awards will
vest and become exercisable, realizable or payable, or restrictions applicable to an award will lapse, in whole or in part, prior to or
upon consummation of such merger or change in control and, to the extent the administrator determines, terminate upon or immediately prior
to the effectiveness of such merger or change in control; (iv) (A) the termination of an award in exchange for an amount of cash or property,
if any, equal to the amount that would have been attained upon the exercise of such award or realization of the participant&rsquo;s rights
as of the date of the occurrence of the transaction (and, for the avoidance of doubt, if as of the date of the occurrence of the transaction
the administrator determines in good faith that no amount would have been attained upon the exercise of such award or realization of the
participant&rsquo;s rights, then such award may be terminated by us without payment) or (B) the replacement of such award with other rights
or property selected by the administrator in its sole discretion; or (v) any combination of the foregoing. The administrator will not
be obligated to treat all awards, all awards a participant holds, or all awards of the same type, similarly. In the event that awards
(or portion thereof) are not assumed or substituted for in the event of a merger or change in control, the participant will fully vest
in and have the right to exercise all of their outstanding options and stock appreciation rights, including shares as to which such awards
would not otherwise be vested or exercisable, all restrictions on restricted stock and RSUs or performance awards will lapse and, with
respect to awards with performance-based vesting, all performance goals or other vesting criteria will be deemed achieved at 100% of target
levels and all other terms and conditions met, in all cases, unless specifically provided otherwise under the applicable award agreement
or other written agreement between the participant and us or any of our subsidiaries or parents, as applicable. If an option or stock
appreciation right is not assumed or substituted in the event of a merger or change in control, the administrator will notify the participant
in writing or electronically that the option or stock appreciation right will be exercisable for a period of time determined by the administrator
in its sole discretion and the vested option or stock appreciation right will terminate upon the expiration of such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">For awards granted to
an outside director, the outside director will fully vest in and have the right to exercise options and/or stock appreciation rights as
to all of the shares underlying such award, including those shares which would not be vested or exercisable, all restrictions on restricted
stock and RSUs will lapse, and, with respect to awards with performance-based vesting, all performance goals or other vesting criteria
will be deemed achieved at one hundred percent (100%) of target levels and all other terms and conditions met, unless specifically provided
otherwise under the applicable award agreement or other written agreement between the participant and us or any of our subsidiaries or
parents, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Clawback</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Awards will be subject
to any clawback policy that we are required to adopt pursuant to the listing standards of any national securities exchange or association
on which our securities are listed or as is otherwise required by the Dodd-Frank Act or other applicable laws. The administrator also
may specify in an award agreement that the participant&rsquo;s rights, payments or benefits with respect to an award will be subject to
reduction, cancellation, forfeiture or recoupment upon the occurrence of certain specified events. The administrator may require a participant
to forfeit, return or reimburse us all or a portion of the award or shares issued under the award, any amounts paid under the award and
any payments or proceeds paid or provided upon disposition of the shares issued under the award in order to comply with such clawback
policy or applicable laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Amendment and Termination</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The administrator has
the authority to amend, suspend or terminate the 2022 Plan provided such action does not impair the existing rights of any participant.
The 2022 Plan automatically will terminate on November 22, 2032, unless it is terminated sooner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Federal Income Tax Consequences</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a brief summary of the principal
U.S. federal income tax consequences with respect to awards granted under the 2022 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Restricted Stock Awards</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The recipient of a restricted stock award does
not have taxable income upon receipt of the award. When the restricted stock award is vested, the recipient will recognize ordinary income
in an amount equal to the difference of the fair market value of the shares on the date of vesting and the amount paid for such restricted
stock, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon the vesting of a restricted stock award,
the Company will be entitled to a corresponding income tax deduction in the tax year in which the restricted stock award vested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The recipient may, however, elect under Section
83(b) of the Code to include as ordinary income in the year the shares are granted an amount equal to the excess of (i) the fair market
value of the shares on the date of issuance, over (ii) the purchase price, if any, paid for the shares. If the Section 83(b) election
is made, the recipient will not realize any additional taxable income when the shares become vested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Restricted Stock Units</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A recipient will not recognize taxable income
upon the grant of a restricted stock unit, and we will not be entitled to a deduction, until the shares and/or cash with respect to the
award are transferred to the recipient, generally at the end of the vesting period. At the time of transfer, the recipient will recognize
ordinary income equal to the value of the shares of common stock and/or cash. The Company will be entitled to a deduction equal to the
income recognized by the recipient. The subsequent disposition of shares acquired pursuant to a restricted stock unit award will result
in capital gain or loss (based upon the difference between the price received upon disposition and the recipient&rsquo;s basis in those
shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Stock Options</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The recipient does not recognize any taxable income
as a result of a grant of a non-qualified stock option. Upon exercise of a non-qualified stock option, the recipient will recognize ordinary
income in an amount equal to the difference between the fair market value of the shares on the date of exercise and the exercise price.
When the shares are sold, any difference between the sale price and the fair market value of the shares on the date of exercise will generally
be treated as long term or short term capital gain or loss, depending on whether the stock was held for more than one year. Upon the exercise
of a non-qualified stock option, the Company will be entitled to a corresponding income tax deduction in the tax year in which the option
was exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon exercise of an incentive stock option, the
excess of the fair market value of the shares of common stock acquired over the option exercise price will be an item of tax preference
to the participant, which may be subject to an alternative minimum tax for the year of exercise. If no disposition of the shares is made
within two years from the date of granting of the incentive stock option or within one year after the transfer of the shares to the participant,
the participant does not realize taxable income as a result of exercising the incentive stock option; the tax basis of the shares received
for capital gain treatment is the option exercise price; any gain or loss realized on the sale of the shares is long-term capital gain
or loss. If the recipient disposes of the shares within the two-year or one-year periods referred to above, the recipient will realize
ordinary income at that time in an amount equal to the excess of the fair market value of the shares at the time of exercise (or the net
proceeds of disposition, if less) over the option exercise price. For capital gain treatment on such a disposition, the tax basis of the
shares will be their fair market value at the time of exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Stock Appreciation Rights</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A recipient does not recognize any taxable income
upon the receipt of a stock appreciation right (&ldquo;SAR&rdquo;). Upon the exercise of a SAR, the recipient will recognize ordinary
income in an amount equal to the excess of the fair market value of the underlying shares of common stock on the exercise date over the
exercise price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon the exercise of a SAR, the Company will be
entitled to a corresponding income tax deduction in the tax year in which the SAR was exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Equity Plan Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following chart reflects the number of securities
granted under equity compensation plans approved and not approved by stockholders and the weighted average exercise price for such plans
as of December 31, 2024:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic">2022 Equity Incentive Plan:</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of securities to be issued upon exercise or issuance of outstanding options, units, warrants and rights<SUP>(1)</SUP>:</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted average exercise price of outstanding options, warrants and rights<SUP>(1) </SUP>:</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of securities remaining available for future issuance<SUP>(1)</SUP></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Equity compensation plans approved by security holders</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">4,437</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">116.07</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">154,392</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: left">Equity compensation plans not approved by security holders</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,437</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">116.07</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">154,392</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>(1)</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Balances presented as of December 31, 2024</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The Board recommends that you vote &ldquo;FOR&rdquo;
the approval to increase the total number of authorized shares<BR>
under the 2022 Equity Incentive Plan by 250,000 shares.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_012"></A>PROPOSAL 3 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>TO APPROVE AN AMENDMENT TO OUR CERTIFICATE
OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT OF OUR COMMON STOCK AT A REVERSE STOCK SPLIT RATIO RANGING FROM 1:3 TO 1:10, INCLUSIVE,
AS DETERMINED BY THE BOARD IN ITS SOLE DISCRETION (Item 3 on the Proxy Card)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our stockholders are being asked to approve an
amendment to our Certificate of Incorporation to effect a reverse stock split of our common stock at a reverse stock split ratio ranging
from 1:3 to 1:10, inclusive, as may be determined at the appropriate time by the Board, in its sole discretion (the &ldquo;Reverse Stock
Split&rdquo;). This means that once approved by the stockholders, the Board will be able to decide whether and when to effect the Reverse
Stock Split without further action from the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The effectiveness of this amendment or the abandonment
thereof, notwithstanding stockholder approval, will be determined by the Board, at its sole option, following the Annual Meeting any time
prior to the one-year anniversary of the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Reasons for a Reverse Stock Split</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Maintaining our Listing on Nasdaq</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The primary purpose of the Reverse Stock Split
is to raise the per share trading price of our common stock in order to maintain our listing on The Nasdaq Capital Market. Delisting from
Nasdaq may adversely affect our ability to raise additional financing through the public or private sale of our equity securities, may
significantly affect the ability of investors to trade in our securities and may negatively affect the value and liquidity of our common
stock. Delisting may also have other negative impacts, including potential loss of employee confidence, the loss of institutional investors,
the loss of analyst coverage or the loss of business development opportunities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Potentially Improving the Marketability
and Liquidity of our Common Stock</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board believes that an increased stock price
may also improve the marketability and liquidity of our common stock. For example, many brokerages, institutional investors and funds
have internal policies that either prohibit them from investing in low-priced stocks or tend to discourage individual brokers from recommending
low-priced stocks to their customers by restricting or limiting the ability to purchase such stocks on margin. Additionally, investors
may be dissuaded from purchasing stocks below certain prices because brokers&rsquo; commissions, as a percentage of the total transaction
value, can be higher for low-priced stocks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Decreasing the Risk of Market Manipulation
of our Common Stock</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board believes that the potential increase
in stock price may reduce the risk of market manipulation of our common stock, which we believe is enhanced when our stock trades below
$1.00 per share. By reducing market manipulation risk, we may also thereby potentially decrease the volatility of our stock price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Providing us the Ability to Issue Additional
Securities</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A Reverse Stock Split is expected to increase
the number of authorized, but unissued and unreserved, shares of our common stock. These additional shares would provide flexibility to
us for raising capital; repurchasing debt; providing equity incentives to employees, officers, directors, consultants and advisors (including
pursuant to our equity compensation plan); expanding our business through the acquisition of other businesses and for other purposes.
However, at present, we do not have any specific plans, arrangements, understandings or commitments for the additional shares that would
become available.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accordingly, for these and other reasons, the
Board believes that a Reverse Stock Split is in the best interests of us and our stockholders. A copy of the draft of the amendment to
our Certificate of Incorporation providing for the Reverse Stock Split is attached hereto as <U>Annex C</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Criteria to be Used for Determining Whether
to Implement a Reverse Stock Split</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This proposal gives the Board the discretion to
select a Reverse Stock Split ratio from within a range between and including 1:3 and 1:10 on a date selected by him based on his then-current
assessment of the factors below, and in order to maximize Company and stockholder interests. In determining whether to implement the Reverse
Stock Split, and which ratio to implement, if any, the Board may consider, among other factors:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the historical trading price and trading volume of our common stock; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the then-prevailing trading price and trading volume of our common stock and the expected impact of the Reverse Stock Split on the trading market in the short- and long-term;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the continued listing requirements for our common stock on Nasdaq or other applicable exchanges, if then applicable;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the number of shares of common stock outstanding;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">which Reverse Stock Split ratio would result in the least administrative cost to us; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">prevailing industry, market and economic conditions.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Certain Risks and Potential Disadvantages Associated
with a Reverse Stock Split</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The effect of a Reverse Stock Split on our stock
price cannot be predicted with any certainty, and the history of reverse stock splits for other companies in various industries is varied,
particularly since some investors may view a reverse stock split negatively. It is possible that our stock price after a Reverse Stock
Split will not increase in the same proportion as the reduction in the number of shares outstanding, causing a reduction in our overall
market capitalization. Further, even if we implement a Reverse Stock Split, our stock price may decline due to various factors, including
our future performance and general industry, market and economic conditions. This percentage decline, as an absolute number and as a percentage
of our overall market capitalization, may be greater than would occur in the absence of a Reverse Stock Split. If we fail to meet Nasdaq&rsquo;s
continued listing requirements, Nasdaq could suspend trading in our common stock and commence delisting proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The proposed Reverse Stock Split may decrease
the liquidity of our common stock and result in higher transaction costs. The liquidity of our common stock may be negatively impacted
by the reduced number of shares outstanding after the Reverse Stock Split, which would be exacerbated if the stock price does not increase
following the split. In addition, a Reverse Stock Split would increase the number of stockholders owning &ldquo;odd lots&rdquo; of fewer
than 100 shares, trading in which generally results in higher transaction costs. Accordingly, a Reverse Stock Split may not achieve the
desired results of increasing marketability and liquidity as described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The implementation of a Reverse Stock Split would
result in an effective increase in the authorized number of shares of common stock available for issuance, which could, under certain
circumstances, have anti-takeover implications. The additional shares of common stock available for issuance could be used by us to oppose
a hostile takeover attempt or to delay or prevent changes in control or in our management. Although the Reverse Stock Split has been prompted
by business and financial considerations, and not by the threat of any hostile takeover attempt (nor is the Board currently aware of any
such attempts directed at us), stockholders should be aware that approval of the Reverse Stock Split could facilitate future efforts by
us to deter or prevent changes in control, including transactions in which stockholders might otherwise receive a premium for their shares
over then-current market prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stockholders should also keep in mind that the
implementation of a Reverse Stock Split does not have an effect on the actual or intrinsic value of our business or a stockholder&rsquo;s
proportional ownership interest (subject to the treatment of fractional shares). However, should the overall value of our common stock
decline after a Reverse Stock Split, then the actual or intrinsic value of shares held by stockholders will also proportionately decrease
as a result of the overall decline in value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Effects of a Reverse Stock Split</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the effective date of the Reverse Stock
Split:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a certain number shares of common stock outstanding (depending on the Reverse Stock Split ratio selected by the Board) will be combined, automatically and without any action on the part of the Company or its stockholders, into one new share of common stock;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">no fractional shares of common stock will be issued; instead, stockholders who would otherwise receive a fractional share will receive a whole share in lieu of any fractional share of common stock (as detailed below);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">proportionate adjustments will be made to the number of shares issuable upon the exercise or vesting of all then-outstanding stock options and warrants which will result in a proportional decrease in the number of shares of common stock reserved for issuance upon exercise or vesting of such stock options and warrants and, in the case of stock options, a proportional increase in the exercise price of all such stock options;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the number of shares of common stock then reserved for issuance under our equity compensation plan will be reduced proportionately; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the total number of authorized shares of common stock will remain at 150,000,000.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes, for illustrative
purposes only, the anticipated effects of a Reverse Stock Split on our shares available for issuance based on information as of the Record
Date (unless otherwise noted below) and without giving effect to the treatment of fractional shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assuming this Proposal Is Approved by Stockholders
and Implemented by the Board:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Status</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <BR> Shares of <BR> Common <BR> Stock <BR> Authorized</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <BR> Shares of <BR> Common <BR> Stock <BR> Issued and <BR> Outstanding</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Number of <BR> Shares of <BR> Common <BR> Stock <BR> Reserved <BR> for Future <BR> Issuance<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <BR> Shares of <BR> Common <BR> Stock <BR> Authorized but <BR> Unissued and <BR> Unreserved</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">Pre-Reverse Stock Split</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">150,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: left">Post-Reverse Stock Split 1:5</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">150,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Post-Reverse Stock Split 1:12</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">150,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Includes shares of common stock reserved for issuance (i) upon the exercise of currently exercisable warrants and options and (ii) under the 2022 Plan less any exercised or converted awards.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A Reverse Stock Split would affect all stockholders
uniformly. As of the effective date of the Reverse Stock Split which shall be determined by the Board in its sole discretion (&ldquo;Effective
Date&rdquo;), each stockholder would own a reduced number of shares of common stock. Percentage ownership interests, voting rights and
other rights and preferences would not be affected, except to the extent that the Reverse Stock Split would result in fractional shares
(as described below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A Reverse Stock Split would not affect the registration
of our common stock under Section 12(b) of the Exchange Act and we would continue to be subject to the periodic reporting and other requirements
of the Exchange Act. Barring delisting by Nasdaq, our common stock would continue to be listed on Nasdaq under the symbol &ldquo;SXTP,&rdquo;
but would have a new Committee on Uniform Securities Identification Procedures number after the effective date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Fractional Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No fractional shares of common stock will be issued
as a result of the Reverse Stock Split. In lieu of any fractional shares to which a stockholder of record would otherwise be entitled,
we will issue a whole share in lieu of any fractional share of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of August 26, 2025, there were 22 common stockholders
of record. We do not intend for this transaction to be the first step in a series of plans or proposals of a &ldquo;going private transaction&rdquo;
within the meaning of Rule 13e-3 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Procedure for Effecting a Reverse Stock Split</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Beneficial Holders of Common Stock</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stockholders who hold their shares through a bank,
broker or other nominee will be treated in the same manner as registered stockholders who hold their shares in their names. Banks, brokers
and other nominees will be instructed to effect the Reverse Stock Split for beneficial owners of such shares. However, banks, brokers
or other nominees may implement different procedures than those to be followed by registered stockholders for processing the Reverse Stock
Split, particularly with respect to the treatment of fractional shares. Stockholders whose shares of common stock are held in the name
of a bank, broker or other nominee are encouraged to contact their bank, broker or other nominee with any questions regarding the procedures
for implementing the Reverse Stock Split with respect to their shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Registered Holders of Common Stock</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Registered stockholders hold shares electronically
in book-entry form under the direct registration system (i.e., do not have stock certificates evidencing their share ownership but instead
have a statement reflecting the number of shares registered in their accounts) and, as a result, do not need to take any action to receive
post-split shares. If they are entitled to receive post-split shares, they will automatically receive, at their address of record, a transaction
statement indicating the number of post-split shares held following the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Material U.S. Federal Income Tax Consequences</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of material U.S. federal
income tax consequences of a Reverse Stock Split to stockholders. This summary is based on the provisions of the Internal Revenue Code
of 1986, as amended (the &ldquo;Code&rdquo;), U.S. Treasury regulations, administrative rulings and judicial decisions, all as in effect
on the date of this filing, and all of which are subject to change or differing interpretations, possibly with retroactive effect. Any
such change or differing interpretation could affect the tax consequences described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have not sought and will not seek an opinion
of counsel or ruling from the Internal Revenue Service (the &ldquo;IRS&rdquo;) with respect to the statements made and the conclusions
reached in the following summary, and there can be no assurance that the IRS or a court will agree with such statements and conclusions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This summary is limited to stockholders that are
U.S. holders, as defined below, and that hold our common stock as a capital asset (generally, property held for investment).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This summary is for general information only and
does not address all U.S. federal income tax considerations that may be applicable to a holder&rsquo;s particular circumstances or to
holders that may be subject to special tax rules, such as, for example, brokers and dealers in securities, currencies or commodities,
banks and financial institutions, regulated investment companies, real estate investment trusts, expatriates, tax-exempt entities, governmental
organizations, traders in securities that elect to use a mark-to-market method of accounting for their securities, certain former citizens
or long-term residents of the U.S., insurance companies, persons holding shares of our common stock as part of a hedging, integrated or
conversion transaction or a straddle or persons deemed to sell shares of our common stock under the constructive sale provisions of the
Code, persons that hold more than 5% of our common stock, persons that hold our common stock in an individual retirement account, 401(k)
plan or similar tax-favored account or partnerships or other pass-through entities for U.S. federal income tax purposes and investors
in such entities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This summary does not address any U.S. federal
tax consequences other than U.S. federal income tax consequences (such as estate or gift tax consequences), the Medicare tax on net investment
income, the alternative minimum tax or any U.S. state, local or foreign tax consequences. This summary also does not address any U.S.
federal income tax considerations relating to any other transaction other than the Reverse Stock Split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of this summary, a &ldquo;U.S. holder&rdquo;
means a beneficial owner of our common stock that is, for U.S. federal income tax purposes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">an individual who is a citizen or resident of the U.S.;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a corporation created or organized in or under the laws of the U.S., any state thereof or the District of Columbia;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">an estate the income of which is subject to U.S. federal income taxation regardless of its source; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 37.35pt; text-align: justify; text-indent: -19.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a trust if (1) it is subject to the primary supervision of a court within the U.S. and one or more U.S. persons have the authority to control all substantial decisions of the trust or (2) it has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 37.35pt; text-align: justify; text-indent: -19.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 37.35pt; text-align: justify; text-indent: -19.25pt"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 37.35pt; text-align: justify; text-indent: -19.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an entity (or arrangement) classified as a
partnership for U.S. federal income tax purposes holds shares of our common stock, the tax treatment of a partner in the partnership will
generally depend upon the status of the partner and the activities of the partnership. If a holder of our common stock is a partner of
a partnership holding shares of our common stock, such holder should consult his or her own tax advisor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>This summary of certain U.S. federal income
tax consequences is for general information only and is not tax advice. Stockholders are urged to consult their own tax advisor with respect
to the application of U.S. federal income tax laws to their particular situation as well as any tax considerations arising under other
U.S. federal tax laws (such as the estate or gift tax laws) or under the laws of any state, local, foreign or other taxing jurisdiction
or under any applicable tax treaty.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Reverse Stock Split is intended to be treated
as a recapitalization for U.S. federal income tax purposes. Assuming the Reverse Stock Split qualifies as a recapitalization, except as
described below with respect to cash received in lieu of a fractional share, a U.S. holder will not recognize any gain or loss for U.S.
federal income tax purposes upon the Reverse Stock Split. In the aggregate, a U.S. holder&rsquo;s tax basis in the common stock received
pursuant to the Reverse Stock Split (excluding the portion of the tax basis that is allocable to any fractional share) will equal the
U.S. holder&rsquo;s tax basis in its common stock surrendered in the Reverse Stock Split in exchange therefor, and the holding period
of the U.S. holder&rsquo;s common stock received pursuant to the Reverse Stock Split will include the holding period of the common stock
surrendered in the Reverse Stock Split in exchange therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In general, a U.S. holder who receives a cash
payment in lieu of a fractional share will recognize capital gain or loss equal to the difference between the amount of cash received
in lieu of the fractional share and the portion of the U.S. holder&rsquo;s tax basis of the common stock surrendered in the Reverse Stock
Split that is allocable to the fractional share. Such gain or loss generally will be long-term capital gain or loss if the U.S. holder&rsquo;s
holding period in its common stock surrendered in the Reverse Stock Split is more than one year as of the date of the Reverse Stock Split.
The deductibility of net capital losses by individuals and corporations is subject to limitations. Depending on a stockholder&rsquo;s
individual facts and circumstances, it is possible that cash received in lieu of a fractional share could be treated as a distribution
under Section 301 of the Code, so stockholders should consult their own tax advisors as to that possibility and the resulting tax consequences
to them in that event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">U.S. holders that have acquired different blocks
of our common stock at different times or at different prices are urged to consult their own tax advisors regarding the allocation of
their aggregated adjusted basis among, and the holding period of, our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Information returns generally will be required
to be filed with the IRS with respect to the payment of cash in lieu of a fractional share made pursuant to the Reverse Stock Split unless
such U.S. holder is an exempt recipient and timely and properly establishes with the applicable withholding agent the exemption. In addition,
payments of cash in lieu of a fractional share made pursuant to the Reverse Stock Split may, under certain circumstances, be subject to
backup withholding, unless a U.S. holder timely provides to the applicable withholding agent proof of an applicable exemption or a correct
taxpayer identification number, and otherwise complies with the applicable requirements of the backup withholding rules. Any amounts withheld
under the backup withholding rules are not additional tax and may be refunded or credited against the U.S. holder&rsquo;s U.S. federal
income tax liability, provided that the U.S. holder timely furnishes the required information to the IRS. U.S. holders should consult
their tax advisors regarding their qualification for an exemption from backup withholding and the procedures for obtaining such an exemption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Accounting Consequences</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The par value per share of our common stock will
remain unchanged at $0.0001 per share following a Reverse Stock Split. As a result, as of the Effective Date, the stated capital on the
our balance sheets attributable to common stock will be reduced proportionally based on the Reverse Stock Split ratio, and the additional
paid-in capital will be credited with the amount by which the capital is reduced. The net income or loss per share of common stock will
be increased as a result of the fewer shares of common stock outstanding. The Reverse Stock Split will be reflected retroactively in our
consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The Board of Directors recommends a vote &ldquo;FOR&rdquo;
the approval of the Reverse Stock Split. The Board of</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Directors retains the discretion to abandon, and not implement, the aforementioned
amendments at any</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>time before they become effective.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_013"></A><B>PROPOSAL 4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>RATIFICATION OF THE SELECTION OF RBSM LLP AS
OUR INDEPENDENT AUDITOR FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Proposal</I>: The Board of Directors is asking
that you vote to ratify the Board&rsquo;s selection of RBSM LLP (&ldquo;RBSM&rdquo;) as our independent registered public accounting firm
for fiscal year 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">During the year ended
December 31, 2024, and 2023, we engaged RBSM LLP as our independent registered public accounting firm. For the years ended December 31,
2024, and 2023, we incurred fees, as discussed below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fiscal Year Ended<BR> December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%"><FONT STYLE="font-size: 10pt">Audit Fees<SUP>(1)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">163,069</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">182,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD><FONT STYLE="font-size: 10pt">Audit-Related Fees<SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">135,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Tax Fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: left">All Other Fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">298,069</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">247,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Audit fees consist of fees relating to the audit of the Company&rsquo;s annual consolidated financial statements and reviews of interim condensed consolidated financial statements.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Audit-related fees consisted of reviews of the Company&rsquo;s registration statements, consents, and the completion of comfort letter procedures associated with the Company&rsquo;s securities offerings.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our policy is to pre-approve all audit and permissible
non-audit services performed by the independent accountants. These services may include audit services, audit-related services, tax services
and other services. Under our Audit Committee&rsquo;s policy, pre-approval is generally provided for particular services or categories
of services, including planned services, project-based services and routine consultations. In addition, the Audit Committee may also pre-approve
particular services on a case-by-case basis. Our Audit Committee approved all services that our independent public accountants provided
to us in the past two fiscal years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Representatives of RBSM will attend the Annual
Meeting and will have the opportunity to make a statement if they desire and will be available to respond to appropriate questions from
stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ratification of the Board&rsquo;s appointment
of RBSM as our independent registered public accounting firm for the fiscal year ending December 31, 2025 requires the affirmative vote
of a majority of votes cast on the proposal. Abstentions will have no effect on the outcome of the vote on this proposal. Because this
is a routine matter, there will be no broker non-votes. If our stockholders do not ratify the appointment, the selection of another independent
registered public accounting firm may be considered by the Board. Even if the selection is ratified, the Board in its discretion may select
a different independent registered public accounting firm at any time during the year if it determines that such a change would be in
the best interests of the Company and our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The Board of Directors recommends that you vote
&ldquo;FOR&rdquo; approval of this proposal.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_014"></A>PROPOSAL 5</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>APPROVAL
OF THE ADJOURNMENT OF THE ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IN THE EVENT THERE ARE NOT SUFFICIENT VOTES IN FAVOR
OF THE DIRECTOR ELECTION PROPOSAL, THE 2022 PLAN AMENDMENT PROPOSA AND THE CERTIFICATE OF INCORPORATION AMENDMENT PROPOSAL,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Proposal 5 is to consider and vote upon the proposal
to approve adjourning the Annual Meeting, if necessary or appropriate in the discretion of the Board, to solicit additional proxies in
the event that there are not sufficient votes at the time of the Annual Meeting to approve the Director Election Proposal, 2022 Plan Amendment
Proposal and the Certificate of Incorporation Amendment Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Annual Meeting may be adjourned to another
time or place, if necessary or appropriate in the discretion of the Board, to permit further solicitation of proxies to obtain additional
votes in favor of the Director Election Proposal, 2022 Plan Amendment Proposal and the Certificate of Incorporation Amendment Proposal
(the &ldquo;Adjournment&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If, at the Annual Meeting, the number of shares
of common stock present or represented and voting in favor of the Director Election Proposal, the 2022 Plan Amendment Proposal and the
Certificate of Incorporation Amendment Proposal is insufficient to approve either such proposal, the Company intends to move for the Adjournment
in order to enable our Board to solicit additional proxies for approval of such proposal. We are asking our stockholders to approve this
Proposal 5 for the Adjournment if necessary or appropriate in the discretion of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Vote Required </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The affirmative vote of a majority of the votes
cast is required for approval of the Adjournment. For the purpose of the vote on this proposal, abstentions, broker non-votes and other
shares not voted will not be counted as votes cast and will have no effect on the result of the vote, although they will be considered
present for the purpose of determining the presence of a quorum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Recommendation </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The Board of Directors recommends that you vote
&ldquo;FOR&rdquo; approval of this proposal.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_015"></A><B>ADDITIONAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Solicitation Expenses:</I> Expenses in connection
with the solicitation of proxies will be paid by the Company. Proxies are being solicited principally by mail and by telephone. In addition,
our directors, officers and regular employees, without additional compensation, may solicit proxies personally, by e-mail, telephone,
fax or special letter. We will reimburse brokerage firms and others for their expenses in forwarding proxy materials to the beneficial
owners of our shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>How To Receive Additional Paper Copies of the
Proxy Statement</I>: The Company has adopted a procedure called &ldquo;householding&rdquo; which has been approved by the SEC. The Company
and some brokers household proxy materials, delivering a single notice and, if applicable, this Proxy Statement and Annual Report, to
multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders or they participate
in electronic delivery of proxy materials. Stockholders who participate in householding will continue to access and receive separate proxy
cards. This process will help reduce our printing and postage fees, as well as save natural resources. If at any time you no longer wish
to participate in householding and would prefer to receive a separate Proxy Statement, or if you are receiving multiple copies of the
Proxy Statement and wish to receive only one, please notify your broker if your shares are held in a brokerage account or us if you hold
registered shares. You can notify us by sending a written request to 60 Degrees Pharmaceuticals, Inc., Investor Relations, 1025 Connecticut
Avenue NW Suite 1000, Washington, D.C. 20036 or by calling Investor Relations at (202) 327-5422.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Stockholder Proposals for Consideration at
the 2026 Annual Meeting of Stockholders</I>: Under the rules of the SEC, if a stockholder wants us to include a proposal in our Proxy
Statement and proxy card for presentation at our 2026 Annual Meeting of Stockholders, the proposal must be received by us at our principal
executive offices at 1025 Connecticut Avenue NW Suite 1000, Washington, D.C. 20036 on or around July 10, 2026. The proposal should be
sent to the attention of the Chief Financial Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under our amended and restated bylaws, certain
procedures are provided that a stockholder must follow to introduce an item of business, including the nomination of someone as a director,
at an Annual Meeting of Stockholders that is not included in our Proxy Statement. These procedures provide that an item of business to
be introduced at an Annual Meeting of Stockholders must be submitted in writing to our Nominating and Corporate Governance Committee at
our principal executive offices and you must include information set forth in our amended and restated bylaws. See &ldquo;<I>Governance
of the Company &ndash; Stockholder Nominations</I>&rdquo; above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We must receive the notice of your intention to
propose an item of business at our 2026 Annual Meeting no later than the close of business on the ninetieth (90<SUP>th</SUP>) day nor
earlier than the close of business on the one hundred twentieth (120<SUP>th</SUP>) day prior to the first anniversary of the preceding
year&rsquo;s annual meeting as specified in our amended and restated bylaws. If the 2026 Annual Meeting is not held within 30 days before
or after the anniversary of the date of this year&rsquo;s Annual Meeting, then the item of business must be received by the tenth day
following the earlier of the date of mailing of the notice of the meeting or the public disclosure of the date of the meeting. Assuming
that our 2026 Annual Meeting is held within 30 days of the anniversary of this Annual Meeting, we must receive notice of your intention
to introduce a nomination or other item of business at that meeting on or around July 10, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may contact 60 Degrees Pharmaceuticals&rsquo;
Chief Financial Officer at the address mentioned above for a copy of the relevant bylaw provisions regarding the requirements for making
stockholder proposals and nominating director candidates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The chairperson of the Annual Meeting may refuse
to allow the transaction of any business, or to acknowledge the nomination of any person, not made in compliance with the foregoing procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>2024 Annual Report</I>: A copy of our 2024
Annual Report, as filed with the SEC on March 27, 2025, is available to stockholders without charge upon written request directed to our
Secretary at 1025 Connecticut Avenue NW Suite 1000, Washington, D.C. 20036 or by phone at (202) 327-5422. The Company makes available
free of charge on or through its website, <I>https://60degreespharma.com</I>, its Annual Reports on Form 10-K, Quarterly Reports on Form
10-Q, Current Reports on Form 8-K and all amendments to such reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act as soon
as reasonably practicable after filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Other Matters To Be Considered At The Annual
Meeting</I>: The Board is not aware of any other matters that are expected to come before the 2024 Annual Meeting other than those referred
to in this proxy statement and as set forth above. The Board has made no recommendation as to how the proxies will vote on such other
matters. If any other matter should come before the Annual Meeting, the individuals named on the proxy card intend to vote the proxies
in accordance with their best judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By Order of the Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 40%"><FONT STYLE="font-size: 10pt"><I>/s/ Geoffrey Dow</I></FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Geoffrey Dow</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Annex A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDMENT TO 60 DEGREES PHARMACEUTICALS, INC.
2022 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[*], 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the approval of
the stockholders (the &ldquo;<U>Stockholder Approval</U>&rdquo;) of 60 Degrees Pharmaceuticals, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;)
at the Company&rsquo;s 2024 Annual Meeting of Stockholders, the 60 Degrees Pharmaceuticals, Inc. 2022 Equity Incentive Plan (the &ldquo;<U>2022
Plan</U>&rdquo;) is hereby amended by amending and restating Section 3.1 in its entirety as of the effective date of the Stockholder Approval
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;3.1 <B>Stock Subject
to the Plan</B>. Subject to adjustment upon changes in capitalization of the Company as provided in Section 15 of the Plan and the automatic
increase set forth in Section 3.2 of the Plan, the maximum aggregate number of Shares that may be subject to Awards and sold under the
Plan will be equal to [__] Shares, In addition, Shares may become available for issuance under Sections 3.2 and 3.2 of the Plan. The Shares
may be authorized but unissued, or reacquired Common Stock.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as expressly amended
hereby, the terms of the 2022 Plan shall be and remain unchanged and the 2022 Plan as amended hereby shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Amendment to be executed by its duly authorized representative on the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">60 DEGREES PHARMACEUTICALS, INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Geoffrey Dow </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer and President</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 44; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Annex B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>60 DEGREES PHARMACEUTICALS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2022 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1. <B>Purposes of the Plan</B>. The purposes of
this Plan are:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">to attract and retain the best available personnel for positions of substantial responsibility,</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">to provide additional incentive to Employees, Directors and Consultants, and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">to promote the success of the Company&rsquo;s business.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The Plan permits the grant of
Incentive Stock Options, Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units and Performance
Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <B>Definitions</B>. As
used herein, the following definitions will apply:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.1 &ldquo;<B>Administrator</B>&rdquo;
means the Board or any of its Committees as will be administering the Plan, in accordance with Section 4 of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.2 &ldquo;<B>Applicable Laws</B>&rdquo;
means the legal and regulatory requirements relating to the administration of equity-based awards, including but not limited to the related
issuance of shares of Common Stock, including but not limited to, under U.S. federal and state corporate laws, U.S. federal and state
securities laws, the Code, any stock exchange or quotation system on which the Common Stock is listed or quoted and the applicable laws
of any non-U.S. country or jurisdiction where Awards are, or will be, granted under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.3 &ldquo;<B>Award</B>&rdquo;
means, individually or collectively, a grant under the Plan of Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock
Units, or Performance Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.4 &ldquo;<B>Award Agreement</B>&rdquo;
means the written or electronic agreement setting forth the terms and provisions applicable to each Award granted under the Plan. The
Award Agreement is subject to the terms and conditions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.5 &ldquo;<B>Board</B>&rdquo;
means the Board of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.6 &ldquo;<B>Change in Control</B>&rdquo;
means the occurrence of any of the following events:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) <B>Change in Ownership
of the Company</B>. A change in the ownership of the Company which occurs on the date that any one person, or more than one person acting
as a group (&ldquo;<B>Person</B>&rdquo;), acquires ownership of the stock of the Company that, together with the stock held by such Person,
constitutes more than fifty percent (50%) of the total voting power of the stock of the Company; provided, however, that for purposes
of this subsection (a), the acquisition of additional stock by any one Person, who is considered to own more than fifty percent (50%)
of the total voting power of the stock of the Company will not be considered a Change in Control; provided, further, that any change in
the ownership of the stock of the Company as a result of a private financing of the Company that is approved by the Board also will not
be considered a Change in Control. Further, if the stockholders of the Company immediately before such change in ownership continue to
retain immediately after the change in ownership, in substantially the same proportions as their ownership of shares of the Company&rsquo;s
voting stock immediately prior to the change in ownership, direct or indirect beneficial ownership of fifty percent (50%) or more of the
total voting power of the stock of the Company or of the ultimate parent entity of the Company, such event will not be considered a Change
in Control under this subsection (a). For this purpose, indirect beneficial ownership will include, without limitation, an interest resulting
from ownership of the voting securities of one or more corporations or other business entities which own the Company, as the case may
be, either directly or through one or more subsidiary corporations or other business entities; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 45; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) <B>Change in Effective
Control of the Company</B>. If the Company has a class of securities registered pursuant to Section 12 of the Exchange Act, a change in
the effective control of the Company which occurs on the date that a majority of members of the Board is replaced during any twelve (12)
month period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of
the appointment or election. For purposes of this subsection (b), if any Person is considered to be in effective control of the Company,
the acquisition of additional control of the Company by the same Person will not be considered a Change in Control; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c) <B>Change in Ownership
of a Substantial Portion of the Company&rsquo;s Assets</B>. A change in the ownership of a substantial portion of the Company&rsquo;s
assets which occurs on the date that any Person acquires (or has acquired during the twelve (12) month period ending on the date of the
most recent acquisition by such Person or Persons) assets from the Company that have a total gross fair market value equal to or more
than fifty percent (50%) of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition
or acquisitions; provided, however, that for purposes of this subsection (c), the following will not constitute a change in the ownership
of a substantial portion of the Company&rsquo;s assets: (i) a transfer to an entity that is controlled by the Company&rsquo;s stockholders
immediately after the transfer, or (ii) a transfer of assets by the Company to: (A) a stockholder of the Company (immediately before the
asset transfer) in exchange for or with respect to the Company&rsquo;s stock, (B) an entity, fifty percent (50%) or more of the total
value or voting power of which is owned, directly or indirectly, by the Company, (C) a Person, that owns, directly or indirectly, fifty
percent (50%) or more of the total value or voting power of all the outstanding stock of the Company, or (D) an entity, at least fifty
percent (50%) of the total value or voting power of which is owned, directly or indirectly, by a Person described in this subsection (c)(ii)(C).
For purposes of this subsection (c), gross fair market value means the value of the assets of the Company, or the value of the assets
being disposed of, determined without regard to any liabilities associated with such assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">For purposes of this Section
2.6, persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation,
purchase or acquisition of stock, or similar business transaction with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Notwithstanding the foregoing,
a transaction will not be deemed a Change in Control unless the transaction qualifies as a change in control event within the meaning
of Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Further and for the avoidance
of doubt, a transaction will not constitute a Change in Control if: (x) its primary purpose is to change the jurisdiction of the Company&rsquo;s
incorporation, or (y) its primary purpose is to create a holding company that will be owned in substantially the same proportions by the
persons who held the Company&rsquo;s securities immediately before such transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.7 &ldquo;<B>Code</B>&rdquo;
means the U.S. Internal Revenue Code of 1986, as amended. Reference to a specific section of the Code or regulation thereunder will include
such section or regulation, any valid regulation or other formal guidance of general or direct applicability promulgated under such section,
and any comparable provision of any future legislation or regulation amending, supplementing or superseding such section or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.8 &ldquo;<B>Committee</B>&rdquo;
means a committee of Directors or of other individuals satisfying Applicable Laws appointed by the Board, or by a duly authorized committee
of the Board, in accordance with Section 4 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.9 &ldquo;<B>Common Stock</B>&rdquo;
means the common stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.10 &ldquo;<B>Company</B>&rdquo;
means 60 Degrees Pharmaceuticals, Inc., a Delaware corporation, or any successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.11 &ldquo;<B>Consultant</B>&rdquo;
means any natural person, including an advisor, engaged by the Company or any of its Parent or Subsidiaries to render bona fide services
to such entity, provided the services (a) are not in connection with the offer or sale of securities in a capital-raising transaction,
and (b) do not directly promote or maintain a market for the Company&rsquo;s securities, in each case, within the meaning of Form S-8
promulgated under the Securities Act, and provided further, that a Consultant will include only those persons to whom the issuance of
Shares may be registered under Form S-8 promulgated under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.12 &ldquo;<B>Director</B>&rdquo;
means a member of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.13 &ldquo;<B>Disability</B>&rdquo;
means total and permanent disability as defined in Code Section 22(e)(3), provided that in the case of Awards other than Incentive Stock
Options, the Administrator in its discretion may determine whether a permanent and total disability exists in accordance with uniform
and non-discriminatory standards adopted by the Administrator from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.14 &ldquo;<B>Employee</B>&rdquo;
means any person, including Officers and Directors, employed by the Company or any Parent or Subsidiary of the Company. Neither service
as a Director nor payment of a director&rsquo;s fee by the Company will be sufficient to constitute &ldquo;employment&rdquo; by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.15 &ldquo;<B>Exchange Act</B>&rdquo;
means the U.S. Securities Exchange Act of 1934, as amended, including the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.16 &ldquo;<B>Exchange Program</B>&rdquo;
means a program under which (a) outstanding Awards are surrendered or cancelled in exchange for awards of the same type (which may have
higher or lower exercise prices and different terms), awards of a different type, and/or cash, (b) Participants would have the opportunity
to transfer any outstanding Awards to a financial institution or other person or entity selected by the Administrator, and/or (c) the
exercise price of an outstanding Award is reduced or increased. The Administrator will determine the terms and conditions of any Exchange
Program in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.17 &ldquo;<B>Fair Market Value</B>&rdquo;
means, as of any date and unless the Administrator determines otherwise, the value of Common Stock determined as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) If the Common Stock is
listed on any established stock exchange or a national market system, including without limitation the New York Stock Exchange or the
Nasdaq Global Select Market, the Nasdaq Global Market, or the Nasdaq Capital Market of The Nasdaq Stock Market, its Fair Market Value
will be the closing sales price for such stock (or, if no closing sales price was reported on that date, as applicable, on the last Trading
Day such closing sales price was reported) as quoted on such exchange or system on the date of determination, as reported in <I>The Wall
Street Journal</I> or such other source as the Administrator deems reliable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) If the Common Stock is
regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair Market Value of a Share will be the mean
between the high bid and low asked prices for the Common Stock on the day of determination (or, if no bids and asks were reported on that
date, as applicable, on the last Trading Day such bids and asks were reported), as reported in <I>The Wall Street Journal</I> or such
other source as the Administrator deems reliable; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c) For purposes of any Awards
granted on the Registration Date, the Fair Market Value will be the initial price to the public as set forth in the final prospectus included
within the registration statement on Form S-1 filed with the Securities and Exchange Commission for the initial public offering of the
Common Stock; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d) In the absence of an established
market for the Common Stock, the Fair Market Value will be determined in good faith by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, for purposes of determining the fair
market value of shares for any reason other than the determination of the exercise price of Options or Stock Appreciation Rights, fair
market value will be determined by the Administrator in a manner compliant with Applicable Laws and applied consistently for such purpose.
The determination of fair market value for purposes of tax withholding may be made in the Administrator&rsquo;s sole discretion subject
to Applicable Laws and is not required to be consistent with the determination of fair market value for other purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.18 &ldquo;<B>Fiscal Year</B>&rdquo;
means the fiscal year of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.19 &ldquo;<B>Incentive Stock
Option</B>&rdquo; means an Option that by its terms qualifies and is otherwise intended to qualify as an incentive stock option within
the meaning of Code Section 422 and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.20 &ldquo;<B>Nonstatutory
Stock Option</B>&rdquo; means an Option that by its terms does not qualify or is not intended to qualify as an Incentive Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.21 &ldquo;<B>Officer</B>&rdquo;
means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.22 &ldquo;<B>Option</B>&rdquo;
means a stock option granted pursuant to the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.23 &ldquo;<B>Outside Director</B>&rdquo;
means a Director who is not an Employee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.24 &ldquo;<B>Parent</B>&rdquo;
means a &ldquo;parent corporation,&rdquo; whether now or hereafter existing, as defined in Code Section 424(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.25 &ldquo;<B>Participant</B>&rdquo;
means the holder of an outstanding Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.26 <U>&ldquo;<B>Performance
Awards</B></U>&rdquo; means an Award which may be earned in whole or in part upon attainment of performance goals or other vesting criteria
as the Administrator may determine and which may be cash- or stock-denominated and may be settled for cash, Shares or other securities
or a combination of the foregoing under Section 10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.27 &ldquo;<B>Performance Period</B>&rdquo;
means Performance Period as defined in Section 10.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.28 &ldquo;<B>Period of Restriction</B>&rdquo;
means the period (if any) during which the transfer of Shares of Restricted Stock are subject to restrictions and therefore, the Shares
are subject to a substantial risk of forfeiture. Such restrictions may be based on the passage of time, the achievement of target levels
of performance, or the occurrence of other events as determined by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.29 &ldquo;<B>Plan</B>&rdquo;
means this 60 Degrees Pharmaceuticals, Inc. 2022 Equity Incentive Plan, as may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.30 &ldquo;<B>Registration
Date</B>&rdquo; means the effective date of the first registration statement that is filed by the Company and declared effective pursuant
to Section 12(b) of the Exchange Act, with respect to any class of the Company&rsquo;s securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.31 &ldquo;<B>Restricted Stock</B>&rdquo;
means Shares issued pursuant to an Award of Restricted Stock under Section 8 of the Plan, or issued pursuant to the early exercise of
an Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.32 &ldquo;<B>Restricted Stock
Unit</B>&rdquo; means a bookkeeping entry representing an amount equal to the Fair Market Value of one Share, granted pursuant to Section
9. Each Restricted Stock Unit represents an unfunded and unsecured obligation of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.33 &ldquo;<B>Rule 16b-3</B>&rdquo;
means Rule 16b-3 of the Exchange Act or any successor to Rule 16b-3, as in effect when discretion is being exercised with respect to the
Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.34 &ldquo;<B>Section 16b</B>&rdquo;
means Section 16(b) of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.35 &ldquo;<B>Section 409A</B>&rdquo;
means Code Section 409A and the U.S. Treasury Regulations and guidance thereunder, and any applicable state law equivalent, as each may
be promulgated, amended or modified from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.36 &ldquo;<B>Securities Act</B>&rdquo;
means the U.S. Securities Act of 1933, as amended, including the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.37 &ldquo;<B>Service Provider</B>&rdquo;
means an Employee, Director or Consultant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.38 &ldquo;<B>Share</B>&rdquo;
means a share of the Common Stock, as adjusted in accordance with Section 15 of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.39 &ldquo;<B>Stock Appreciation
Right</B>&rdquo; means an Award, granted alone or in connection with an Option, that pursuant to Section 7 is designated as a Stock Appreciation
Right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.40 &ldquo;<B>Subsidiary</B>&rdquo;
means a &ldquo;subsidiary corporation,&rdquo; whether now or hereafter existing, as defined in Code Section 424(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.41 &ldquo;<B>Trading Day</B>&rdquo;
means a day that the primary stock exchange, national market system, or other trading platform, as applicable, upon which the Common Stock
is listed (or otherwise trades regularly, as determined by the Administrator, in its sole discretion) is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.42 &ldquo;<B>U.S. Treasury
Regulations</B>&rdquo; means the Treasury Regulations of the Code. Reference to a specific Treasury Regulation or Section of the Code
will include such Treasury Regulation or Section, any valid regulation promulgated under such Section, and any comparable provision of
any future legislation or regulation amending, supplementing or superseding such Section or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3. <B>Stock Subject to the Plan</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.1 <B>Stock Subject to the
Plan</B>. Subject to adjustment upon changes in capitalization of the Company as provided in Section 15 of the Plan and the automatic
increase set forth in Section 3.2 of the Plan, the maximum aggregate number of Shares that may be subject to Awards and sold under the
Plan will be equal to 238,601 Shares, In addition, Shares may become available for issuance under Sections 3.2 and 3.2 of the Plan. The
Shares may be authorized but unissued, or reacquired Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.2 <B>Automatic Share Reserve
Increase</B>. Subject to adjustment upon changes in capitalization of the Company as provided in Section 15, the number of Shares available
for issuance under the Plan will be increased on the first day of each Fiscal Year beginning with the 2023 Fiscal Year, in an amount equal
to the least of (a) a number of Shares equal to four percent (4%) of the total number of shares of all classes of common stock of the
Company outstanding on the last day of the immediately preceding Fiscal Year, or (b) such number of Shares determined by the Administrator
no later than the last day of the immediately preceding Fiscal Year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.3 <B>Lapsed Awards</B>. If
an Award expires or becomes unexercisable without having been exercised in full, is surrendered pursuant to an Exchange Program, or, with
respect to Restricted Stock, Restricted Stock Units, or Performance Awards is forfeited to or repurchased by the Company due to the failure
to vest, the unpurchased Shares (or for Awards other than Options or Stock Appreciation Rights the forfeited or repurchased Shares) which
were subject thereto will become available for future grant or sale under the Plan (unless the Plan has terminated). With respect to Stock
Appreciation Rights, only Shares actually issued (i.e., the net Shares issued) pursuant to a Stock Appreciation Right will cease to be
available under the Plan; all remaining Shares under Stock Appreciation Rights will remain available for future grant or sale under the
Plan (unless the Plan has terminated). Shares that actually have been issued under the Plan under any Award will not be returned to the
Plan and will not become available for future distribution under the Plan; provided, however, that if Shares issued pursuant to Awards
of Restricted Stock, Restricted Stock Units or Performance Awards are repurchased by the Company or are forfeited to the Company due to
the failure to vest, such Shares will become available for future grant under the Plan. Shares used to pay the exercise price of an Award
or to satisfy the tax liabilities or withholdings related to an Award will become available for future grant or sale under the Plan. To
the extent an Award under the Plan is paid out in cash rather than Shares, such cash payment will not result in reducing the number of
Shares available for issuance under the Plan. Notwithstanding the foregoing and, subject to adjustment as provided in Section 15, the
maximum number of Shares that may be issued upon the exercise of Incentive Stock Options will equal the aggregate Share number stated
in Section 3.1, plus, to the extent allowable under Code Section 422 and the U.S. Treasury Regulations promulgated thereunder, any Shares
that become available for issuance under the Plan pursuant to Sections 3.2 and 3.3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.4 <B>Share Reserve</B>. The
Company, during the term of this Plan, will at all times reserve and keep available such number of Shares as will be sufficient to satisfy
the requirements of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <B>Administration of the
Plan</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.1 <B>Procedure</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.1.1 <B>Multiple Administrative
Bodies</B>. Different Committees with respect to different groups of Service Providers may administer the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.1.2 <B>Rule 16b-3</B>. To
the extent desirable to qualify transactions hereunder as exempt under Rule 16b-3, the transactions contemplated hereunder will be structured
to satisfy the requirements for exemption under Rule 16b-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.1.3 <B>Other Administration</B>.
Other than as provided above, the Plan will be administered by (A) the Board or (B) a Committee, which Committee will be constituted to
comply with Applicable Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.2 <B>Powers of the Administrator</B>.
Subject to the provisions of the Plan, and in the case of a Committee, subject to the specific duties delegated by the Board to such Committee,
the Administrator will have the authority, in its discretion:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) to determine the Fair
Market Value;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) to select the Service
Providers to whom Awards may be granted hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c) to determine the number
of Shares or dollar amounts to be covered by each Award granted hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d) to approve forms of Award
Agreements for use under the Plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e) to determine the terms
and conditions, not inconsistent with the terms of the Plan, of any Award granted hereunder. Such terms and conditions include, but are
not limited to, the exercise price, the time or times when Awards may be exercised (which may be based on performance criteria), any vesting
acceleration or waiver of forfeiture restrictions, and any restriction or limitation regarding any Award or the Shares relating thereto
(including but not limited to, temporarily suspending the exercisability of an Award if the Administrator deems such suspension to be
necessary or appropriate for administrative purposes or to comply with Applicable Laws, provided that such suspension must be lifted prior
to the expiration of the maximum term and post-termination exercisability period of an Award), based in each case on such factors as the
Administrator will determine;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f) to institute and determine
the terms and conditions of an Exchange Program, including, subject to Section 20.3, to unilaterally implement an Exchange Program without
the consent of the applicable Award holder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g) to construe and interpret
the terms of the Plan and Awards granted pursuant to the Plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h) to prescribe, amend and
rescind rules and regulations relating to the Plan, including rules and regulations relating to sub-plans established for the purpose
of facilitating compliance with applicable non-U.S. laws, easing the administration of the Plan and/or for qualifying for favorable tax
treatment under applicable non-U.S. laws, in each case as the Administrator may deem necessary or advisable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) to modify or amend each
Award (subject to Section 20.3), including but not limited to the discretionary authority to extend the post-termination exercisability
period of Awards and to extend the maximum term of an Option or Stock Appreciation Right (subject to Sections 6.4 and 7.5);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(j) to allow Participants
to satisfy withholding tax obligations in a manner prescribed in Section 16;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(k) to authorize any person
to execute on behalf of the Company any instrument required to effect the grant of an Award previously granted by the Administrator;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(l) to allow a Participant
to defer the receipt of the payment of cash or the delivery of Shares that otherwise would be due to such Participant under an Award;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(m) to make all other determinations
deemed necessary or advisable for administering the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.3 <B>Effect of Administrator&rsquo;s
Decision</B>. The Administrator&rsquo;s decisions, determinations and interpretations will be final and binding on all Participants and
any other holders of Awards and will be given the maximum deference permitted by Applicable Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <B>Eligibility</B>. Nonstatutory
Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units and Performance Awards may be granted to Service Providers.
Incentive Stock Options may be granted only to Employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <B>Stock Options</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1 <B>Grant of Options</B>.
Subject to the terms and provisions of the Plan, the Administrator, at any time and from time to time, may grant Options to Service Providers
in such amounts as the Administrator, in its sole discretion, will determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.2 <B>Option Agreement</B>.
Each Award of an Option will be evidenced by an Award Agreement that will specify the exercise price, the term of the Option, the number
of Shares subject to the Option, the exercise restrictions, if any, applicable to the Option, and such other terms and conditions as the
Administrator, in its sole discretion, will determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.3 <B>Limitations</B>. Each
Option will be designated in the Award Agreement as either an Incentive Stock Option or a Nonstatutory Stock Option. Notwithstanding such
designation, however, to the extent that the aggregate fair market value of the shares with respect to which incentive stock options are
exercisable for the first time by the Participant during any calendar year (under all plans of the Company and any Parent or Subsidiary)
exceeds one hundred thousand dollars ($100,000), such Options will be treated as nonstatutory stock options. For purposes of this Section
6.3, incentive stock options will be taken into account in the order in which they were granted, the fair market value of the Shares will
be determined as of the time the Option with respect to such Shares is granted, and calculation will be performed in accordance with Code
Section 422 and the U.S. Treasury Regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.4 <B>Term of Option</B>. The
term of each Option will be stated in the Award Agreement; provided, however, that the term will be no more than ten (10) years from the
date of grant thereof. In the case of an Incentive Stock Option granted to a Participant who, at the time the Incentive Stock Option is
granted, owns stock representing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company
or any Parent or Subsidiary of the Company, the term of the Incentive Stock Option will be five (5) years from the date of grant or such
shorter term as may be provided in the Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.5 <B>Option Exercise Price
and Consideration</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6.5.1 <B>Exercise Price</B>.
The per Share exercise price for the Shares to be issued pursuant to the exercise of an Option will be determined by the Administrator,
but will be no less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant. In addition, in the case
of an Incentive Stock Option granted to an Employee who owns stock representing more than ten percent (10%) of the voting power of all
classes of stock of the Company or any Parent or Subsidiary of the Company, the per Share exercise price will be no less than one hundred
ten percent (110%) of the Fair Market Value per Share on the date of grant. Notwithstanding the foregoing provisions of this Section 6.5.1,
Options may be granted with a per Share exercise price of less than one hundred percent (100%) of the Fair Market Value per Share on the
date of grant pursuant to a transaction described in, and in a manner consistent with, Code Section 424(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6.5.2 <B>Waiting Period and
Exercise Dates</B>. At the time an Option is granted, the Administrator will fix the period within which the Option may be exercised and
will determine any conditions that must be satisfied before the Option may be exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6.5.3 <B>Form of Consideration</B>.
The Administrator will determine the acceptable form of consideration for exercising an Option, including the method of payment. In the
case of an Incentive Stock Option, the Administrator will determine the acceptable form of consideration at the time of grant. Such consideration
may consist entirely of: (a) cash (including cash equivalents); (b) check; (c) promissory note, to the extent permitted by Applicable
Laws, (d) other Shares, provided that such Shares have a Fair Market Value on the date of surrender equal to the aggregate exercise price
of the Shares as to which such Option will be exercised and provided further that accepting such Shares will not result in any adverse
accounting consequences to the Company, as the Administrator determines in its sole discretion; (e) consideration received by the Company
under a cashless exercise program (whether through a broker or otherwise) implemented by the Company in connection with the Plan; (f)
by net exercise; (g) such other consideration and method of payment for the issuance of Shares to the extent permitted by Applicable Laws,
or (h) any combination of the foregoing methods of payment. In making its determination as to the type of consideration to accept, the
Administrator will consider if acceptance of such consideration may be reasonably expected to benefit the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.6 <B>Exercise of Option</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6.6.1 <B>Procedure for Exercise;
Rights as a Stockholder</B>. Any Option granted hereunder will be exercisable according to the terms of the Plan and at such times and
under such conditions as determined by the Administrator and set forth in the Award Agreement. An Option may not be exercised for a fraction
of a Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">An Option will be deemed exercised
when the Company receives: (a) notice of exercise (in such form as the Administrator may specify from time to time) from the person entitled
to exercise the Option, and (b) full payment for the Shares with respect to which the Option is exercised (together with applicable tax
withholdings). Full payment may consist of any consideration and method of payment authorized by the Administrator and permitted by the
Award Agreement and the Plan. Shares issued upon exercise of an Option will be issued in the name of the Participant or, if requested
by the Participant, in the name of the Participant and his or her spouse. Until the Shares are issued (as evidenced by the appropriate
entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any
other rights as a stockholder will exist with respect to the Shares subject to an Option, notwithstanding the exercise of the Option.
The Company will issue (or cause to be issued) such Shares promptly after the Option is exercised. No adjustment will be made for a dividend
or other right for which the record date is prior to the date the Shares are issued, except as provided in Section 15 of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Exercising an Option in any
manner will decrease the number of Shares thereafter available, both for purposes of the Plan and for sale under the Option, by the number
of Shares as to which the Option is exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6.6.2 <B>Termination of Relationship
as a Service Provider</B>. If a Participant ceases to be a Service Provider, other than upon such cessation as the result of the Participant&rsquo;s
death or Disability, the Participant may exercise his or her Option within three (3) months of such cessation, or such shorter or longer
period of time, as is specified in the Award Agreement, in no event later than the expiration of the term of such Option as set forth
in the Award Agreement or Section 6.4. Unless otherwise provided by the Administrator or set forth in the Award Agreement or other written
agreement authorized by the Administrator between the Participant and the Company or any of its Subsidiaries or Parents, as applicable,
if on such date of cessation the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion
of the Option will revert to the Plan immediately. If after such cessation the Participant does not exercise his or her Option within
the time specified by the Administrator, the Option will terminate, and the Shares covered by such Option will revert to the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6.6.3 <B>Disability of Participant</B>.
If a Participant ceases to be a Service Provider as a result of the Participant&rsquo;s Disability, the Participant may exercise his or
her Option within six (6) months of such cessation, or such longer or shorter period of time as is specified in the Award Agreement (but
in no event later than the expiration of the term of such Option as set forth in the Award Agreement or Section 6.4, as applicable) to
the extent the Option is vested on such date of cessation. Unless otherwise provided by the Administrator or set forth in the Award Agreement
or other written agreement authorized by the Administrator between the Participant and the Company or any of its Subsidiaries or Parents,
as applicable, if on the date of such cessation the Participant is not vested as to his or her entire Option, the Shares covered by the
unvested portion of the Option will revert to the Plan immediately. If after such cessation the Participant does not exercise his or her
Option within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert to the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6.6.4 <B>Death of Participant</B>.
If a Participant dies while a Service Provider, the Option may be exercised within six (6) months following the Participant&rsquo;s death,
or within such longer or shorter period of time as is specified in the Award Agreement (but in no event later than the expiration of the
term of such Option as set forth in the Award Agreement or Section 6.4, as applicable), by the Participant&rsquo;s designated beneficiary,
provided such beneficiary has been designated prior to the Participant&rsquo;s death in a form (if any) acceptable to the Administrator.
If the Administrator has not permitted the designation of a beneficiary or if no such beneficiary has been designated by the Participant,
then such Option may be exercised by the personal representative of the Participant&rsquo;s estate or by the person(s) to whom the Option
is transferred pursuant to the Participant&rsquo;s will or in accordance with the laws of descent and distribution (each, a &ldquo;<B>Legal
Representative</B>&rdquo;). If the Option is exercised pursuant to this Section 6.6.4, Participant&rsquo;s designated beneficiary or Legal
Representative shall be subject to the terms of this Plan and the Award Agreement, including but not limited to the restrictions on transferability
and forfeitability applicable to the Service Provider. Unless otherwise provided by the Administrator or set forth in the Award Agreement
or other written agreement authorized by the Administrator between the Participant and the Company or any of its Subsidiaries or Parents,
as applicable, if at the time of death Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion
of the Option will revert to the Plan immediately. If the Option is not so exercised within the time specified herein, the Option will
terminate, and the Shares covered by such Option will revert to the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6.6.5 <B>Tolling Expiration</B>.
A Participant&rsquo;s Award Agreement may also provide that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(a) if the exercise of the
Option following the cessation of Participant&rsquo;s status as a Service Provider (other than upon the Participant&rsquo;s death or Disability)
would result in liability under Section 16b, then the Option will terminate on the earlier of (i) the expiration of the term of the Option
set forth in the Award Agreement, or (ii) the tenth (10<SUP>th</SUP>) day after the last date on which such exercise would result in liability
under Section 16b; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(b) if the exercise of the
Option following the cessation of the Participant&rsquo;s status as a Service Provider (other than upon the Participant&rsquo;s death
or Disability) would be prohibited at any time solely because the issuance of Shares would violate the registration requirements under
the Securities Act, then the Option will terminate on the earlier of (i) the expiration of the term of the Option or (ii) the expiration
of a period of thirty (30) days after the cessation of the Participant&rsquo;s status as a Service Provider during which the exercise
of the Option would not be in violation of such registration requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7. <B>Stock Appreciation Rights</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.1 <B>Grant of Stock Appreciation
Rights</B>. Subject to the terms and conditions of the Plan, a Stock Appreciation Right may be granted to Service Providers at any time
and from time to time as will be determined by the Administrator, in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.2 <B>Number of Shares</B>.
The Administrator will have complete discretion to determine the number of Shares subject to any Award of Stock Appreciation Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.3 <B>Exercise Price and Other
Terms</B>. The per Share exercise price for the Shares that will determine the amount of the payment to be received upon exercise of a
Stock Appreciation Right as set forth in Section 7.6 will be determined by the Administrator and will be no less than one hundred percent
(100%) of the Fair Market Value per Share on the date of grant. Otherwise, the Administrator, subject to the provisions of the Plan, will
have complete discretion to determine the terms and conditions of Stock Appreciation Rights granted under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.4 <B>Stock Appreciation Right
Agreement</B>. Each Stock Appreciation Right grant will be evidenced by an Award Agreement that will specify the exercise price, the term
of the Stock Appreciation Right, the conditions of exercise, and such other terms and conditions as the Administrator, in its sole discretion,
will determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.5 <B>Expiration of Stock Appreciation
Rights</B>. A Stock Appreciation Right granted under the Plan will expire upon the date determined by the Administrator, in its sole discretion,
and set forth in the Award Agreement. Notwithstanding the foregoing, the rules of Section 6.4 relating to the maximum term and Section
6.6 relating to exercise also will apply to Stock Appreciation Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.6 <B>Payment of Stock Appreciation
Right Amount</B>. Upon exercise of a Stock Appreciation Right, a Participant will be entitled to receive payment from the Company in an
amount determined by multiplying:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) The difference between
the Fair Market Value of a Share on the date of exercise over the exercise price; times</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) The number of Shares with
respect to which the Stock Appreciation Right is exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">At the discretion of the Administrator,
the payment upon Stock Appreciation Right exercise may be in cash, in Shares of equivalent value, or in some combination thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>8. Restricted Stock</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.1 <B>Grant of Restricted Stock</B>.
Subject to the terms and provisions of the Plan, the Administrator, at any time and from time to time, may grant Shares of Restricted
Stock to Service Providers in such amounts as the Administrator, in its sole discretion, will determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.2 <B>Restricted Stock Agreement</B>.
Each Award of Restricted Stock will be evidenced by an Award Agreement that will specify the Period of Restriction (if any), the number
of Shares granted, and such other terms and conditions as the Administrator, in its sole discretion, will determine. Unless the Administrator
determines otherwise, the Company as escrow agent will hold Shares of Restricted Stock until the restrictions on such Shares have lapsed.
The Administrator, in its sole discretion, may determine that an Award of Restricted Stock will not be subject to any Period of Restriction
and consideration for such Award is paid for by past services rendered as a Service Provider.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.3 <B>Transferability</B>.
Except as provided in this Section 8 or as the Administrator determines, Shares of Restricted Stock may not be sold, transferred, pledged,
assigned, or otherwise alienated or hypothecated until the end of the applicable Period of Restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.4 <B>Other Restrictions</B>.
The Administrator, in its sole discretion, may impose such other restrictions on Shares of Restricted Stock as it may deem advisable or
appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.5 <B>Removal of Restrictions</B>.
Except as otherwise provided in this Section 8, Shares of Restricted Stock covered by each Restricted Stock grant made under the Plan
will be released from escrow as soon as practicable after the last day of the Period of Restriction or at such other time as the Administrator
may determine. The Administrator, in its discretion, may accelerate the time at which any restrictions will lapse or be removed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.6 <B>Voting Rights</B>. During
the Period of Restriction, Service Providers holding Shares of Restricted Stock granted hereunder may exercise full voting rights with
respect to those Shares, unless the Administrator determines otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.7 <B>Dividends and Other Distributions</B>.
During the Period of Restriction, Service Providers holding Shares of Restricted Stock will be entitled to receive all dividends and other
distributions paid with respect to such Shares, unless the Administrator provides otherwise. If any such dividends or distributions are
paid in Shares, the Shares will be subject to the same restrictions on transferability and forfeitability as the Shares of Restricted
Stock with respect to which they were paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.8 <B>Return of Restricted
Stock to Company</B>. On the date set forth in the Award Agreement, the Restricted Stock for which restrictions have not lapsed will revert
to the Company and again will become available for grant under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9. <B>Restricted Stock Units</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.1 <B>Grant</B>. Restricted
Stock Units may be granted at any time and from time to time as determined by the Administrator. After the Administrator determines that
it will grant Restricted Stock Units, it will advise the Participant in an Award Agreement of the terms, conditions, and restrictions
related to the grant, including the number of Restricted Stock Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.2 <B>Vesting Criteria and
Other Terms</B>. The Administrator will set vesting criteria in its discretion, which, depending on the extent to which the criteria are
met, will determine the number of Restricted Stock Units that will be paid out to the Participant. The Administrator may set vesting criteria
based upon the achievement of Company-wide, divisional, business unit, or individual goals (including, but not limited to, continued employment
or service), applicable federal or state securities laws or any other basis determined by the Administrator in its discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.3 <B>Earning Restricted Stock
Units</B>. Upon meeting the applicable vesting criteria, the Participant will be entitled to receive a payout as determined by the Administrator.
Notwithstanding the foregoing, at any time after the grant of Restricted Stock Units, the Administrator, in its sole discretion, may reduce
or waive any vesting criteria that must be met to receive a payout.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.4 <B>Form and Timing of Payment</B>.
Payment of earned Restricted Stock Units will be made at the time(s) determined by the Administrator and set forth in the Award Agreement.
The Administrator, in its sole discretion, may settle earned Restricted Stock Units in cash, Shares, or a combination of both.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.5 <B>Cancellation</B>. On
the date set forth in the Award Agreement, all unearned Restricted Stock Units will be forfeited to the Company.</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">10. <B>Performance Awards</B><U>.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.1 <B>Award Agreement</B>.
Each Performance Award will be evidenced by an Award Agreement that will specify any time period during which any performance objectives
or other vesting provisions will be measured (&ldquo;Performance Period&rdquo;), and such other terms and conditions as the Administrator
determines. Each Performance Award will have an initial value that is determined by the Administrator on or before its date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.2 <B>Objectives or Vesting
Provisions and Other Terms. </B>The Administrator will set any objectives or vesting provisions that, depending on the extent to which
any such objectives or vesting provisions are met, will determine the value of the payout for the Performance Awards. The Administrator
may set vesting criteria based upon the achievement of Company-wide, divisional, business unit, or individual goals (including, but not
limited to, continued employment or service), applicable federal or state securities laws, or any other basis determined by the Administrator
in its discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.3 <B>Earning Performance
Awards</B>. After an applicable Performance Period has ended, the holder of a Performance Award will be entitled to receive a payout for
the Performance Award earned by the Participant over the Performance Period. The Administrator, in its discretion, may reduce or waive
any performance objectives or other vesting provisions for such Performance Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.4 <B>Form and Timing of Payment</B>.
Payment of earned Performance Awards will be made at the time(s) determined by the Administrator and set forth in the Award Agreement.
The Administrator, in its sole discretion, may settle earned Performance Awards in cash, Shares, or a combination of both.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.5 <B>Cancellation of Performance
Awards</B>. On the date set forth in the Award Agreement, all unearned or unvested Performance Awards will be forfeited to the Company,
and again will be available for grant under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11. <B>Outside Director Award
Limitations</B>. No Outside Director may be granted, in any Fiscal Year, equity awards (including any Awards granted under this Plan),
the value of which will be based on their grant date fair value determined in accordance with U.S. generally accepted accounting principles,
and be provided any other compensation (including without limitation any cash retainers or fees) in amounts that, in the aggregate, exceed
$500,000, provided that such amount is increased to $750,000 in the Fiscal Year of such individual&rsquo;s initial service as an Outside
Director. Any Awards granted or other compensation provided to an individual (a) for such individual&rsquo;s services as an Employee,
or for such individual&rsquo;s services as a Consultant (other than as an Outside Director), or (b) prior to the Registration Date, will
be excluded for purposes of this Section 11.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12. <B>Compliance With Section
409A</B>. Awards will be designed and operated in such a manner that they are either exempt from the application of, or comply with, the
requirements of Section 409A such that the grant, payment, settlement or deferral will not be subject to the additional tax or interest
applicable under Section 409A, except as otherwise determined in the sole discretion of the Administrator. The Plan and each Award Agreement
under the Plan is intended to be exempt from or meet the requirements of Section 409A and will be construed and interpreted in accordance
with such intent (including with respect to any ambiguities or ambiguous terms), except as otherwise determined in the sole discretion
of the Administrator. To the extent that an Award or payment, or the settlement or deferral thereof, is subject to Section 409A the Award
will be granted, paid, settled or deferred in a manner that will meet the requirements of Section 409A, such that the grant, payment,
settlement or deferral will not be subject to the additional tax or interest applicable under Section 409A. In no event will the Company
or any of its Parent or Subsidiaries have any responsibility, liability, or obligation to reimburse, indemnify, or hold harmless a Participant
(or any other person) in respect of Awards, for any taxes, penalties or interest that may be imposed on, or other costs incurred by, Participant
(or any other person) as a result of Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13. <B>Leaves of Absence/Transfer
Between Locations</B>. Unless the Administrator provides otherwise or as otherwise required by Applicable Laws, vesting of Awards granted
hereunder will be suspended during any unpaid leave of absence. A Participant will not cease to be an Employee in the case of (a) any
leave of absence approved by the Company or (b) transfers between locations of the Company or between the Company, its Parent, or any
of its Subsidiaries. For purposes of Incentive Stock Options, no such leave may exceed three (3) months, unless reemployment upon expiration
of such leave is guaranteed by statute or contract. If reemployment upon expiration of a leave of absence approved by the Company is not
so guaranteed, then six (6) months following the first (1<SUP>st</SUP>) day of such leave, any Incentive Stock Option held by the Participant
will cease to be treated as an Incentive Stock Option and will be treated for tax purposes as a Nonstatutory Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14. &#8239; <B>Limited Transferability
of Awards</B>. Unless determined otherwise by the Administrator, Awards may not be sold, pledged, assigned, hypothecated, transferred,
or disposed of in any manner other than by will or by the laws of descent and distribution (which, for purposes of clarification, shall
be deemed to include through a beneficiary designation if available in accordance with Section 6.6.4), and may be exercised, during the
lifetime of the Participant, only by the Participant. If the Administrator makes an Award transferable, such Award will contain such additional
terms and conditions as the Administrator deems appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15. <B>Adjustments; Dissolution
or Liquidation; Merger or Change in Control</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">15.1 <B>Adjustments</B>. In
the event that any dividend or other distribution (whether in the form of cash, Shares, other securities, or other property), recapitalization,
stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, reclassification, repurchase,
or exchange of Shares or other securities of the Company, or other change in the corporate structure of the Company affecting the Shares
occurs (other than any ordinary dividends or other ordinary distributions), the Administrator, in order to prevent diminution or enlargement
of the benefits or potential benefits intended to be made available under the Plan, will adjust the number and class of shares of stock
that may be delivered under the Plan and/or the number, class, and price of shares of stock covered by each outstanding Award, and numerical
Share limits in Section 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">15.2 <B>Dissolution or Liquidation</B>.
In the event of the proposed dissolution or liquidation of the Company, the Administrator will notify each Participant as soon as practicable
prior to the effective date of such proposed transaction. To the extent it has not been previously exercised, an Award will terminate
immediately prior to the consummation of such proposed action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">15.3 <B>Merger or Change in
Control</B>. In the event of a merger of the Company with or into another corporation or other entity or a Change in Control, each outstanding
Award will be treated as the Administrator determines (subject to the provisions of the following paragraph) without a Participant&rsquo;s
consent, including, without limitation, that (a) Awards will be assumed, or substantially equivalent awards will be substituted, by the
acquiring or successor corporation (or an affiliate thereof) with appropriate adjustments as to the number and kind of shares and prices;
(b) upon written notice to a Participant, that the Participant&rsquo;s Awards will terminate upon or immediately prior to the consummation
of such merger or Change in Control; (c) outstanding Awards will vest and become exercisable, realizable, or payable, or restrictions
applicable to an Award will lapse, in whole or in part prior to or upon consummation of such merger or Change in Control, and, to the
extent the Administrator determines, terminate upon or immediately prior to the effectiveness of such merger or Change in Control; (d)
(i) the termination of an Award in exchange for an amount of cash and/or property, if any, equal to the amount that would have been attained
upon the exercise of such Award or realization of the Participant&rsquo;s rights as of the date of the occurrence of the transaction (and,
for the avoidance of doubt, if as of the date of the occurrence of the transaction the Administrator determines in good faith that no
amount would have been attained upon the exercise of such Award or realization of the Participant&rsquo;s rights, then such Award may
be terminated by the Company without payment), or (ii) the replacement of such Award with other rights or property selected by the Administrator
in its sole discretion; or (e) any combination of the foregoing. In taking any of the actions permitted under this Section 15.3, the Administrator
will not be obligated to treat all Awards, all Awards held by a Participant, all Awards of the same type, or all portions of Awards, similarly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">In the event that the acquiring
or successor corporation (or an affiliate thereof) does not assume the Award (or portion thereof) as described below or substitute for
the Award (or portion thereof) as described above, then the Participant will fully vest in and have the right to exercise his or her outstanding
Options and Stock Appreciation Rights (or portions thereof) not assumed or substituted for, including Shares as to which such Awards would
not otherwise be vested or exercisable, all restrictions on Restricted Stock, Restricted Stock Units, or Performance Awards (or portions
thereof) not assumed or substituted for will lapse, and, with respect to Awards with performance-based vesting (or portions thereof) not
assumed or substituted for, all performance goals or other vesting criteria will be deemed achieved at one hundred percent (100%) of target
levels and all other terms and conditions met, in each case, unless specifically provided otherwise under the applicable Award Agreement
or other written agreement authorized by the Administrator between the Participant and the Company or any of its Subsidiaries or Parents,
as applicable. In addition, unless specifically provided otherwise under the applicable Award Agreement or other written agreement authorized
by the Administrator between the Participant and the Company or any of its Subsidiaries or Parents, as applicable, if an Option or Stock
Appreciation Right (or portion thereof) is not assumed or substituted in the event of a merger or Change in Control, the Administrator
will notify the Participant in writing or electronically that the Option or Stock Appreciation Right (or its applicable portion) will
be exercisable for a period of time determined by the Administrator in its sole discretion, and the Option or Stock Appreciation Right
(or its applicable portion) will terminate upon the expiration of such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">For the purposes of this Section
15.3 and Section 15.4 below, an Award will be considered assumed if, following the merger or Change in Control, the Award confers the
right to purchase or receive, for each Share subject to the Award immediately prior to the merger or Change in Control, the consideration
(whether stock, cash, or other securities or property) received in the merger or Change in Control by holders of Common Stock for each
Share held on the effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration
chosen by the holders of a majority of the outstanding Shares); provided, however, that if such consideration received in the merger or
Change in Control is not solely common stock of the successor corporation or its Parent, the Administrator may, with the consent of the
successor corporation, provide for the consideration to be received upon the exercise of an Option or Stock Appreciation Right or upon
the payout of a Restricted Stock Unit or Performance Award, for each Share subject to such Award, to be solely common stock of the successor
corporation or its Parent equal in fair market value to the per share consideration received by holders of Common Stock in the merger
or Change in Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Notwithstanding anything in
this Section 15.3 to the contrary, an Award that vests, is earned or paid-out upon the satisfaction of one or more performance goals will
not be considered assumed if the Company or its successor modifies any of such performance goals without the Participant&rsquo;s consent,
in all cases, unless specifically provided otherwise under the applicable Award Agreement or other written agreement authorized by the
Administrator between the Participant and the Company or any of its Subsidiaries or Parents, as applicable; provided, however, a modification
to such performance goals only to reflect the successor corporation&rsquo;s post-Change in Control corporate structure will not be deemed
to invalidate an otherwise valid Award assumption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Notwithstanding anything in
this Section 15.3 to the contrary, and unless otherwise provided in an Award Agreement, if an Award that vests, is earned or paid-out
under an Award Agreement is subject to Section 409A and if the change in control definition contained in the Award Agreement (or other
agreement related to the Award, as applicable) does not comply with the definition of &ldquo;change in control&rdquo; for purposes of
a distribution under Section 409A, then any payment of an amount that is otherwise accelerated under this Section 15.3 will be delayed
until the earliest time that such payment would be permissible under Section 409A without triggering any penalties applicable under Section
409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">15.4 <B>Outside Director Awards</B>.
With respect to Awards granted to an Outside Director, in the event of a Change in Control, the Participant will fully vest in and have
the right to exercise Options and/or Stock Appreciation Rights as to all of the Shares underlying such Award, including those Shares which
would not be vested or exercisable, all restrictions on Restricted Stock and Restricted Stock Units will lapse, and, with respect to Awards
with performance-based vesting, all performance goals or other vesting criteria will be deemed achieved at 100% of target levels and all
other terms and conditions met, unless specifically provided otherwise under the applicable Award Agreement or other written agreement
between the Participant and the Company or any of its Subsidiaries or Parents, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">16. <B>Tax Withholding</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">16.1 <B>Withholding Requirements</B>.
Prior to the delivery of any Shares or cash pursuant to an Award (or exercise thereof) or such earlier time as any tax withholdings are
due, the Company (or any of its Parent, Subsidiaries, or affiliates employing or retaining the services of a Participant, as applicable)
will have the power and the right to deduct or withhold, or require a Participant to remit to the Company (or any of its Parent, Subsidiaries,
or affiliates, as applicable) or a relevant tax authority, an amount sufficient to satisfy U.S. federal, state, local, non-U.S., and other
taxes (including the Participant&rsquo;s FICA or other social insurance contribution obligation) required to be withheld or paid with
respect to such Award (or exercise thereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">16.2 <B>Withholding Arrangements</B>.
The Administrator, in its sole discretion and pursuant to such procedures as it may specify from time to time, may permit a Participant
to satisfy such tax liability or withholding obligation, in whole or in part by such methods as the Administrator shall determine, including,
without limitation, (a) paying cash, check or other cash equivalents, (b) electing to have the Company withhold otherwise deliverable
cash or Shares having a fair market value equal to the minimum statutory amount required to be withheld or such greater amount as the
Administrator may determine if such amount would not have adverse accounting consequences, as the Administrator determines in its sole
discretion, (c) delivering to the Company already-owned Shares having a fair market value equal to the minimum statutory amount required
to be withheld or such greater amount as the Administrator may determine, in each case, provided the delivery of such Shares will not
result in any adverse accounting consequences, as the Administrator determines in its sole discretion, (d) selling a sufficient number
of Shares otherwise deliverable to the Participant through such means as the Administrator may determine in its sole discretion (whether
through a broker or otherwise) equal to the amount required to be withheld or paid, (e) such other consideration and method of payment
for the meeting of tax liabilities or withholding obligations as the Administrator may determine to the extent permitted by Applicable
Laws, or (f) any combination of the foregoing methods of payment. The amount of the withholding obligation will be deemed to include any
amount which the Administrator agrees may be withheld at the time the election is made, not to exceed the amount determined by using the
maximum federal, state or local marginal income tax rates applicable to the Participant with respect to the Award on the date that the
amount of tax to be withheld is to be determined or such greater amount as the Administrator may determine if such amount would not have
adverse accounting consequences, as the Administrator determines in its sole discretion. The fair market value of the Shares to be withheld
or delivered will be determined as of the date that the taxes are required to be withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17. <B>No Effect on Employment
or Service</B>. Neither the Plan nor any Award will confer upon a Participant any right with respect to continuing the Participant&rsquo;s
relationship as a Service Provider with the Company or its Subsidiaries or Parents, as applicable, nor will they interfere in any way
with the Participant&rsquo;s right or the right of the Company and its Subsidiaries or Parents, as applicable, to terminate such relationship
at any time, free from any liability or claim under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">18. <B>Date of Grant</B>.
The date of grant of an Award will be, for all purposes, the date on which the Administrator makes the determination granting such Award,
or such other later date as is determined by the Administrator. Notice of the determination will be provided to each Participant within
a reasonable time after the date of such grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">19. <B>Effective Date; Term
of Plan</B>. Subject to Section <B>Error! Reference source not found.</B>3 of the Plan, the Plan will become effective upon the later
to occur of (i) its adoption by the Board or (ii) the business day immediately prior to the Registration Date. It will continue in effect
until terminated under Section 20, but no Incentive Stock Options may be granted after 10 years from the date adopted by the Board and
Section 3.2 will operate only until the 10<SUP>th</SUP> anniversary of the date the Plan is adopted by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">20. <B>Amendment and Termination
of the Plan</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">20.1 <B>Amendment and Termination</B>.
The Administrator, in its sole discretion, may amend, alter, suspend or terminate the Plan, or any part thereof, at any time and for any
reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">20.2 <B>Stockholder Approval</B>.
The Company will obtain stockholder approval of any Plan amendment to the extent necessary and desirable to comply with Applicable Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">20.3 <B>Effect of Amendment
or Termination</B>. No amendment, alteration, suspension or termination of the Plan will materially impair the rights of any Participant,
unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be in writing and signed by the Participant
and the Company. Termination of the Plan will not affect the Administrator&rsquo;s ability to exercise the powers granted to it hereunder
with respect to Awards granted under the Plan prior to the date of such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">21. <B>Conditions Upon Issuance
of Shares</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">21.1 <B>Legal Compliance</B>.
Shares will not be issued pursuant to an Award unless the exercise or vesting of such Award and the issuance and delivery of such Shares
will comply with Applicable Laws and will be further subject to the approval of counsel for the Company with respect to such compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">21.2 <B>Investment Representations</B>.
As a condition to the exercise or vesting of an Award, the Company may require the person exercising or vesting in such Award to represent
and warrant at the time of any such exercise or vesting that the Shares are being acquired only for investment and without any present
intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">22. <B>Inability to Obtain
Authority</B>. If the Company determines it to be impossible or impractical to obtain authority from any regulatory body having jurisdiction
or to complete or comply with the requirements of any registration or other qualification of the Shares under any U.S. state or federal
law or non-U.S. law or under the rules and regulations of the U.S. Securities and Exchange Commission, the stock exchange on which Shares
of the same class are then listed, or any other governmental or regulatory body, which authority, registration, qualification or rule
compliance is deemed by the Company&rsquo;s counsel to be necessary or advisable for the issuance and sale of any Shares hereunder, the
Company will be relieved of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority,
registration, qualification or rule compliance will not have been obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">23. <B>Intentionally Omitted</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">24. <B>Forfeiture Events</B>.
The Administrator may specify in an Award Agreement that the Participant&rsquo;s rights, payments, and benefits with respect to an Award
will be subject to the reduction, cancellation, forfeiture, recoupment, reimbursement, or reacquisition upon the occurrence of certain
specified events, in addition to any otherwise applicable vesting or performance conditions of an Award. Such events may include, without
limitation, termination of such Participant&rsquo;s status as an employee and/or other service provider for cause or any specified action
or inaction by a Participant, whether before or after such termination of employment and/or other service, that would constitute cause
for termination of such Participant&rsquo;s status as an employee and/or other service provider. Notwithstanding any provisions to the
contrary under this Plan, all Awards granted under the Plan will be subject to reduction, cancellation, forfeiture, recoupment, reimbursement,
or reacquisition under any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities
exchange or association on which the Company&rsquo;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform
and Consumer Protection Act or other Applicable Laws (the &ldquo;<B>Clawback Policy</B>&rdquo;). The Administrator may require a Participant
to forfeit, or return to the Company, or reimburse the Company for, all or a portion of the Award and any amounts paid thereunder pursuant
to the terms of the Clawback Policy or as necessary or appropriate to comply with Applicable Laws, including without limitation any reacquisition
right regarding previously acquired Shares or other cash or property. Unless this Section 24 specifically is mentioned and waived in an
Award Agreement or other document, no recovery of compensation under a Clawback Policy or otherwise will constitute an event that triggers
or contributes to any right of a Participant to resign for &ldquo;good reason&rdquo; or &ldquo;constructive termination&rdquo; (or similar
term) under any agreement with the Company or any Parent or Subsidiary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">* * *</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Annex C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STATE OF DELAWARE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE OF AMENDMENT</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF CERTIFICATE OF INCORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Pursuant to Section 242 of the General Corporation
Law of the State of Delaware)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">60 Degrees Pharmaceuticals, Inc., a corporation
organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>FIRST</B>: That at a meeting of the
Board of Directors of 60 Degrees Pharmaceuticals, Inc. resolutions were duly adopted setting forth a proposed amendments of the certificate
of incorporation of said corporation (the &ldquo;Certificate of Incorporation&rdquo;), declaring said amendments to be advisable and calling
a meeting of the stockholders of said corporation for consideration thereof. The resolution setting forth the proposed amendment is as
follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;RESOLVED, that the Certificate
of Incorporation of this corporation be amended by deleting Section 4 in its entirety and inserting the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">4. (a) The total number of shares of
stock which the Corporation shall have the authority to issue shall be One Hundred Fifty One Million (151,000,000) shares. The Corporation
shall be authorized to issue two classes of shares of stock, designated as &ldquo;Common Stock&rdquo; and &ldquo;Preferred Stock.&rdquo;
The Corporation shall be authorized to issue One Hundred Fifty Million (150,000,000) shares of Common Stock, each share to have a par
value of $0.0001 per share, and One Million (1,000,000) shares of Preferred Stock, each share to have a par value of $0.0001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(b) Effective as of 12:01 a.m. Eastern
Time on ________ (the &ldquo;<B>Effective Time</B>&rdquo;), each ____ shares of the Corporation&rsquo;s Common Stock issued and outstanding
immediately prior to the Effective Time shall, automatically and without any action on the part of the Corporation or the respective holders
thereof, be combined and converted into one share of Common Stock without increasing or decreasing the par value of each share of Common
Stock (the &ldquo;<B>Reverse Stock Split</B>&rdquo;). No fractional shares of Common Stock shall be issued as a result of the Reverse
Stock Split and, in lieu thereof, upon surrender after the Effective Time of a certificate or book entry position which formerly represented
shares of Common Stock that were issued and outstanding immediately prior to the Effective Time, any person who would otherwise be entitled
to a fractional share of Common Stock as a result of the Reverse Stock Split, following the Effective Time, shall be entitled to receive
one whole share. The Reverse Stock Split shall occur whether or not the certificates representing such shares of Common Stock are surrendered
to the Corporation or its transfer agent. Each certificate or book entry position that immediately prior to the Effective Time represented
shares of Common Stock shall thereafter represent the number of shares of Common Stock into which the shares of Common Stock represented
by such certificate or book entry position has been combined, subject to the right to receive a whole share in lieu of any fractional
share of Common Stock as set forth above.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>SECOND</B>: That thereafter, the
holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action
at a stockholders meeting at which all shares entitled to vote thereon were present and voted, approved of the proposed amendment at the
Annual Meeting of Stockholders held on July 16, 2024 pursuant to Section 242 of the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>THIRD</B>: That said amendment was
duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>IN WITNESS WHEREOF</B>, said corporation has
caused this certificate to be signed on [*], 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Geoffrey Dow</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer and President</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 59; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have executed this Amendment as of the date first set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>COMPANY</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">60 DEGREES PHARMACEUTICALS, INC.,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">a Delaware corporation</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>OPTIONHOLDER</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 35%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_003.jpg" ALT="" STYLE="width: 811px; height: 1050px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 1pt; color: White">This
proxy is solicited on behalf of the Board of Directors VOTE BY INTERNET - www.SXTP.vote 60 DEGREES PHARMACEUTICALS, INC Use the Internet
to vote by proxy up until 11:59 P.M. Eastern Time on October 7,2025. Have your proxy card in hand when you access the website and then
follow the instructions. Enter the 12 digit Control Number below and follow the instructions to vote your proxy. 1025 Connecticut Avenue
NW Suite 1000 - Washington, D.C. 20036 VOTE BY MAIL Mark, sign, and date this proxy card and promptly return to EQUITY STOCK TRANSFER,
237 W 37TH ST, Suite 602, New York, NY 10018, ATTN: Shareholder Services. VOTE BY FAX or BY EMAIL Mark, sign, and date this proxy card
and promptly return it by fax: (347)-584-3644 ATTN: Shareholder Services or by email: proxy@equitystock.com ATTN: Shareholder Services.
CONTROL# The undersigned hereby appoints Mr. Geoffrey Dow, the true and lawful proxy of the undersigned, with full power of substitution,
to vote all shares of the common stock, $0.0001 par value per share, of 60 Degrees Pharmaceuticals, Inc., (the &ldquo;Company&rdquo;),
which the undersigned is entitled to vote at the 2025 annual meeting of stockholders of the Company to be held at 12:00 p.m., Eastern
Time, on October 8, 2025, (the &ldquo;Annual Meeting&rdquo;) to be held virtually by calling (877)-407-3088 (toll free) or +1-877-407-3088
(International), and any adjournment or adjournment or postponement thereof. There will not be a physical meeting location. THE BOARD
OF DIRECTORS RECOMMENDS THAT YOU VOTE &ldquo;FOR&rdquo; THE ELECTION OF EACH OF THE DIRECTOR NOMINEES IN PROPOSAL 1, &quot;FOR&quot;
PROPOSALS 2 THROUGH 5. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: 1. Election of five (5) Directors. For Withhold Nominees:
1a. Geoffrey Dow 1b. Charles Allen 1c. Cheryl Xu 1d. Stephen Toovey 1e. Paul Field For Against Abstain 2. To approve an amendment to
the 60 Degrees Pharmaceuticals, Inc. 2022 Equity Incentive Plan (the &ldquo;2022 Plan&rdquo;) to increase the number of shares of common
stock available for issuance by 250,000 shares. 3. To approve an amendment to the Company's certificate of incorporation, as corrected
(&ldquo;Certificate of Incorporation&rdquo;), to effect a reverse stock split of our common stock at a reverse stock split ratio ranging
from 1:3 to 1:10 inclusive, as determined by our Board of Directors in its sole discretion. 4. To ratify the selection by our Board of
Directors of RBSM LLP as the Company's independent auditor for the fiscal year ending December 31, 2025. 5. To approve adjourning the
Annual Meeting, if necessary, to solicit additional proxies in the event there are not sufficient votes in favor of the Director Election
Proposal, the 2022 Plan Amendment Proposal and the Certificate of Incorporation Amendment Proposal at the time of the Annual Meeting
. Note: To transact such other business as may properly come before the Annual Meeting or any postponement or adjournment thereof. If
you encounter any technical difficulties with the virtual meeting platform on the meeting day, please call 877-804-2062 (toll free) or
email proxy@equitystock.com Please sign exactly as your name appears hereon. When signing as attorney, executor, administrator, trustee,
guardian, or corporate officer, please indicate full title as such. Joint owners should each sign personally. All holders must sign.
If a corporation, please sign the full corporate or partnership name, by authorized officer. Signature [PLEASE SIGN WITHIN BOX] Date
Signature (Joint Owners) Date</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !( +<# 2(  A$! Q$!_\0
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MLP?LD_&+P_IWC?XO_$WPYK3^'GU_5=<\7^/-#_L7Q!KC%]NA>%?^$)T4(/%
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MXR\)Z\EIJ=C%JWAO78H=;T+5%&MK%, \;I*OF1H0CJQ6-"B#^$ZR_:L\9?\
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MQD_[3)\"Z*L,>C:2NL#X<^%(FU\ Q"26#QAX0\7[F+?\)VS.Q/VK_P %!/\
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M3_PK3PDW]BZ =&U=V\1;O#R2;CKG_"<_\(PK^-O^$UY8'P&=U?N'\&?V4/\
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M>+L7C.+^(J/ F43?]F0G3SWB*O%M)913E%QR>,XM)5,QDG>*GS1CNDKGZK?
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M  ZF_P""NO[9'BCP_IW[9_Q+N/"'@#PO>1$:GXV^(VB_$1;'?B/6=;\#^!_
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M7AS5?%-W\/;KP&Y\;_&GPOX!U<Z#XY\:3:,/#?BX:#X>'B,ZV47PMXQ\(/\
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M_+\.O.3_ (BB-8[?L36H_P"[BX__ )R([\]>P]Z**X%]$WP6Y5_P@X[X4_\
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3#^Q,'4M)\Z<HP;MRVNX)]4?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !( +<# 2(  A$! Q$!_\0
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MLP?LD_&+P_IWC?XO_$WPYK3^'GU_5=<\7^/-#_L7Q!KC%]NA>%?^$)T4(/%
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MXR\)Z\EIJ=C%JWAO78H=;T+5%&MK%, \;I*OF1H0CJQ6-"B#^$ZR_:L\9?\
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MQD_[3)\"Z*L,>C:2NL#X<^%(FU\ Q"26#QAX0\7[F+?\)VS.Q/VK_P %!/\
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M3_PK3PDW]BZ =&U=V\1;O#R2;CKG_"<_\(PK^-O^$UY8'P&=U?N'\&?V4/\
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M>+L7C.+^(J/ F43?]F0G3SWB*O%M)913E%QR>,XM)5,QDG>*GS1CNDKGZK?
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M  ZF_P""NO[9'BCP_IW[9_Q+N/"'@#PO>1$:GXV^(VB_$1;'?B/6=;\#^!_
M/B/Q7X6_X2,+'C;XK_X0^0)&$7QL6"I7]#GQ'_X)X_ /QI^Q#%^P99V%SHG@
M3P_X3T[2/"&O1VD>H^)-%\;Z*W]M0_$D/+Y*2^)I_$AU;Q-XQ=6A_P"$R?7?
M$<,TQ/BB83>?"AB,PCF2C%0C&-HP24=8N+46HVCI915EVLGJU\I6X6S;B+%<
M09G@^&?[#_X0HJEAV_9JK5@XS25.+C!MN"@VH:7NW>Y[%^PY\2=#^*O['O[-
MGC_1KG2IH/$'P:\#+K=QI]YNAT_Q-H_A72=#\8Z/DI&#-X;\1Z1K/AVX!#%9
M]&D =E <_P Q'[.&O-^TU_P<,^+/B+X6(U_PQX.^)'Q>2^U;3=06_P!.'AGX
M6?!G7/A%HNL;XR5.B-XD?P0L7EN5>?Q @4D,&KE;3_@F/_P6P_9WMO$GP+^!
MGCW6;GX1>)KS53<ZO\-/C1HW@SP3=/KV%.K_ -BZ_P"(O"?B;PY(^Y4\9KX1
M\([I^?)\T#-?M?\ \$G/^"8$/[ ?AG7/'?Q$UG1?%GQZ^(EGIEGXDN=%T\1>
M&_ _AEG36CX+T'5YH?.UUF\0E_$/C+Q0S1?:!H_AN)8BGA:.[\5]#^LXC^S5
M/ <JIVYZDGHN3W;V;>R5[/30]"E'B/B;%<*97B>'993#)7"6>5)ZPDZ48QI^
MSEJFIN$9:-ZMWND?KA\3OAOX/^,OPX\<_"KXA^'[3Q9X#^(_AW5O!OC+0+[:
MVGZWX9U_2?['UJW9>3M:*21#SN5?F0EB&'\2_P"P-\4/'/\ P0W_ ."H'Q _
M8)^.7B*\NOV4_P!H;Q-IH\!^-/$%TVF:;:?VS*N@_!'XQHEP;>/0//6-OA9\
M9KB0I&WC'0UF23[/\)RS_P!UD!^ZV3QN!&#GG'(R.W''T[5^$7_!=7_@FVW[
M>G[*FI>*/AQX;$_[2W[/YUCQI\+_ +-;!]6\=>&CL?QQ\,>2=O\ PE2:,GB?
MP2-KX\:Z%X957BA\3^+$F_0>"\WP]'$9AP]F\%_9&=)4)*3N\/7E:-#-J;VA
M*%>4(R2E%<C;DFD?IN?Y=54:6:X/7,<I479)VG2BH\T;?:_=IM:/4_>K*L V
M>",@YQU_ST/XBI2%",1T]@.,'/L?8_G7\[W_  0 _P""DMQ^VI^S3;_!WXI^
M(GU+]H_]F^TTGPSXMNM2OG.J>/\ X;()-'\"_$R4A"FKZZ4A'A/QO.[$3>,]
M$/B]]O\ PEMJC_T-<G<.O3'3USZ8^O<U\[G&48K(\RQV68J";R^4O9-+W*O-
MS2A.$K/FC.#IS33:M.SNXMOU\MQ^'S/"K%4/BLE436JG97NO*2>ENENI^/'_
M  46_P""KW@W_@G9X]^!7PYUOX#?%GXY^)_V@)/$W_"(Z3\*AH\FI/JF@ZOX
M?T:/15T64!]>U[Q-+X@!A5-BQM&V%5FPGR?X,_X.*?@?8?$?PU\._P!I?]F;
M]JK]D@^.+HZ/X9\:?&[P*FD>"FU15  ULF2/Q+H>A-*J@>)8_"?B6 J[F0HB
MEA\A?\'!_C[5?A'_ ,% /^"1WQ)T+P%XF^)VK_#SQYXK\8:-\-_!-BNI>)O'
M6J:'\2_A#K1\'Z"@! \0>*!E4!0[@FXAMVYO$_V\/BC^WC_P6E\*?"_]D+X9
M_P#!,/X]_LX^&K;XN>&OBCXC^-7[16CZYX9\,:$-!TC7= ED75_$/P\\+>'-
M""GQQJWB)!N\:>,_%BHD,/@9%?8?T[*N&N'JV0\.8G,LLIQ>=4*KSC/WG<*,
M\HE&=:$:4,-.SJ+DA3DDHR4G-1BDU<^4QN<9I1QN/P^'Q_M(PG"T'E$IJWNW
MBJB3M>]G)63MV/U+^*GQ5\"_M_\ _!2?X^?\$D_VF/@;X%\??L\_#3X#>'?V
M@-&\4F_\7Z7\26\<-I7PC"ZEHNL:!XAMH="$ ^*6L16LWA:..Z5(T62X;S;G
MS\_P7_P;/?\ !-7P?XRTGQ3JL?Q\^(OA[0[D7ME\,_B!\4QJ7P[21L@'9H7A
MGPMXD;:"I&[Q:P!!W*XX/Y2?$NT_;1\'_P#!?O\ :#^%G[!TWPZ'QPU_]EWX
M1_#"\^)?QBM?MOASP+X%T;X/_ C6];^)>M/L\2?\5'(W@K0O"T<G_"'^, Y\
M0*Y\&S;A/)^E/_!/3]M3_@H%X=_X*"?$_P#X)L_\%"=5^&?Q(^(&E?"Y_BUX
M(^+_ ,-](TWPW9>(M(BDT9AH5JVC:'X,BUO0&T?7=8E6>3P;X2\4^%?%?ASQ
M+ ?^$TM)(+B!YAE&?9;ET8Y#GT,!ED>'<LSV62PS)JM65ZE&>=4Z7LG.$YI1
MDX?6(5(\S?([<QGAL5E^*JN6:X&7/_;7)&3NXW4$UM))0NN9PLXZV:MH?T5^
M'_#^C^&]%TCPYX=TK3=$T+0])T[1]*TO2;1=,T[3].T1(HM(TO2M*CC,<6CP
M1;XD6-P%B B0^7M\KJPJN=QSU!*G/Z\C@X_#IP:_EF_:F_:-_P""L7@GXH?%
M/4_$?[=__!,7]B'1_#.K>)$^"GP%^(GQ)^&\OB3XK>%M$0-H&M>(-?\ B#X?
M;Q'HA\5[@LDT3^%<L"'\%^$"I(X+QU_P6J_:*\7_ /!%BQ_;K^'>E>"? G[0
MVA_'?2/@=XZ#^&T\2^![S4XG1M9U?0-$U\+(T7BC0=:T2>/S&D=)99%1DC6.
M-/B*7"F:8V>"K8?'QJ5,SQ$,/)3=2\<3B%.<'5E5HQ2<[2E*<)UG>_-)R>GT
M$^(<#AG:*7*DU&,>6ZA%V48V;LDK)12BKO16/ZR_M'S>2&&3T.TXQG."/0#J
M<]>V.:!/\XA!!;D[MN!].G7''7C XXS7\R_PF^//_!9W0OV</VG/VV?VG=4^
M O@SX3I^PI\4?BK^S]\&/"OAK33XC\#?$W0= T7QY\+M<\>!_#8\1SQGPY+K
MHF\./XQDC>XVI+X)\(72(@^)O#W[=/\ P7K^*G["]I_P4B\+>+OV:?!GP1^&
M7AS5?%-W\/;KP&Y\;_&GPOX!U<Z#XY\:3:,/#?BX:#X>'B,ZV47PMXQ\(/\
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M_+\.O.3_ (BB-8[?L36H_P"[BX__ )R([\]>P]Z**X%]$WP6Y5_P@X[X4_\
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3#^Q,'4M)\Z<HP;MRVNX)]4?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP"$  8&!@8'!@<(" <*"PH+"@\.# P.
M#Q80$1 1$!8B%1D5%1D5(AXD'AP>)!XV*B8F*C8^-#(T/DQ$1$Q?6E]\?*<!
M!@8&!@<&!P@(!PH+"@L*#PX,# X/%A 1$!$0%B(5&145&14B'B0>'!XD'C8J
M)B8J-CXT,C0^3$1$3%]:7WQ\I__  !$(")@&I ,!(0 "$0$#$0'_Q "B  $
M @,! 0$!            !08#! <"" $)$  !! (! P$$!08)"08  AL!  (#
M! 4&$0<2$R$4,4%1%18B,G$C4E1AE-,(%S=7<G6!LK,S-39"5G1VDK0D-&)S
MD95#D](E.%5F@K$8H29&4V.%H\+$)T2$HN)D97>#I $!
M     !$!                     /_:  P# 0 "$0,1 #\ ^J40$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0%YGG@K036)I&
MLBB8Y\CS[FM:.22@JG\:73S_ &IQ_P#\8G\:73S_ &IQ_P#\8@F'[EJS,-'F
M79FJ,>^3QLM%_P"3+^2. 5(8[*XW)4(;N-M1V*\O/9-&>6N[26E!E46_<-89
MF?H5V8K#(EX8*O=^4[G#N X02B("("("("("("("((C(;;J^'OPX_(9>M7MR
MM:60O=PYP>>!PI= 1 1 1 7Y;N5:-6>U9E;%!#&Z261QX:QC1R24&KA=EP.>
MAFFQ62@MQQ.#9'1.Y#25K8K<-7S%V>ECLQ5LV(6.?)%&_ES6M(:24$HB"&S.
MSZ[@37&7RM>GY@XQ>5W;W!GOX4Q%)'+$R2-P<Q[0YKA[B#Z@H/V*6*4$QR->
M XM):0>"T\$?B$0$08+^1Q^,IS7;]F.O6A ,DKSPUH)[0OW#YW#YRH;>,O0V
MJX>6&6)W+>X>I"#,B B B H>?;-8JY=F'GR]9F0>]C6U2[[9,GJT<()A$!$$
M16VW6)LT<-%EZSLB'O8:H=^4#F N<.%+H"("B\5N&KYB[/2QV8JV;$+'/DBC
M?RYK6D-)*#4S^X:MKIB;E\Q7J&0<L8XDO</F&MY/"DL!GL'GZ9N8F]%;@#RP
MO9SP'@<\(-U$!1&<V3 8"!D^7R<%2-YX89'>KS\FM'J4'K7]PUK9([#\/DX;
M8A[?+V<@M[_=R' *50?@EB=(^,2-+V %S01RT.]W(41];-7BS0PS\Q5&2+PS
MV4N_*=SAW <()A$!$!0&3W_2\3>FHW\]3KV8B!)$]_#F\@.0:3.J'3U[N!M.
M._MF 5KK7*ERO'8JV(IX7CEDL;P]CA\P6H/U$!$!$!$$-3VO6+>8?B(<O6DO
ML>]CJH?]L.C^\"%,H"("JN7ZA:1@KII9+/58;#?O1>KW-_I]@/""T8^]2R%.
M"Y2G9-7F8'QRL/(<T_$*-S.QX' LA?ELG!39*XACI7=H<1[P$$,.J/3S_:G'
M?_&JU8_,XK*5?:<=?K6XB>!)#(V1O/XM0:N9V/7]>C@?E<E!3;,2(S*[CN+5
MN5;5>W6@LUY6R0S1-DBD;ZM<QXY!'ZB$'ZB B B )8O*Z(2-\@:'%G([@#Z
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M*"!ZXC0#-@/K4_+@]EGV;V'Q_-G?W]ZU>LF\08/3<=A\99O06KM2!]>5GH?
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MAD>M/J]INT9GJ1@\ACL18L5(JU023,'H"R9[B@^F%K9W&OR. R^/8X!]NC/
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MR6D6LE@(.3@\G99>I_)CX^06KI'6^.A+E>F,>1(%)_I9)/'$)=$'H)?'X?\
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MT/<4'V+I-5U34,!7-HV?'0A:V8L=&7L#?LGM?ZA3" B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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M]*JK;[GIL)K-N6F.;U@LJ4&?%]FP>QB#@7307.GO5'(:E?G+X,C$PPRGW/D
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MJ[YN?%'PY\C@/>0Q@)02N-RF/R]&&[CK<5BM*"6RQNY!5-M[_1J]0*VL/?$
M^B9'/(>7^T/>T1Q#\6E!!:SU6P+L:/I_-5(+INV8BW@@,8R8QL[^.0Q7S-;/
MK^ B@ER61B@\QXA!Y<Z3^@U@)*#<PN6Q.:H,N8V[%9KN<1WQGD=P][3\00J]
MGL_D*.Z:7B82SV;)#(>T\CEW_9H0]G"!:ZEZ+3F,5C/UF.$CF.'VCV.8XL/?
MP/LK3V'J%CL-M.MX=\\/COMF?/*>XEC S\EV\?GN02&1WK3L3?=1OYJO#99Q
MWL/+A%W>[R%H(8I#-;AK&!9$[)Y6"LV2$RQEW)[V @$MXYY^\@CK74?2*D8?
M/G8&\QQ2!O#R\LF9WL<&@$D$*8^LN =A1FAE:XQQ9W^U=X$?'/""/Q&ZZGDX
M;LM++12BI"9IQPYCV1@<E_8X EJCNGNYP;=A'6V^)D[)Y6S11AWV&B1PC]7?
M$M"#&_?Z+.H0U=TD0'L D[^'EYLO?P(O^5;<W4#2:N2=CIL]5;8;+XGCD]C'
M_F%_':'(+0]P:USC[@.2M5FQ81^#.;;?B..$)E]I_P!3L'O*")RV[:GA#5;D
M,M#$^>(2L9PY\AC/N?VM!(:H;;NHV)PN+P-ZK:K6(<E?@B9)R7L\!>!+(.SX
MM""=RN]:EB!4-[+Q1&S")H6<.>\QGW/[6 D-4U2R%&_3AMTK$<\$K Z.6-P<
MQP_40@H%OJ%2Q&Z9S&YB_#7IP5*;ZP["9'/E[B_T9R2KC#M6NSPXN:'*0/CR
M,ACIO:>6RO )[01\4&V,ECXLE#CGV&BY-"Z9D/J7&-A#2[]0Y*U<OL&#P3('
M93(156S%X8Z0\!Q8WN("##C-QUK*U;UFEE(I(Z;2ZUZ.8^( <\O:X A:M+?M
M.O\ M_LN<JO%*$367\D,C8[W$N*#+A-XU3/6)*^,RT4\S&=YBX<QY9^<T/ )
M"S#;];.&?F/I2#V%DOB=,>0 \.[.PCCGNY02-#,8W(378:MELDM201V&<$.C
M<X=P#@4Q62QV3K&S1L-GB$CX_(WGM[HW%K@/P(0>JF6QUV2]'6LMD=3F,-@#
MG[$@ =VE03]VU*M0HY";,UV5KC9'5I3R&R"+[W""0PFSX'.Q3R8R_'8$+@V5
MH!:]A/P<UP!"V[&1QU&S1K6+#63W)'1UV'GF1S6]Q 0:\F;Q%6W9JS7&,L5Z
M1N2QGGEE<$@R*%J]1-(M7ZU"OGJSIYRT1-'/#G/'(:'<<=R"$J;_ $K6V;+@
M6V((G4*[/9Y2'DNE#'F;N_5'PF-VG*2YW3:)NU;4&1Q%FS//#&6ME?%V<.CY
M]P/*"[Y+(08O'V;LT<TC(6\ED,9DD=R> &M;[R2J=H>V9G/7=F9DZ'L(IVXH
MX*IX,D;'QAX\A'O>4&AD=]RAW7!8>EC)HJ$N0GJV;L[.P3/BC<2R 'X CU>N
MA297&5\E3QLMEC;5IDCX(3SS(V+U<1^"#E5;9]RS.3RXH9[ 4H(<K8IU(+41
M=-,("&EXX>%/9O.;._8<7K6+FIPW78PWKUV6(R,CC#A%Q%'R.2YZ"5U+8,G<
MR&=PF7\!R.*DA[YH 61SPV&=\;PTDEI^841M^9VENVZ[@\)?J5?;JMJ5\LT'
MG_R'"#6BSNYX':,#BL]9Q]^KEW31135X702Q2Q,[_5I<X%I5CZCYZ_KVEYC+
M4"P6:[(S&7CN;RZ1K$#3MGDRFI-R63+(K57SQ9  <".:J2V15SI7N&<VB+.R
M92..+PV8O9HV-X+(9XQ*P.0=)7*,7D>H>PY39QC\YCJ=;'YB:G''+2,KB& $
M$D/""^XM^9Q&.NV-FS5*9D9[_.R'V:..,#X\N*U<+N^HYJ^VEC\Q%-8+"]L)
M:]A>T?%G>!W(,;M]TR+)G'2YRN+ F\)'KV"7\POX[0Y:%??*!Z@6-8,D0#*;
M'-=P[O?8+CS'_8T()9_4+2V9,XTYVL+(F\)'KV"7\PO^Z')F-VU/ 3N@RN8@
MJS 1GQNY+N)>0T\ (,%WJ+H^,DDAM9V!DD<KHY&</<YCF>_N !X"M$$\%B"*
M>"5DD4C ^.1IY:YKAR""/>"@Y'N-_J3@32GCS^-?#=R\%.)GL)YC%EY )/>K
M,9-NQ$-+Z7V7&.=8RU.%CA4=$'L>2'0C@N^V_P"!0;V0Z@:5BYYH+N;@BDAF
M,4L?#G.8]H!/<&@\#U6>OO>G292#%Q9RJ^W*0&,:20YQ'(:'C[/*#UF-UU3
MVFULGEH8)RSO\7#GN:S\YX8#VA3U:S6M5HK%:9DL,K ^.1C@YKFGU!!""&SF
M[ZK@++*V3RT,$[F=_BX<]X9^<0P'@+9M[9K5.A2OV,O594M<^"<OYC?PTO\
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MXIS^(/Y:4'9Y] MT=PU3-19S+WXZUF=DT-R?S-B9)7D D8NC[#_F#,?[C/\
MW"@^9>@>M'+:ODYAG,O3[,F6=E2P(F'\DQ=9K:';QF\X/,LS65R$+:]J&47)
MO,(>]G(+$'2;'LQB,<_C,<OY,M?QVO[_ $[>#[^5\X[GT!(M.RVF7#2M,>7B
MH7EG_P 3(@V>EO5+8W[#]3]NA<+XY9#.\=DA>P<]DJ^A4%$ZQ?R:;-_N[/\
M$:J%TJQ>V6>F>$..VB&E%(+(8PT1.^/\N_W$O:@N^D],</J-NWDG6I[^4M<^
M6Y/[_M'D\!<M_A._YMUC_>;"#L7U)S/^WN?_ /\ E_<KY[ZUX6YB\UI LYV_
MD?)9FX-KQ?8X?%]WQ,8@^M5QW8<]%9ZD4H78[)7:. A,KA3JOLCVZP/L]_9^
M8Q!S?K9?.2&%V/'8;-T[F,F ?/9HR0L#.>6$O/R>OIK5\_6V/7<9EH. RU7:
M\C\Q_N>W^PH/GW^$[_FS6/\ >;"P]8X=XPT./EOY^YD->GD;%?C@CBJR?@3&
M/<]!WC1L9J=#6Z3M;AC90G8)F/!),A=\7D^I<H7K#_)ML?\ Y,?^*U!SKK_K
MMEM3$[?CN67,5.P2/'O\9?RQ_P#](]6C-;J<]H&%^AWAM_8RRE ![X7/])W?
MA$ 4'-OX0F,J8G4=-QU1G9!5E?%&/U,C7T_!_D(OZ#4'(=TS45G>L'BS0OW*
M6'XR-QE.L^P?:7#BNUX9_:]4#K=;9L&&HY*G@\]6N8R;O\\]"6%@A=[^7H._
MZ%LT>T:GBLL"/)+"!./E,S[+POF[,@U?X2U22S]R6S6,7X/K",(/K!$$!U!_
MT#VS^IKO^"5PSHCK!R6C^T_3^9J?]NF;XJMD11H.EX?1[>$W^'+_ $ODK]>;
M#V('NN2^8PO$L3@&GY.6]U79STWV?_<T$1T(_DQPGZI+7^.]=004'I1ZX'*G
MX'/9+_'*OR#YKZ!_Z7]0O]X;_BR+Z40?->S_ /S1NM?[O%_<D6Y_"8AG?KF!
MF /C9?>UWXO8@[?H\T4^EZS)$>6'$U./[(@IE 7)NH^79:V37, :5ZW6AE&2
MR452!UAY9$>(6.:SX.>@I76BW!M.JAT&O9^&U0E\\<LV/EC8(_=("Y=;Z6[4
M-ITK&7GO[K,;/9[7_FQ(*C_"%_DZF_WZNK]TY_T!U3^J:O\ AA!8UI9S!X+/
M4)\1DZ\5B*5O<8G'[0X] ]OQ!"#Y<S_2'=-&N2YO2<I8FA9ZOA!XG#!\"WW2
MA=CZ2=2SN^,LLN0LAR5(L$X9]Q[7^Y[4'3405+JC_)YM/]72JJ] OY-<=_O-
MG_$03=_^5O!?\/W?\9BYUUAT"]6N,WC6>8<C3(DMLC][PS_X4(,C]^H;K@-'
MMQ<1W(=LQC+E?XQO6I_"8AG?KF!F /C9?>UWXO8@[?H\T4^EZS)$>6'$U./[
M(@IE 1 1 1 1 1 1 1 1 1 1 1!R[9[]7 =3L!F<G,(*%G#ST/:7^D3)O()0
M'E8,MFL5LW4/28,+=@O#'.N6KDT#Q+'"QT78P%S?BXH*'D;]7$XO9I,5L6.F
MHMO67V];S$#/(9B_ES&<'O/>?N*6GL7X>HUNW/FZN -W!TC2-RLV9I8!S+ Q
MSW,#2UR"[=+HJS*NQVJV5-^*SEI'^8516@?*  ]T #WAS"F1O4Z?6+$&U8BA
M%C7)H(#(X,\DKK+"&-057 4ZO\36Z'PLYE&<>_\ 6YA?P5#!]ZKMFJVY,]6Q
M+)]0JQ5+EJNV:(R#UEC!>Y@:]!?^F<=<Y/<+T.<&2;/<@$L\545JQFC9P\P\
M/>'K:VS^4WIE^&8_Z<(*SK%2J>G74,F%G,U[.&3]?'(6K!?J4;/1"U>LQP0_
M0T[3-*\-;WR4XT%<P<\U"CN%7([ECL7(,G=??IVJ+)991(>0\%\C3('M5@U[
M%P0;%TL@>^:PV#!WWPOLP^*3C[/82SEW!#2@N.M5J_\ &CO\QB9WQU,2QA^3
M7Q/Y"Y%<AG9I=&2.85Z-/>[+K,AB\T<$8E>&O?'\6-*"^8GLO]1,!._<J^7M
M5J5HD4:3&1B"1O'$\K)7?'@M4[T:NTY=.CJ1V8W6:ERX+$(<"^(OLR%O>$&'
M)W(:O5SL?:B@FM:GX*A>X-[YC:)#6JDX?-ZG4Z,W,/?GKLOLJ6J]F@\CVDW2
M2/N>\O+D';M69>K:K@:]TN]KBQM9ECGW^1L8#EQ*:E8&<FZ;B-WL=C-MR7ZA
MC#S8?%_\:.Q!;,+E,1A.H6]C-W*U.>R:DM66R\1B6HR+CB,N^#2J 'P0:HS)
M#\CB).HT-NF]_P!B-M/RC[8^3$$PRY8@ZB;;.-NH8H78:<].>S79.RS4$7OA
MD>]@X"O_ $GKU8==O25K[[D$^5M313&M[*SAY'/A8'/_ "9<"0@A(,MK^,ZO
M[*_)VJU:9^)I"O-.\,' Y+VASE6:>(FS.F[ID,5&0QFQS97!D#T+JW![X_U/
M(*"[].K8V;*9S<2PB*T(J5 'X00#E_\ S2%:_4VSB:6>Z>V,H6-J19>4O>_[
MK2(3VN*""SURAEMMV2[AYXIZ]?3+<%^> A\1D?RZ)A</0O6OF:,$'2+0Y15Y
MH0/PUG)L8WGFMP'RER"=V/+87-[CH0PEVM;MUK<L\TE9XD$5/Q$/#RWW!RH4
MLN..Z/VP4W'46Y@,D=WGPF^ 8_;^SXQAR"V[]?MZEL5G*XZ,O^L.+-*,,_3X
MO2N_^T.75=<P\.!U_%XF'U;5K,C)_.=[W._M*#FV V3"8#-=1X,I?@JS?2YL
M,AD>&ODCDA9VF,>]ZH&#MXFAA^BEC+.C96CDR/+Y/NL?P0QSD'4<+9HY3JME
M+^(FCFIPX&.O<GA/,3[1F[F#D>A<UBR=0[=:CG] R%N5L-.#+3,FG?Z,898'
M-;R4%3R68QN7W3=IL?:CL0Q:1+"98SWL+P]Y(!3,5*T'1C3C%"UA;]"2C]3W
MOC)<@EC=IU]]ZDU9K$4<]K#4S7B<X!\HC@E+^P*%TS_.O2;_ (6M?_4C0=W5
M!TG_ $OZC_UI6_Z9J!N_^EW3G^M;/_3N5YL9#$19:C3GEA%Z=DCJS'#[;FL'
M+^U!P&Z>D4NG;(78RK2OB2T'UK'!R+;?)[>TDN>I6S"(3HLN4S]G!["<*(SD
M9&1N@D #2^O/Y3P7H)/I?1#]DW/,0Y":_6GDJUV7Y..+4L#3Y7L#>!V D-:F
M]8H97J3IM4W[M/FAD#YJDOBE' :@MN(T'#XK+1Y6:]D\E>AC<R">_9,YA#_?
MV>X!5CJGD\=D>F6W&G:9-[-*RM/V_P"I-'.SN84%=V=EJCL^<U. /$6V3U9X
MB/=&#]B[_P"K&*T:?9H8K.]2YYY&05*N1@+W'T:QC*[4'3J]B&Q7AL0O#XI6
M-?&\>YS7#D$+YNQ5/IW/L&\NV3+,JVAL5D1,.0?5YCX'P8\(+9G,EI.)T#),
MP)IY:J+L E;/:?:@BDF> ))W$N(8.%#6<C9GZA: +6TX[*2MM6>648&LBKB2
M @ O#WDEZ"%N9&KA\!EG8K/XZYC&7IC+K.7@9[0)?-RZ-G:>\DGU:K_+?#>I
MN2C,K*ER]J4#:<4KPQQF\CSV-^9"#EV,? >F)QE[<Z5:(,?7LXGZ.9)=;.7\
M%@!E#G2<KK&OT6#J?:]I!FFAU.C'Y)6<//+R'$A TBE5?%U-D?"QSY=BOQ2$
MCWL;$Q6+I22>G6K\_H+4$;U7_P WZM_Q5C/[ZS]3?\AIW_%V*_Q$%>P-6NY_
M5R0Q,+I+\\;R1[V"L" J_)6@AZ4=-C%&QO&4P\GX/?)R2@QT9KN.W#?&6=NH
M86>6_P"?BY49(9ZA8!&YCWO9RT+I72RM7J:73\%N:Q6?-/)!)+7]F/9)(3]A
MG+N&(*[KF6PN#W+?V9VY6J6Y[D4\4EEXC$M/Q ,#"_WAJH>*IQ34M/)K\8ZS
MOMJQCHGMX JD/='P$'5BQK>LK"  7ZB_O_7Q;:K^@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@+CW5?4\H[)8#<,)5=/>P\K3-69]^:!KN[AJ":R_4/"9+6;<6$=)
M>R5NL^&"A&P^=LLK>/RK?]0-^)*V=,Z>5L-T]^K-[A[K<$WMI;\7SC@\(*=T
M\S$>@8VYJ^T3>R&G9D?2L/:[PVH)#SS$5O:1KU[,[[F][R%26O#*T08J"9I9
M)X@T,,Q:@["N.==<G4?I5_#P!\UZ::OQ!%&YY #Q(2>$&/IOONN8K2L+C;SK
MT-JK6[)8C1LN_N,*T-RR.Y]0H/H'7<)<HXN9P]LR5Z,U@]@^#&N0=0U77,1I
M.L04(Y>V" %\\[_0R2.][ROG6OGJ=;KO?V&2"Y]%O!B%D59G#TKB+G@!!WQ_
M5/2XHR1:NOX'N;0M?NTT3-9+93ELW8KV*M.6<5Z-28%I$,/OE<W\YY<@Y':T
M_8^F>Z3;'KN.ER&$M<BW2@]98F//) :NMU>K&@6*XE?G8*S_ /6@L\PRL_46
M.0<AI5[NS]<:6RXJA:EP\$8#[KXG0QGB L]/(KCUURE672LAAX.^:]--7X@B
M8YY :\2$GA!-=(LK0GTC"8QW++<%4QSUY8W,>.UWR<N6W\=ENDN^?26)H6+6
MO94_EZT+"\Q(.[_7S6),5)>9<?V!A/889&R\\<]O86\\KYTZ$;!0U:GG8,W%
M=JF>:%\1-2=X<&@@_<84':LQU>UBE2FFIQ9&].&GL@CI6&=Q_&1@ 62QF'XO
M0'NSEA[LE=QT\SX@USW>6<%WB8T<GAA<&!!R'H9L^,UC7<I1S3+M6:2^9F<T
MYW@M,;6^^-A74,WU<P%#'3/Q=;(9&X6D0P,I3Q@O^'<Z1C4&'>6;'C>GN)="
M9KF9AO4)?B\RV/*'N 4M2ZKZF*[/IB:;#W./RM2]"^)[#^HD<."#G].@=XZK
MT=KHTYH</C*S6-MRQF+VR5O/!8'+OR#F/6;+4V:/F\6POENV(HVQ01L<]YY>
M"M/H=EJC=&Q&'F[X;U<V ^"5CF.]972(.M+Y>_A#WXLRS!4L9'/;EK2SNG\4
M3W!B#Z8P^=QF8J"U3F+V]K2YI:6.87?!S7 $%?,/7;*0Y;.:I]&13VQ0?*^=
MT,+W =[V?_((/H'*;]@*.#FRD4LEGACO%!'$\R22 <AG;QR%7.D%FM/K3I7R
M..4MV9[F2#V.8\33/^3D%UV^/$3ZWE*V5D[*EBN^%Y[2XCO'H0&\DE?.?07;
M9\-6MX#-5[=>%TWFIS/A?V O]'L0/X0]^+,LP5+&1S6Y:\L[Y_%$]X8OH5EG
M7=OP-FL[B>I9@#)H7-+' /'/!#@"'!!P'3\GFNE>S7]9RU:Y:P<S_+4MQ1/E
M\0?\>&*_=5]GQ%WI]E:U&9]FQ;CC$$443R\\2A!T&.S@-JP-NNU_FK6JYCF8
M6ECP)6^XAP!!7%>BN@9;"YK-3Y;O+,99FJX\/^[S+P99F?B $$/_  B+\.8@
MPE#&LFM35YYGSB*)[PQ=U;O6O0Z^W)>>1S&0MYB;$\R]Y;R(^SCGN*"J=(,C
M!D,?E+]GO9F,C>GM7(9&.8Z-@=V1L'<!RQK5TW.'%G$7V9-S13DA=%/R">62
M#M(X"#Y7Z(;/)K%W+83)0W&8Z>8RU++X) P/'H>?D'A=-ZO].KVR1T,]@G!N
M8QW!B^!F8T]X /P<TH,F ZU8/P,J[5%/A<I&.)HIX)!&]P^+%9V;@,[&:VK,
MEG,GH_)/A>RK7;\7 R >1_R:$&'J'D:&+T?-8U\\TMF?$300,X=--*Y[#&">
M%R[HKMV&US3WX[,"[5LB[*\--*P_ECP/BQA07C/]5\7!1?%@*EV_DIN(JS/8
MYXXV/?Z!SS*QJOM_7A?U"Q@K=N24S8XUI;#CW/<\LX,A0<(Z<;0[IQ7MZMN-
M>>BR*T]]2]XWOKR-?\ YJZ)<ZIX6S&ZKJT<^;R4@XABKQ/$3"?C+(X -:@M6
MF8&77-8Q^+EF$EA@?)9E'N=-,XR/(_M*ELCE*.,K^>Y.(HN>.2"XD\<\ -!)
M*#YAZ)96#&;5MLN1BL5([[P^N^:%[&GB1Q7U1--'!%)+(X-8QI<YQ]P ]24'
MRGL6:K3=<\/FXH;+\=6$44EEL$A9]TA?1>SX'$[QJEJ@9@Z"RSF&=OKV2,/H
M\(.*:7MV7Z;0'6MSQUF.E!([V/)Q,,T'85U>#J?J-QHCPT]C*V#]RO4@D>X_
MB2 UGXN*"7AOS83%6<GL%KMDE?WNAB#I60#C[,,0:.7$ >I^)5$Z49FME[>R
M96VR6'*Y*^3X)HW,<RK  V%@Y0=9OR4XZ5AUPM%?QD2]PY':?0@KY*Z1[ -0
MVS/8N:"[]"6[#Q6LF"7AIC<1&\_J>U!?^O.7IWM.&+H]]FU)<A?XH8W/X8 7
M<E2.C]3-<QVHX*A>BR4-FK1B@E8:$[_6,<>]C2@V[_42+9<EC==P5#(\79P+
M=V6N^!D59GVY .\ \N X7O=LYF<!OFNW*&(N9"L,999>BK1F1XB,C#WH)Z3J
MYH$<!><Q^5_1?#*+'/YOC(Y5/Z/ZID:>0V?9[U%] 9>T]]6F\</BA+R_[00;
M>M]7V9/>[6L3X26JT6)H(+#G<E\D/)X>%UY!SGJME:-;2\Y0+GONV:99#!&Q
MSWDO/'N:JWT)RE2#3*N'LF2O=CL3DPRQO82"2_EJ#8R.V88]5,-8$DKJL>'L
M0261%(8FR2O#P"[CY-788Y(YHF2,<',>T.:1[B"@^9-HZ8/UWJ/K&;P\3AB;
M>;IF>%GNKRF7^X5]";GJU+:]=O8>T>T3-YCDXY,<C?5KT'"]+V[+]-H#K6YX
MZS'2@D=['DXF&:#L*ZO!U/U&XT1X:>QE;!^Y7J02/<?Q) :S\7%!9\+'E8J\
MT^4F!MV']Y@8[F*NWCAL3/GQ\7?$K>0$0$0$0$0$0$0$0$0$0$0>;%>"S$^*
M>&.6-PX<Q[0YI_$%*>/H4(RRI4@KL)Y[(HVQC_T:@_7XG%RVV6Y<=5=89QVS
M.B:9!Q\G$<K'<H4+L0BN4X+# >0V6-L@Y^?#D&2..*&-L<;&L8T<-:T<  ?
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MSV=WVG$YR"%\&#Q!F-*9X+7WIY6]A>T?")JP:&R&7I=F39 +I9<P;?/Q<99
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M$;'S/;^(C!X02^K[?K.S5GS87)Q60SCRM'+7LY^;'@$*80'.:UI<X@ #DD_
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M&R)LX['GB)K>7."CV],XF5:N-GV+)6,+6F9)#C)/%V_DW=[&.D#>\L:@Z(B
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M$!KFN^ZX%$!$!$ D $D@ ("" 04!SFM'+B /F40$0$EFA@87RRL8S\YQ#0@
M@@$'D%"YH(!(Y/N" US7#EI!"("("-<UPY:00@(@=S>X-Y'/'/"("("("( <
MTD@$$CWA$!$!$ V:S>1YHP?Z07XQ['CEC@X?,'E!^H@(@('-)(!!(]Z B @<
MUW/!!X/!0/(SO[.]O=QSV\^O"(#G-:"7$ #XE.YI=V]PYXYX0$#FDD @D>]
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M5TD+B 6,X^Z@TNIMO8H,GI+,9[/V2YJ,<2321"20,<0QX8T_84!A;NX1[EU
MBPF+HSO%VM)/):G=%'S[.WAC.UI)*"QGJ;Y]7US(4\:#D,S,^"O4DF#&,DB)
M$I?)^8SM4K@-OR<N??@<W6HQ6W539K3TYS-!,QAX>W[0!:]J"S9NGFI\=)%B
M+L%6V]S0+$L9E$3#]YS6_%WRY5 Z44YZV%VJG[;+++%LF2A%J7[;W%A#0]Z"
MG;CIN!UW7*5>KW6MNM66>PWF<BY/:+^72^\\,"[Z9?!6,MA[0(X^Z1WP':.2
M4' -XVK;,YTWS.3;@:S,+<K\0GSDVVQ%_#9GLXXX*NDVR8C"[+G+5F@UKJ6L
MUK,UMKR9)(^]W$0:@UKN][QBZF(OY+6J+*F1MUH(Q%:<^6O[0X >8%@4'MF4
MG9ANJOT11AJV*TT+;5D3R-?*TP ]X^3P@[%KDN0."QSLBRNRP86]S8'ND9Q\
M."\-//'O7,-9P>-WC*;'F]@KBZROEIZ-"K-RZ&"&MZ<AGN[WH+%6PN-Z>P[%
MEH+;X\-X!/\ 1H;R(9&?>,))_P!=1SMZVS&U,=F,Y@*<&(MS1,>8;#GV:@G/
M#'S M *#8?M^X9#.[%BL'@Z$GT5/&U\]JPZ-CP^,/#6AK3]M5+/;=G\]CNG&
M4Q5>"!EW+@/@FG>SF>(/88W]C3S'RU!</KAM-O;<M@\=A*<D6,EJ>V699RP!
MEF(/(8./5RT&;]M=_%V]AQ.O5)L' 92SR6',MV88"0^6-H:6A!ZQF4J9;JAC
M,C5>3!:TDS1D_)]IA73D!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!!#")'2"-@
M>1P7\#DH"($D<4K2R1C7M/P<.0@ :    !P @+\EAAF;VRQL>/DX A  #0
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M#C#DI1/+-+=N/LSR2<<DD!C6@   -:T *20$0%^2PPS-[98V/'R< 0@ !H
M  '  7Z@(@)'##%W>.-C.3R>T <E >QDC2U[0YI]X(Y!1C&,:&M:&M X  X
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M+G@R-BQU2T06MHH969@O]XIP-CB@[ZYX:7AS^2Y!GP%2K_$SNA\#.91G'O\
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MTCIAE9,E3SGEJXX/@RLK'W:#2VO=>0"Z8+0SEN&IU9Q_DM10/LZQ8KU72.#
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M\*__ -6NOJ1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1!#[GKL6S:OEL0]S6^TP$1O=[F2-/+'?V."H
M72;II8T2ME'WK,%BY;>P!\7/ BC0-YZ77<MGZ^S:WEQC,U$T O(YCE5</2G=
M]HR=&?>MFK6Z55_>RG3!#'_C]AB#M^:Q[\C@LICH"QAL49J\9/HUID86#W?
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MV36]G\-^S5#2_O[O9WEG=[@ICD<\<H#G-:"7. '!/JOQTT+(Q(^5C6'CAQ(
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M7T+5<K8;:L5)FSB$0&:&Q+ ^6-HX#)#&X%X5FQV.Q^)H04J-:.O6A;VQQ,'
M 0>D0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0:62R^*Q-<6<E>@J0=X9Y9GAC>X^
MX<E1-;J!HLLD4,6SXM\DC@UK!8827%!-9/,X;"5A:RF1K5(R> ^:0,!/R'/O
M*_,+L&!S<#Y<3DZMMC#P\PR!_'X@(,]6_0MRVH:]J*5]:3QSL8X$QOXY[7?(
MHW(8XW)J7M</M$,0EEA[AWL8[W.</D4$5/N6H4JE.U/GJ$4%L.->5\[ V4,/
M!+"M6'J#HUB:.&+9\8^1[PUC&V&$N<4$]CK^.R-*.Y2MPV:\G/9+$X/8[@\'
M@A*61QUJQ<KUK<,TU5X988QP<8G$<AK@/<4&KE\[A<+7;/DLC6J0EW ?-(&
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MG$Q[VB.>+DM>>#Z^_P"*"91 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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M?U6ZGS.8"]EIS ?U/F<@[^OAWIL_I&VEE1N@9[5[8?!R+)/C_P#]"#HW1ZU
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M>D9^]2G=#9@J%\4@][2@H@H6+/5W#V#EKS"[6?.6-,?;PR9@,7JS[CUU] 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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M^#V'T>P_$%!5AH%FP[/6\QG3<OY'#RXP3LK-@9#!)\HP3R55]EK4-<RV _\
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M&4@RV4OX'99,6W(O$EN$UF66&4#@RQ]Q'8XKPSIKCV4L#C/;9G8VA9=:GKO
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MG4^3#P2PWKE^*2@_T!D8(V!YC)58DUV2?+ZE=QFK9]OLF8K2WKF3F<^;M]Q
M:][OQ<0@F,[KVVYS.6=O@I>"UAI1'AZ,K&\VH6<F4R?(R\\,76ZV;N3W<9#]
M"W(XK-0S23/  KO'_P %(/SD%:ZI4)[^@9^*LSOEBBCL ?/V:1LQ_NK:S.?S
ML<6OYC#43D<5,PONP0 &P8I6 QR0\D \?$(*9#J][;\YLN1L4KV$H7\1%C@#
MVQVIRV3O,SVCGCT^PM3)].<]%LFF"MLF:EK5W6PZ?B >Q,$'#>SA@ #_ +J"
M[;-BK^5W33 :SW8VB^S<G?\ Z@G8SLA4YN^0BQVH9^U)[F4)@!\WO:6M;_:2
M@I^)Z88N;"8 9&?(LM5L96@D;#;EA8'1L^3"M^ULVT8;,9:"YK=R_6>X/QL]
M"-KN6D>L<_<X=I!04*KINQ83'Z=DYL6;KZ&3O7;V,@(<6>V^XQ<\!SH5*R:W
M=W78\Q>DH9#"8^?"?1[WO#(;5AQE#RXL]>  .$&MD^G.>BV33!6V3-2UJ[K8
M=/Q /8F"#AO9PP !_P!U=&ET/"2YT9HSY$61.V;M%N41=S?AX^>.$%/R>:VY
MV+SN"R>I6K]N<SPU9Z[&>QSQ2^D;I'.=]A:%?6,UJ61U+,^P394T\ ,3>;6X
M?-'P1(V2-KB.\($&C7-NM[1DLBR]AH,E:HF" =@G<RBT\.F:>\>I*S5-%S];
MJ32NR9_,6:L6(/?:E\7VW"PT^RNX8/L.00NT]+,G3TZ_3Q.PYJX73Q2^Q.\)
M$KWV&O>]_# 25W#'5YJ="O5ENSVGQMX=/-QY)/7GEW: $'*\!H3L[;SF?S_T
MG4N7[[_%#%:EK%E6'[$(>(RI?1,%?U7.;+A17L'#O>R[0L/<7\.D'$L1<4$C
MK>+R%;?=_O3UGLK7#C/9I3[I/% 6OX3JKB\AEM#S%&A5?/9E-;LB9[SV3L<4
M'OJIC+^5T#/4:%9\]F:*,1Q,][B)6E1G4W5,EDZ(R^#'&9I0RL8W])K2CB2!
MR"1U23*875M*QLN'LOE=4A@M$<#V4L9[Y%;<M5ORXB_%C[0K77UWBO.6APCD
M(^R2""@Y+=SN<R.$.(SO3:_>R7@,1/9"^F^3CCR"8N^PLV U/.8G,]/([3'3
MC'82Y!:L#U8Q[^SAB#)E,5MT65ZGV\- ^.U<HXT8Z8\ 2/AC>'ABI4^N3VK.
MJ6L=JVP&:GF:-B_=R<SWR]C'_;#&/>Y!T_6,%>;8W^*W!)!'D<I*8'G_ %XW
MP-9WA<EHZ>:6 ;@[.A9.WF(P8!/[9,W'3#G@2N>V4<-X][4'6L'@KM#?K<_L
M992;KM*K%(.3'WPO=RQI<J7/JFQFIF;M;'N?9I[X_+UJSR&&U UC6\,06+_Y
M;;9M6L6Q@;^.H8A\UB:6ZUL<DLLD?8V.-H)57QNM;)B\3J^79B9IK.'S64EF
MHC@2R5[KWM+XT$G+2S>U[5F[$V%N8VA:U*SC8)K+0UYDED'JYK2>%4:NI!V$
MIX67I]DI,LT103RSW)QC2&<!TW>R9!UK 8FY2WC=;<E5S*MB#%MK2?"3PQ/#
MP%8MFJ9ZQ@+[,';96R78#6>\!S>YI!+3W CAP'"#E>SY/*;5@K.(L]-;_P!)
MSP&)LMAL/LM>1PX\K9^5JY[2IZ.>P^3R.*OYJF,'!0M&G*]EAD\'_P +PQ["
M]CT&O;U*[/I>W'':I-1??N8_V>O)-)-;FBK3L/?,)'O 74^H.%MY77)'4&=V
M1HSQ7J/S,]8]X:/Z0Y:@Y]?U;.S=)=BC?1D?FLS*^[8@'J\233 B/_Z1@5AG
M.6U?==@R@PE[(T<S#4(=3:))(9JK#'V/82/1R"K;'@-FS#M:V',X!UCV:6XR
MQBZ<KHYXJUCCQ$%CQW2,X^VMS":](9MAOXG2S5!Q1JU6Y6>9\MLO/<^-['R/
M#8D$9K^#N5]BP4FNX#.X.-L_=EH+,I]@,7;ZM8TO=W.)]Q"Z=U$P%_.ZK:J8
MX,-N.6"S QQX:]\$@D["@JF4GSFZ7M:IC6LACH*.5KW[L]P,8&FMR1%%P27E
MQ5DT+&WL;#M/ME=\/GV;(V(N?]>*5_+'H+@B B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
M B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
M B B B B B"'AU/$1;%+GWFQ)<+"R+RS.?' ' -=XF'T87<*80$0$0" 000M
M3#XBGAZ$=*J'BO$YYBC<>>P/<7=C?_".> $&VB L&5PU')LILMA[HJUF.P(N
M>&/?%ZL[Q\0#Z\(,Z("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("(-7+W'X_#92^Q@<ZK3FF8UWN)
MC87 %0^L;AALMC\.'Y*@W)6\?7LR4F3M,C3+&'D!A/*"?KVZ=DS>"Q%*89#%
M*&/#NQ[?>QW'N</D5^U;-2W#YJMB*:,DM[XW![>6G@CD?$%!@O['K^-LQ5K^
M8HUIY/N133LC>[\ XK-:R6+QX8;E^M!W,>]IED:SEK."YP[B/0<^I0:)V[56
MTHKKL_C!5D>61SFU'XW.'P#N>.5(6,EBZ-/VRS>KP5N ?/+(UD?#O<>XD!!&
M_3^.MX3(WL+D<=:\$$KFR>T-, D8TD>5[">UJB,=LUV;:L?A)(JQ9+KHR,DL
M+B\&7RMC(8?BQ!:*=RG<K,L5+,-B%_/9+$\/8[@\'AS5KW<_K^+\HO9>C6,?
M9Y/-.R,M[_N\]Q''/"#9?EL8RM!9-^L(9BT12F5H8\N]P:[G@\K1^LVMG&G(
MG-4/8>XL]I]HC\7=\N_GCE!FAS>".-^DFY6D:7QM"=AA^7W^>%GGR.-INA98
MNUXG2AQC$DC6E_8.3V@^_@(/7TCC_8?;O;(/9/'Y/:/(WQ=GYW?[N%5L]M#Z
M-FECL71^D,G;C,L, >&1LA'H9YG^O;&@K+=LW$"66+(:??,4C8Y*E:V^.0/=
M[HQ(\N'>5?\ 7]@Q^9Q R$(= UI>RQ', Q\$L1X>R7Y%J#9QF?P67=*W&Y:E
M<,7^4$$[)2W\>PE:\VPZ[7NNI3YJA%98PO?7?.QL@:!R26DH-Z/(4))F0QVX
M'2O@$[&![2YT1/ D ^+?UJ)S.8-;%WYL=:QQM5I(F/;9G#(HR][01*1]TD'T
M010WG"0[;<P$UJI$:] 6'SOL,:.[D\Q\'XM Y*M<E_'P4_;)+D#*W8U_G=(T
M1]K_ +I[B>."@C[.PZ[2O1T[N9H067<=E>6PQDAY]WV205#W=SQE';\;KLLL
M#9;-=\I>Z9K2QX(#(^WXN?R@FI]CUVG>91M9FA#9?QV023L9([GY-)Y6UD<I
MC,76,]Z]7JP\\&6>1L3.3\.7$(*UG]KBQ]+ 7,;)5N0Y#-4Z/D8\/9V6']I<
MPL5E;=HON.IBW#[0V,2.@[QY P^@<6^_A!ENWJ5"N^S<M0UX&?>EE>(V-_$N
MX"Q8W)XF_4-RED*UF <\S0RMDC''O^TTD(,.*S^ R;Y8L=EZ-N2/_*-@G9*6
M_B&DK!-LFM5I616<YCXGNE=$UC[$;29&'@MX)]X*#8@S6$FR+\;'E*;[C!RZ
MJV9AF'XL!Y6T@YQC.H4EG>9L,ZG&,<Z>Q3J7 3R^Y58Q\K"IC:[^]8QERYB*
M^#?1K5'3/]JDG$Y,8+G<!C2$$/KV9ZH9K$T\FVIK;(+=-L\ ,MD/!>WE@?\
M94:-EZIC:/JZ*.L^U#&"_P!_EL^+Q&7Q(,V?ZD935LYKE#-TJAAM53)D;%<O
M+*Y[_&'@N_U%;=AV&?%9+5JT4,4C,ID/9WEW/V6>,OY:@LE>W3GFL0PV89)8
M"!,QCPYT9<.0' >[E5+;=DR&)GPF.Q=*&?)96>2.L)WF.%@A9WO>\A!KX[/;
MG2SU#%['BZ+X;S9/!=QQE,<;XQW%DPD]W*R83?\ %V#EV9>_CJ+Z^<N4*[))
MVQ&5E=X:'</*"Y9#+8O&5Q9OWZU6#W>6:5L;/_5Q"Q5LYA+=!]^OE*<M.,$O
ML,F8Z)O'S>#P$'BMG,%,+H@RU*0U/^]%D['>'_S.#]E,3F<)EV2/QV3IW&L/
M#_!,R4-_'L)0533NH.*S6"PMG(Y''5<A>8YPI^=K7GAY8 QKCRK1DLSAL5&R
M3)9.I3B<>&NL3,B#C\AWD((/:-G^BL3BK]#P6H[>3J5@X.[F%EA_87 M4];S
M>#Q<T$60RM.K+-Z11SS,C<_\ XCE!!ZEM?TQK)S.1->HQMFRQ[B_LC8V"8Q@
MDN5@HYW#9*I)9Q^3J6H&<A\L,S)&,X')[BTGA!CH9C!WK#Z]3*4[$[8FRNBB
MF9(\1O\ 5KR&DG@\JL;5LN5QV5P^$PU.M/DL@V:1C[3RR"&*  N<[M]7% PV
M>VZ'/PX;8L74YL5WS5KU#R.@YC]\<@D]6.5D=L&NU\BW'2YF@R\> *SIV"4D
M_ ,)Y0>[V9PN,Y^D,I3J]K \B:9D?#2[M#CW'W<K-3OT;D3I:EJ&>-KRPNB>
MUX#F^\$M^(01U?.>U9N&*K;QTV/DQ[YFOCG#YW2-E#.6M!X,7S=\UN-V+7WY
M$XUF9HF]^BB=AE_Y.>4#([%@,7-%!D,Q1JRR_<CGG9&YWX!Q"R7<EBL;6%O(
M7ZU6#D<232MC8>?UN(0*5^A?K,LTK<-F!WW9(7MD8?[6\A94!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$$=MW^B>Q?U7:_P (K@N1I:U7Z+Z[9Q,549(B@:$L8'G-\O9W
MH)_;LI:TK8]BDJ,_TBQK746__P!SC(@X'XAX<NK:WAH<%KV+Q$)Y95K,8YWY
M[_>YW]I0<*P5/+7[.^/GBUJ1_P!+VQ?.39(9F0CT9^$0;]Q9\3BJMRUT:J7K
M,.4@95R[F2ECQ'*V,-,7I, 4%EUO6=>?OO4F.7%U7QL?19'&8FEC!/6#Y.T?
M#O5.P%N*SJW2S'#%5[^3DAMR4S=F,=2(0\@EX />4!GGBRO5B"9V,$WU3<9X
M\<PL@$@C?\_>]7+4O].-7_\ \>P?XT:#K&&BPE;&0,Q#:K:([O"VMV^'[Q)[
M.ST]ZY?5J8&QUBV/V]E=]EN'I^S,E /V3SY" 4'.9J5.WAC0A:U^%EZDP05&
M#[A@D/$C8_\ P<KH63Q6"K]4=<H6J-2+&C$69*%?QL9 ;QE >0WW%X8@U*L6
MM5]OZB0$5VX#Z)@?DXV^D#+!Y#OP>6*%Z4M)S[69\6S<.+'T +G'^;/WOYZ#
M5CBF#ATQ//8W/%Y_J@?]K'_R"W=QM2QGJ"XRF R93$4+$P]#!CY(V<D'X E[
MD&UM-?18=TT#'5/HZM[#)+;G?&6,;'7KQ][!(?UN"@=FDMV=-S^7@ BQF8VJ
MM+S*'-C=2 9"99./4,D<Q!9!C;];<].FFM:U3GYF$$6.BF#[-?Q_:8?>.P*O
MT:NMS=$L]/E(ZWTD&7C=ED \XR D=V(+7KTT<&]ZH97M9YM"C9%R> ]PE8XA
M4S.VZUS7^KD]>5DD1S^. >T\@EDD+4'1/8,3-U=S,-FO7(GUN#T<T<N+Y7M<
MJ;AO:;\^"Z>6"7G#Y>9]XG_7HT>):W/ZGE[4#*XU\1WF[CA@LWC'7;#\K4O-
M?7MP/:T=\;)O[BG:<V'O[WH=]M-D,5K69)863<%X/,98"7>]S4$?J%'5;?3O
M8;&>BJ/NFQD/I>2<-,K)A(Y:FH!UW/Z$S9&"4?5#OI-L^H=9,O!(#_?)XD'O
M<H\&RL*VJ>-EIN[8WR<@FJVZ[Y#^^ K?TQ?!0.Q8[* -S]:TZ3)V9#ZVHW>L
M4X)_U.$'C;'XR]N?3T7)()\3,;KV$D/KR6@P>)5CJ$W5JU;8J^+#HB^YBOI\
M0<B%M9TG'P] Y!/[;3P5+8>G;\'#4AO.RK&-%4-:7T#&[R\]GO8JS5P6'L:;
MU?NST()+)RF=XE>P%[?""]B#>MXC&8[#=(K-2G#%8?EL>'SM8!(_SUWF3N=\
M>]=3V[.LUW6,KER 37@/B;^?*[[+&_VN*#AMW4^HV,T2@P4,/WXB<943LL3.
MM&=A,K^06<$E=LOY>KF^GF0RE4\PV\)/*S]7="3P@=.?] =4_JFK_AA0(_EK
M=_P</^L0:N?H5,CU3QE*W"):\^LW8Y6'XM=*U<[,V2P^VZ5I^2,DIQV:$N.M
M'_X>B^)X8"?SXT'T53BPD5W)24VU1:?(PW3%V^0O ^SY>/7GCW<JD[_+J=FW
M@\-L=9[(;DDCJM_O\(@GB'( D!!:YR"L,.1U+:=;H4-NM9>KDK)AEH7)&V)H
MHPPN\[)!ZAK%K:SKV$N87J?9LXZO--+GLRQTDD8<\-8@BL9;]NK=-J%?$U+V
M7;KHGAFR$SFUH8N PD, =WR*(A+VT.M\+Y,>7,H5C(*#2RL)#"\.[ 4$SNF&
MI8O3=+AH4:%>M8OXX9"25G$,P#"6>U%GJ6%ZG<=C;]7J/@);-K 5K)HV1)5Q
ML4P?8K]OH9/>T!CD%*H8#"L_@\SW!CX/:G5);!G[!Y?*R<\.[E?,/%C[_4[.
M?3;(9IV8;'G&,G </"]I,[F!W_C04.85XZ>;AQW'T1'ON.%(,_R0<7-,PC_4
M'*_X"I@[FV]1?IZ"K):99C'%D-/;0\(["WO]S$')Z8+].Z>5JKJAQLFPY#_O
MO<:SG"1YKB;A7X8^[5VS*OL7,'#:?K=KVFECHYF^2,?<EDY!:""@NW2?"8FC
MI&NVJU&".S/CHG33A@$C^_AQY<M?>/JAD<[A\'GHI*\DD,D]#)"7P=DS2 8F
M2 @AY"" IV,SK6XX?"4-HL9JM?@LE]:V]L\]3PQ][)#*WX$KG.$QUV[TQO3W
M)=9C@?[0;]NU',;T5DO/+WD>OE!0=#JX:GE>H>M19>.'(&'26RN,L?+))O*U
MAD[)%'[/<LZ?F-GQ..9V'9*T+\4QOH&W9'"K*!_80]!(G%NP6Y08W%@]]/I]
M8BK?,R,G;PL&!J]/6=+M>N9"*(C_ +*]\T/_ 'HWR\<\%GVR_O00^'IY>]GN
MH1?%K<DHR\[+ RC'NE94 'B_"'L6+'XGSX7I_'3V7&SY&N+YQC+E>9].W"3P
M6_; (,807_I]E*=>?;JUS%4<5:I6X9,A)6G+J<CYF<A[>_@,72FN:]K7-<'-
M< 00>004!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$'Y/!#8AE@FC:^*1CF/8X<AS7#@@J
M'IZ1J%'(QY"K@*,-IC0&3,B <W@<>B"!RN"S>9V_&6+\5)F)Q,YLU.UQ?/-.
M6<-+P1PP,5W00V5TK4\S=%S(X.E9G: !))$"Y2<F/QSK-*?V2'RTVO;6D[1S
M"V0!K@SY @($=&E!:N6H:T;)[18;$C1PZ3QM[6]Y^/ 4?:T[5;6+JXVSA:;Z
M=8DP0F,=L1/Q9\D&2MJ6L58Y(Z^%IQ,?4=4>UD0:'0/))C/S:25LLQ6*KV(+
M$-*%DT-058Y&M +8 01&#^;R$'O'8RABZ4-.E5BKUHN?'#&T-8WN)<> /UE4
MFUT_I97;\YD<S0I6Z-FI39 R0=SV/@[N2@NWT%AO9*53Z.KBO3ECEK1",!D+
MXO5KF >XA,Q@<-G*HJY3'P6X0[N#)6!W!^80:<>HZQ%BCBH\+3;1+P]U81@1
MN<#R"X?$K>N8S%V;%.Q/3ADGJ/+Z\CF@NB+AP2T_#E!3==P.:^LF2V3/Q4H[
MTM6.E6AJN+VQP,<7DN>X#DO*S[-I]N[??E<39K17)*WLUNO:B\M2[!\&3-^8
M^#D%/.I9^2M7I#0=.B$#R^*5\CI8F/=[WB,0@KH6%U^:GC+5?+7WY.2V2;'F
M \/!''CBA]6LC0>\3J.K8*>6?%X:I5D>.'/BC <0H?;.GV!S5'-3PX:@,M:H
MSPPVGQ@$221E@<XH-YVGX._@L-C\YBZEU]*I%&"]O>&N8P-/:5)_5C6HJ=FF
M,/3;6L&(RPMB 8\P\=G('YO:.$&7(8'$V[L&4?C:TN0JL(JSR-^TP_ !WOX5
M8U3 9:#+9K8,VRHS(W_%$(JQ+V100#AK>]P!)*"5RFEZ?D[_ +=>P-&Q:].9
M7Q D\?G?-263P."R,M&6[C:T\M-X?5>]@)A<.#RP_!!'9'2]0O9(9&W@:,]P
M$$S/B:22/<7*5S.O8/.5FULIC:]N)IY8R5@<&GYM088]<UZM1J4HL5596K3L
MG@A;& UDK#R'@?G!;%C$8B:Z;\U&%UDUG5S,6CO,+O4QD_FH-:UK>O38>/$3
M8FK)08 (ZSHP8V\?()0U_ 8K'RXZEBJL-63GR0-C'8_N'![Q\4&+#:=JV"GE
MGQ6%IU99!PZ2.,!W"WAB,1'4OU648!#=?*^U&&CMF=/Z2%X^/=\4'J;$XI\-
M"*6G"Z.E)')486CB%\0[6EGR(!7K)8W&Y"!D-VK%-&R5LK&/:' /8>0[@_$(
M/T@$$$<@K#6P^(HXLXNK2ABI]CV>SM:!'VR<]PX^1Y09*M6K2K0UJT+(H(6!
MD4;!PUK6C@ !'8^@,@<C[-'[9[/X#/Q]OQ=W?V<_+E!^2T*#[\=XUHS;CB,3
M9R/MM8X\EH*\7L7C+MNG:L4X)9ZCBZO,YH+XB[WEA09JN,Q]2S<LUZL4<UM[
M76)&MX=*6#@%Q^/ 7YD<1C,I3?3OTX;,#^"Z.9@>TD?J*"&P^IZM@99),1AJ
M=61XX?+'& \CY=RF(,7C:T-QD52*..U+)+.QK0!(^;[[G?,N01E[3-4R%*E3
MMX2I+!4;VUHW1C\D/DQ>F:MK%>"U!#AJ<<<]=M>:-D36M?$WW,< @DK&/Q\]
M!U&Q5AEJNC$9@>P.86#W-+2M'!ZGK> ,IQ.(JU'2CB1T3 '.0;+<!A6X@X@8
MZ 8\L+/9>P>+M)Y([5JYK5=:S<4#,KB:MIL XB\C 2P?)I09'8/!-H5J#<76
M;5KR,D@@$8#&/C/+7 #W$%8LSJ.LYR>&?*8>I:FB^Y)+&'. 09OJW@'8N3%N
MQ=5U%[G%U8Q@Q$N=W$]OXK%B=3UO#5[%?&XBK6BG'$PC8!Y!\G(-^I4JTJL-
M:M"R&"%@9%$P<-:UOH  O.4PF(R]/V3)4*]N#GGQS,#P#\QS[B@B\+JVMX(R
MG$XBK3\@X>Z)@#G#Y$K';TG3K&3^E+& H27"\/,SH6DEX^)03#J-'V\9 UH_
M:Q 8!/Q]L1%W?V<_+D<I>QN-MV*=BS4AEFJO+Z\CV@NB<X<$L/P*#RZA1]O;
M?%:/VIL!@$_'V_$7=Y9S\N1RHQFG:C!ECE8\%1;?[R_SB(!P>?\ 6_% S>G:
MIF;#+63PE*U.P "26(%Q ^!6]D]:P&5H14;^+JSUHN/%$^,%K.!P.P?!!CK:
MMK=7$S8F#$58Z,O/EKMC 8_G\X?%;\<<<4;(XV!K&-#6M'H !Z ! 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 5 V'JQH>NWWT;^4YL,/#XH6.E+/U/+4%JUS
M:->V.A[=B+[+,0/:[MY:YCODYKN""JUL75S0M=O/HW<MW66'B2*&-TI9^):@
MLFL;CK>U57V,-D8[ 80)&<%CV?TFNX(6KA=[UC.YG)8BA?[[M(O$\)8YA!8[
ML=P7#UX*#W)M^OP[$[ 267"^RL;!A\;^/&!W<]W'"I?\?/3'_P"?$O[+,@FL
M9U7TC+4LM;I9%[X<= )K+C!(.QBA1UXZ8\_YYE_99T'1\-L.'SN.9D,5=CM5
MGD@2,^8]X(/!!7/<CUHZ=8J\^K-F#+*PEKS!$^5C4%^P.P8+/XYM_%7XK-?W
M%[/>T_)P/!:5IZOMNO;/3FNX:X;$,,OBD>8WQ\/X!XX> @F9IHH(99I'!K(V
M%[C\@T<DJFUNI&KRT,!=CDL%F9MFM2YA/<^0/[$%S1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1!J
M;->FQVN9N]!_E:V/LS1_THXRX+B70'7<//I\^6M4X;-V[<F$TTS!(_AJ"XNT
MW!Z+B]RSV"9/%/-0LS^(/YA8Z)A>T,8J;T!UK#2ZB_,V*D-F]<MS"6:9H>\!
MB"'M4JNJ_P ('"PXB)D$&4I<V:\8X9R\/_=ARY,UF>Q6W;CN&)Y<<+L,@LQ?
M.&Q+("@ZW@\UC]@ZYT,I2>'UK> #Q_:S@M*=?L7C*D.H^S4*\/?DR']D36<H
M.I]2,9C:73W:S4HUX"['/#C%&UB^=]6ZCX#7]&Q5/):');Y9,QMR6%@AL$O<
M> ]X03F'PFQZ7T6W&_8'L\U\Q/@A8\.\44SFQ<KJO2'4==K:!AYOHZK-+>K"
M:S+)&UY>7H*%I$$6M];-OP&.^QCI:1E\ ^XQQ8R4?WU)?P9_]$<S_6I_PF()
M[K?/EZ.LRVJ6RLH1LKRLGJ=C'/N"8MCX9RN$8[#9D['I6&&[TV-IXWVZO+V1
M^.BZ7U,7R<]!]KH@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@_)Z\-F"6"9@?'*QS'M/N+7#@A?/.
M+U7JUT]EOT-6J4<OBIYC+ )WACX2?Q>Q!;^G6@YW'#8<GM5P3W<QR)ZK'DQ,
M8]4_$ZGU9Z>6+U+5Z]+,8F>8RQ1SR!CXB?Q<Q!.Z7H6T/VV?<=PG@.2,996J
MPGED ([%(:!I.4Q65ZANS5&,U,Q?+X&E[7B6%SY>>0/U/05#0.DF?U+J7->$
M;7X=D<[()S(TOXD'H"U7+K%IV?VB+6QB:S934OF6;F1K.&(+QO.&NY;3L[CJ
M3!)9LTWQQ-)#07%5'7M \W2FGJNP0!DHAF#N"'F*0RN>Q[2$$+H>E;5'J>;T
MW:JX..+'LI6F3,>0PJ PF(ZX:33=A,50QF6H1O?[+/)(&&(._4Y[$%MZ;=.\
MOA;N9V+8;;+&:R0(?V>K8F$\D+G6BZ]UMTC&V:&-UW%2QSV#,XSS@GG@-^$K
M4$UMNI;]NV%P[,]KE)F1AS+6]]:8!L-!X'D<>9"MG!=&<&-SV6?(ZXR/$,$#
M<7'YR02!]M_H\N0=\1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 6#+W9\?C)[->FZU*SM$<#7!
MAE>]P:&@GW>I04FQN^?K;%CL#)K5<6[E:2>+B_\ 8#(O?R?$E_><U1?AV6M>
M9 ;6?AQ<O-GO[#, \2,X9]H%J"^H@(@(@K-G9+=3=L7@#0C\-RI/.VSY23^1
MXY;V<*S("(,$]K+,S-6%E*)V/=7D=-9,O#V2@CM8&?$%9T!$!:.?R5C$X/)9
M&O4;8=4K23>)TGB#A&TN(YX<@]8#+/RVO8?)OC$;[M""PY@/(89F!_"B-:VB
MWE\QLV/LT8ZQQ5F&$%LID[_*SOY]S4%C1 7B[+8AJ3RP0MED8PN9&Y_8'$?
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MD^VX4C&LKROMOOUS8K1UF&1\D+0"9/U!!3-YS&.SG2S-Y7%W)PP5GNCDC?)
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M/9Z<EQ;QR&CXN6_<WK5Z%+#6Y;SA!E'Q-J3")Y8[R^HY=QPU Q>YX3(3Y*O
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M,YC&6<O%FJ$%6!];+-#>\]Q=Q!*]GH]S4&KU,G&*SVJ9R[!:DQ%;VN"\^N9
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MMFA)+4<Y]>.I"^-K7N88RYSY'.)]'$ (+$B B B B B B B B B B B B B
MB B B B B B B B B"'S^RXG7J,5W(&;POF;$SQ1.D'>\]H#BWT"F$!$$-8V
M?$5[\M!IGLVH@'30UH'SF('W>0L!#.?@"MO%;)ALI8N5:<[C-4;&;$3XWQ/B
M\O/:'-> 03VH-Y$!$!$!$!"0..2!R> @(@B:>R8NQL5K!L\_MM>L)Y Z)S&!
MA=V@@NXY4L@*%SNQXS7XJDM_SAEBRR",QQ.>#)(> "0.&H)I$$16V+%3['-@
M!Y_;8J?M3FNB<QGB[PSD.=QRMG-YO'Z_BK.3O^45H&\R&.)TI_\ 1@*#=JV8
M[56"Q'SV2Q-D;SZ'AXY'*_4#D<@<CDH@C,/L&#S-O)5:%QMB2BYC; 8#VL,G
M) Y]Q]RAL[U!U+7[?LV2O/8]H:90R&241!_N,IC!#4%KK6JUJM#9K3,EAE8U
M\<C#RUS7#D$%:N1S6.QAK,L/>9+#RV""-CI)92T<GM8P$D >\H,F/S&*N8YV
M0@M,-=G?Y'OY9XC%Z/#P[@L+?B"M3&[5ALG9AKUYI6R30F:N)87PB>(>]\1D
M [@@DD0$0$0%7CNNN1Y2QB_+=?>@C#Y8(Z%J1S6.]SOL1E!+8K.XS)SVJ]5U
M@2UA&98YZTU=P$O/:>)FLY![2MM 3D<D<CD#GA 1 1!5[_475*$5Z:S:ML@J
M3OAL3^P6W0,D8_QEIE;&6?>4G0VW"7[[:$+KC++H'3,CGI6:_=&P@$M,S& \
M<H-["YBKE\76OUXK$44O=VLGC,4@[7%IY:Y9T!$!$!$!>+5FM5KRV+,S(88V
MESY'N#6M:/>22@@SO. 9#'9E=;AJ/X[;DM6:.OZ^XE[F@!I^#BIYK@X!S2""
M.00@_5^ AP!!!!0)9&Q1/D<'%K6DD-:7NX'R:T$E:6O;'C-BQ4>3H.D-9\DC
M&E["QQ,3BP^A0;R("C[.=QU*Z:1\\UIL0E?%!"^9T<9/ <_L!XYX]/B4&WC<
MA1OTH;E.=DT,H)8]OZCP?P(/H0LJ"FOZE:55RPQL^4[)C.8!*8I/!Y1Z%GEX
M[.59LEF<?C/9VV)'=\\GCABC89)97\<\,8T$G@#DH,E3/XBWCI\A';:*T!D$
M[Y 8S"8OOMD#^"TM^(*K^%ZBZCF\D<;3OO%LL+V130R0&5@^,?D [D&WL>YZ
MQJPJ_3.0%83EWB'CDE+^SW^D8<IG&Y:CE<=6OTI7/KV&=\3RQT9+3\>'@%!D
M6O%D*CKTE1KB^6-@=*&CD1AWN[S\"?@$&KL6TXK7:3+=YTWB?,V)IBB=(.]S
MNT D>@4D@(3P@UX\QCO9*UELI,=B0,@(8[F8GU'8..2.!SS[N/59Y9(X8WRR
M/#6,:7.<?0 #U)*#\Q^5I9/&U,A2E$M>S$V2%_NY:X<KT@(@(@B]BV3%ZQC'
MY+)>80-<UO,<3I/5QX'/'H%*((?$[9KN2R>0Q=2XYUZDT&S ^&6%[ ?U2M:I
M#+YC%X'&6,GD[+:]2  R2$$\<G@>C02224'[C<E3R5&"[3>]T$S ^-[XGQ$M
M<.00) T\%9T!)IXXH)I/5PB:7.#!W.]!SP />4#$Y*#*8RI?@CFCBGB#V,E8
M8W@'X.:40%#.W#78<_9P+KG;>@J>TR1%CO\ ) <D@\<%!@PVYZWE\=3R-*X7
MU;,Q@9,6%C6R@\!C^[[I=\%8$#D<\<CGCGA$![@QKG'G@ D\ D^GR 4?@-FQ
M>?IV;5 RF.&U)6=Y(S$[R1?>]'()!$$/]8\8S9(, _SB[)7?.T&)PC\;/CWD
M %3" YP:TN// '/H.2H[ [/C,_7NST#*6U;LE23RQF(B6( N':[@H,.3V3%X
MO)8FA:\PER$_BK]L3BPO_6_[H4N@+39E*YSGT28;'F%/VKO\3O#V=_9QW^[O
M_4@W$!!'((* B".L;/BZ^PTL"_S>VVHGRQCQ.$99&.2>\C@K\PFR8K+W<M3I
M>;R8^5D5GRQ.BX>\<@ / *"22>=E>"29X>6L:20QCGNX'R:P$E!I8'8<=L.%
MJY;'E[JU@O\ $7M["?&\L)(_%JW4!$!)96PQ/E<'D,:20UI>[@?)K022@K Z
MA:X=5?LP=:..:9!W"!Y?]AYC)+0INQL%.N_#-=#9=])/[82R(O:W['?S(1]T
M(-Q$!$&A]8L/#C),B^P14#PQDW:2)G.(:!$!R7\D\-X'JLM'/XZ[<?2:98K3
M8A+X)HGQ/,9/'> \#D(*9/UBZ<P2SQ/SIYB>YCRVK8> 6?K#%,YKJ#J&#BQL
MN2R9A%Z'S5AX)GN>S@'DM8TD(&)ZA:IF:]ZQC;LL\5/L-IPKS,\0?SPX][0K
M&Q[)&->QP<UP!:X'D$'XA!^J.HYW%7LOD\56L"2U0;$;+ #PPS<EH)0:UC;,
M!3M3PRVG?D)60SSB)[H(97^YDD@':TK7V'==7UB2K%F,C[.^P'F)HBDE+@SW
M^D37(,VL[EK.S>U_0]XV#6[/,3#+$&>3GC_*M:IJ]=J4*DUFS,V*&)O+WGX(
M(;7]UU[8;=NI0LR^TU@'35YH9()0T^YW;* >%ZO;5@\;8L0V9Y.ZO&V2R8XG
MR-KL?[G3.8"&(-V]E\;CX:LMB;GVEX979$TROF<1W ,:SDGT'*R8[-8R\;<<
M,CF2U2/:(I6&*2/N'(+FO ]"/<4$94VW!3^QN;+*V*U((ZMA\,C(9GN]P9(1
MP>[X?-3:#7BR%1UZ2HUQ?+&P.E#1R(P[W=Y^!/P"S@@CD$%!^J%H;CA<A%FI
M(/:BW%S&*T#7D#PX#N(:SCO*#=P.;H9O$5,K1+W066%T1>WM/ )')"S9#*T\
M4VNV;O?-8D,<$$8[I)7AI>0T?J ))*#6U[8<;FZ$MJIY6B.=\$T<L9CDCEC^
M\QS2I! 6*W>J43 ;3BQDL@C:\C[#7N/#0\_#N)X"#*B B B B B B B B B
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M(Y0P(+'A\UM)VEM&>M/:Q<U4O%U]-]1T$S?]1P=[VN4=U<#AJ] L:"[Z<Q_
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M*]>AQT4%BA89BX+=OBH^W+%+8YXAX;Z#CM/)*DL!+F-EU/(5-CQOLT\AL5)
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M'8X2X2[1L2/,TG$HI>X#['Q0=-'/ Y !X]0%![EJU/9\0*LL[J\\,[+%.TP
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MV"QLC&.+F,?6C<T.=P"0"%6L'H&.Q.XYK-14,<R">&JVE'%"UKZ[HFELA'
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M# R:-KVAP=VN'(Y;Z@D+]0$0$0$0$0$0$0'5X#.V<Q-\K6EH?Q]KM/O'/R1
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M*NX6"I(YLD=V,LD+0 0X#X@EW 04$==:D4<%ZUJ6;@P\KP&9%\7V%9=HZH'
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M@C<^2,LD;VO8^)Q8YKA\""%!'?M=BQ#,D'6'137)*M6-D1?-:EB<6'PL;R7
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M#7B'WI)7AC1_:Y*.7Q61B=+0R%:TQIX+H)6R@'\6DH,-_,87%]GTCDZ=3O\
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M)2.6*6-LD<C7L<.6N:>01^HA!^H@(@(@+D>J5;MOH6VM2Y]IFPMQD('Q>[O
M""ZZMF]>&CXN\RW7CHU\=$R4N(#8?&P!S'_(A:'2J&:MHF*$K'1L>ZQ+!&[W
MM@EF<^,?\I05'-Y"UJF2V[$TAQ+G!%:Q ^5NVX5I@/P<1(I"SC:&K[9T^BF+
M68ZMC;5"O*_T8RTX,XY/P=( 4$IOTT%G-:/CZSVOR(SL-H,;ZO96B:XS//R:
M0MG8_P"4?0/]WR_^'&@@]A@RD_5.JW'YEF-D&LO)F? R<.;[2/L\/(5\PS<A
M3@LG+;#!? <")1"RN(V_(]I*#=SY;]7\N!^@3_W"OGO"VK.#P-;#53V2;-K^
M*?0_59EB94G/]C>)$$A'8DPFG[EB,/'Q:N;1/BL=&/G+'&S_ .PQ3.$?DM:W
M3$"U@OHS'9.A%C /:&3@V:C28"2SXEG+4$)KL&_PZ1=OX'+US''?R#Q1]D!F
M+6V7]_9(7$%Z6*5>:ATJKZIE#&R:Q>,5V8!\C3+ ]TSW#W>1!>NF\C,,_(:E
M=B9'DZ<CI_-\;\,I]+7)][_@]8M_AO3;EH+*62;0F)R?%DQ"4-XA'P<@KK#>
MI;3L]2_E8<Q:L:M+(+C&"%U:*$D"%S&$CAQ?RNC]/;-?ZC:FSS1]WT13''(Y
MY\000G2V>O7P5_&SR-;DJ>4O'(,<>']\DSGB0_J<TC@KFV6,=J';LU6'?@QM
MN,GE+1RR6*KV-LR#YM[D';=CV#7*N+J37A%<AM6(&586!DQGD>\=AC:?1W'O
M7$\CKVPYC-;[-2EAGJ4<U!9.*<#Q??'#&XQR%!?,UF=4V;#ZK8^D;-!UJX3C
M;L7##4M1L/,4A=Z ^]O:5FQ=W/8W=<9B,O>H9=UFE9?!<CKM@M5Q'P2)0WD=
MCT'CJ)%<FV;0&4\@*4YNW>RP8Q*&<5G?!RB:!OT-_M5\CF(<Q9MX";LL1QB%
MU2*%X/8YC"1P\E!J]/,=M,FDZ^^MNU>K":;"R T8GF,?+DO5LQ\T3.J>QETK
M&@X2AP2?_'(@Q;#/5J=0M.OVY6"BZK=JPS$CL9;D[" 3\"]H("][]-!9S6CX
M^L]K\B,[#:#&^KV5HFN,SS\FD(*A'"1N)T_@>+ZR',G_ '41"Q_CIJT#Y=KQ
MNL.',6M7LE9X/YDG'LG_ *-G*"[=5?\ 16+^ML;_ -2Q4V[@;F0V[>\CBB&9
MC%WZ$]%_P?\ ]B8'P/\ _!*$$YTOS4&=RF[9*&-\;9[]7F-XX?&]M5C7L/ZV
ME:EVKE['5#.C'9]F,(PU'O<ZNR?OY?)\'D(*5-,^+!;%0FLQ79JVX8U\^3C'
M#+3YI(W?@TL'#2 NX[:&6]1V2O7>R663$W&L:T@DET+@ $%)S>8QDG12:9ER
M(MFUYL,?#O?*^$,#%H6Z68^OV%@IYAF,GCU "21\#9N0)V@LX>0@ZE@(,I7B
MG;D<]%DGEP+',@9!V#Y<,)509+#1ZL6W7GAAO8.!F.>_T#O#(XRQ-/S]04&M
MLLL%SJ'KT5)X?/1QV2DOEAY\<,L89&U_XO7/<8S>Z/2K#WJN:C?C!0;[36@I
M@6HJI]'F)[W$/<U!W_6(,37UW$0XF3R4&4XA6?SSW1]OH25P+ XS/6>G=]T6
MYUZ%-S\F#6DK1GAGGD#P920X!Z"SX'(P6]DZ=7!6%.*35;)9"3Z1CF(  E3_
M %+OS2Z]%AL:/-=S-@4XXV/ /BX+YCS_ $ @@,3/F,3N=RG/AQBH,_C^*C!.
MR9HN4H^WT+/=S&K)TQR6*K]/,6Q\\4!H0.AO,>0TP31$B02(*3FN=BS/3OZM
M2G$06Z&6\<G@#'Q0'Q\F)@] 7*Z],[<-.A/J]BM'6R>(/$[&>ZPQ_JVTWYB1
M!L;%_*/H'^[Y?_#C7--:K6<#KU#<J$3GB"WD(<Q SWSTQ<E/D ^+X4$7CH[]
M_!]+68J\RM//D\SXK);W]C'F;EX"ZATWD9AGY#4KL3(\G3D=/YOC?AE/I:Y/
MO?\ !Z!U,LW+CL'KE&F;<MZT+%FN)!'W5*9$CP7'W!QX"K^)R<V(RFZ8S/8:
M2K4R%2;*PU&2"P7-[>RTQA8@U;SK^NZC'E<;LU3,X".&(QXW(0QO<^+TXB9,
MSWO'P!"ZIN9YT?926D<X:Y_@E!7]*Q.V1XO7IY]HCEI^PP$U!18PEAB'#?('
MK'TZF@K6=OQUB1K<BS/VYYF./#WQ3$.BE_6TM0<WVR6"Y6ZK7Z+VNHN.)@,C
M/5DEF"0"0A=USLL#L#F V:,N]@L>@<"?N%!&=/;-?ZC:FSS1]WT13''(YY\0
M4)TMGKU\%?QL\C6Y*GE+QR#''A_?),YXD/ZG-(X*"DV*IRN+ZFY;%\/K1Y6"
M]CWM]TEC'1L?*]GXN8DT@OXG+[U!ZB#8:UFL[YTJ'_9G_P!A#I"@WX8\'8TI
M^1S4]BLS.[$;<-R$\.JO=+Q5E+S[@&L"F&V]@PFRZU3R>6HYR"]/)'7D=69#
M=KGQ%WE:6>A9P.'%!T;$4Z%*M*RK,Z2-]B61W=*93WO=RX<DG@ _#X+:0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0?&U<ZX-]ZA?3&F9'.__ "W?XO9(WR>#[<G/
M?VD+Z%T"?5\=K.6R='6[F!JQ2/?9BML<Q[A#&'&3AQ*#YKH7\ECK^*ZHSS_]
M]S\[+-<'DBH_["[-UAM2YC-:)J[+3V4,O;[[1C/'EC!;P$%BM=%]7BR6'R.#
M,N(L4)@_O@)=Y@/@[O7.\_L?U=ZZY&]]%7[_ #AHX_#3C\LGJ&H&N[#]8>NE
M&[]%WJ'&&DC\%R/Q2*^]<\W>P>@SNI3/BEMV8ZID:>"UCP7.01][HCH\.FSU
MXZ/%V*B7B_WN\AF:SGO7&MFSUS.=$M3GR+GSRPY\5WO/J^5L4<B#J6C,Z;WM
MFI-QF@9;'6HN98K5F!S&,+!\_(5VS8=?PFP46TLO19:@$HD$;BX /:" >6D(
M/FWI]H&GY3>NH="[AXIJU"Y&RK&7/ B!<]9[FQC5NN>RV68>_?!P\$ @I1^6
M1H+(3R@V-1S_ -8.N=B_]&W:/.$+/!;C\<HXX7,-!.IC&7_I;0,MFY_I&7BU
M5A>]C6<-XC):0@^O-#CQ$.KTWXS"6,37E?*\4IP6RL(>6DN#EQG)Z]A=@Z]9
M.EEZ3+-885DG8XD?: 8@S8O%U=%ZV8["X8OBQF8QKY9:I>7L8]@?^[7-J/\
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MWS"L=BM!:KS5YXFR12QNCD8X<M<QPX((^10(88J\,4,3&LCC8&,8T<!K6C@
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M ,@@QMU#+Q=6;&TDP>P/Q8K =Y\G>J!J&H]9M/H6Z&+9KSX)KC[),[Y7/Y>
MU!VS6)-L.,?]96T&W?,[@4^[Q^/@<??^*YAL6H=0H>H]S:=<&)(DHLK<7'O0
M2>JZ/L@VZ7;=MOU)\DVMX*L%0'PP,53K=*=IBZ;[7KY-/VS(99EF#B0]G8'L
M*"W[ATTFV'2<+3CDC@S6*JP>R6 2 )(F@.;W*!VO3^H^:.AY.-N,^EL/Y76/
M)*[PODY9PY!:L+)UG.5IC+PZZ*'D'M!@,OE[/_!RJ[/I&^ZKL69R6E3XZ:IE
M)?+/2N\@1R_-G""U].M0V'".R^2V#+>U9')3>26.-Q\$/ZF!8<3I^6I=5MEV
MB4P>P7<?%!" _F3O8(O_ )!!J;WH.=N[%CMKU>]!6S%2+Q/CGY\4\:KQTC?M
MLSF(N[I/C8*&-E$L5"EW$2R#XOY06C#:;E:'4[:MCL> T,C3CAA:'<OY:(P>
MX+0U/0\[IVZY27%OKG6[_P!M]8O(?7E^; @FNJ^H93:]1=BL881.;44G,KBP
M<,54ZN])[.X1X^]B3!'D86B*7O)8R6%!([=TYS.0^K.8P=^*IGL/6CB8Z3UB
ME8!ZL*@;^E=1MVNXV/<Y\95Q-2<3/JTNXNL/""PYGI[?R>^9?*R^ 8VYKLF.
M]_VP]ZYK3Z);/!T[RN(,E(Y.YE()N?*>P00-0=7ATS,-ZK-V?F#V 8D5OOGR
M=ZA-7Z53LZ>9G6,]X.^W>FGBDB)>(R0.QZ"NX+I/M5#ICM>N3OIF[?MQRP$2
MDLX:6*:Q-/KMBL70QU>'5S#3K101EYF+BR)H8$#:]1ZA7-PUG:,.,2;E'%"&
M9L[WB+SO#P_@#X</5FP9ZL39%D6QQ8)N-?'(V8TS*)_5IX[>4%*I:OUFURK?
MPV)NXK(T)WR&&U=<\SQ"1=)Z<:>=*U:#$R66SS^5\T[V_<[W_!J"&ET[,'JK
M)L_,'L!Q)K<=Y\G>H#7>D]C^*^WJN<-<6'SRS0RQDO$4GO8]!8>C^FYC3=9N
MT,L^ SRY*2P#$\O'8Z-C%[V/3LODNI.I[! 8?8\=#*R?EY#^7AWW0@Z(N5:#
MTXLXS ;1B,_%7F@R=^67LC<7#QO""/U;IQG*>M;%I^=M13X:<N^CYV/YFC'/
M(Y:HREKW7#"8<:]0OX66G&PQ5[\A>)XHD'O+]'+</3!FL8BQ#-==?9:LSRDQ
MM>]=TKL=%6AC=QW,C:T_B @Y5N&A[*W;8MPU&[6AR1@$-NO9Y\4[ HJCH^[9
M_:L5G=TL4&18QW?3H4^2SR>_N>2@V;^K]3<!M&8RFK7:-VGDGA[Z=][SX7_^
M!0M7IGNU;6]SE-NB_.[%(T3!A+((8B27H):MT T;Z"CKS47_ $A[&&/M">7C
MS]G!D#56KO33?[>@ZWA'NH&]B<F98GNF)8Z  EB#H.'FZS?2=/Z7AUT4#(/:
M# 93+V?^#E=*0<^U#3\MA]UW;+VC#[-E)H7UNQY+N&<_?6[H6<SV5AS[\K)6
ME%?*RP5)8!Q&^-@'N/QX)X)071<ZZHZ;E]HKZ\S'> &EE&69?(XM^PU!T5<1
M&B[_ *=G,M;TNQC9\?D)C*^C=Y'A>4$KJ/3W/0Y+.[)L=Z"SFK]5\#&0\^&!
MA":ATP?#TUL:IL+87&:69_?">_L+CRQ[4$[TTP^V:]@78?/2UYQ5?VTIHWEY
M,/P:\%7Q!SOJ3I^7V6[J,U P=N-RC;$_D>6_8!:?LKHB#FFK:3D,9N&]9/(M
MK24<P]OA8#WDL]>0\*-T_IWF=:R^QXD/AGU3),D[(72'RPF0((7$ZCU=TR"?
M$:Y;Q%[%F5[JK[G(E@#U*8OI7DL=I&V5);T5O.YV-YM6#Z1F0H.AZ/B+F"U'
M"XNX6>>K6$<A8>6DJK=0M!RN:R>(V' 7XZF;QO(B=*/R<L?YCD%3OZ5U&W:[
MC8]SGQE7$U)Q,^K2[BZP\*P;1JN^T]N^LNIWZTGEK"&QCKCWB'\6((7#:)OK
M<KLNU9*;'-SES&NJTJ]<EL,1( #WE-:Z":A7P--F?H>TY/@FQ*RQ,&$DH(8=
M*MRBT#8M3$M.2)^29/C9#*?2+OY<'JU8J+KG3CH57P:S[- (HB09B_L8@QW]
M7ZFX#:,QE-6NT;M/)/#WT[[WGPO_ / I7IMI68UZSL&8S=JO)D\O.))F5QQ%
M& 24'35\Y9'0NJT^\VME8S!V)&O<*++4CWMKQ _8[6H.^X!^=.&J?3OLWTAP
M[VCV?GQ$]QX[>?U*D=4M+R^TX_!P8TP!]3*1V)3*XL'8T%!M]6=2RNW:D<7C
M#")S:BEYE<6MX8G4C4\IL>A2X6B81:/L_K(XM9^2()00US0\Y-N>@Y=AK^SX
MB@(+7+SW=_86_87C,Z!FZ'4&CM>KFNP3<LRM61YC;,U!I971MSP.VY/8]+M4
M'LR1YO4+G(89/F"%NZGH6SS;<=OW"Y5DOQ0&&E5J\^*!I00K-,ZE:EG\_9U*
M7%6J.5L&P8;G(="\J?TKIC-0UO8Z6PV8[-O.RR27C#]UO?\ F(*WC]8ZS:UC
MOH+$VL'?H1DBK9M!PEA8@Z09RGTPSNO1WZUG)9*[%:>_UCA:0]A(07S9=4RF
M3Z7G7*YA]M..J0<N<1'WPEG*M&K8^QA]7P6.M=GGJ8^O!)V'EI?&P-*#EN>U
M[JWY=CQ]#)T+N+RO>R.6X]PEIQR\@L "LN/UO9M8QFFX?!V*CZ5-Y&4?..'R
M,<X/<84'0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M  '   0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0%2=_P#;)I]3HP9&Y29=S/AFDJRF*0L\$CT&ID]*-'&W;8VS:'F"
MM)+Q[?QSV-)X^XN&83*=0L]CHLAB\3L]BJ\N#)1GF#DL/!]\:#MU73GC$U+F
M2VS9*,KX(GSQR9,<0R. )87]JVV:17D@\\>[[(Z+CGR#(@LX0>&:90ED$3-Z
MV%[RSO#!D@26K<_B^_\ HPVC]O0/XOO_ *,-H_;T_B^_^C#:/V] _B^_^C#:
M/V]/XOO_ *,-H_;T#^+[_P"C#:/V]/XOO_HPVC]O0/XOO_HPVC]O3^+[_P"C
M#:/V] _B^_\ HPVC]O3^+[_Z,-H_;T#^+[_Z,-H_;T_B^_\ HPVC]O01N7TF
MQ2Q.0MU]HV>::"M++'$<AQWEC>0WGL7*3G(!TQ;N'T]LWF,WA%+Z4]/+Y>SC
MO[$#Z<@'3#ZX#/;-Y?-X/8OI3T\GE[.._L5KQV'S4^;J4[>6V.O4DQ4=J6V<
MN#XY7 $Q=A8@@X\MC;ND9S9\=LFU/91D>UD$N2#'R!I:.X\-/"NNNX"KF,3A
M[;]TV&&Q=H0V?9?I,%[1*P/05^*$'J%DM7EV79(H:N,%PW'93YE@X(+%>V:/
M!-"R:'<]ED8\<M>W(!P/]H:@\P:;1L2R0P;UL,DD?WV,R0<YOX@!4K'4Y+G4
M/-ZJ=AV9K:%*.P+/TGR7]X8>.WL_\:#-O%2MK&N97*0;;L-R:D80^L,H&G\K
M((_7AA5JQ.EF_BZ%T[9L[#8K13=@O\\>1H=Q]Q!(?Q??_1AM'[>G\7W_ -&&
MT?MZ!T\?<%//UK-^U;]DSMNO%+9D\DGCCXX!*N2 B B B B B B B B B B
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M8I&'-33-#Y?,?+)(9OMQN"^QM6_T9P/]6UO\,(-U$%/T#_[KO^)[RN" B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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MV*Z::)@\B,CCL#!#:!Y;)R]_9^M@>2&J>;KV%KYJYF8J;!D+4(AGGY<2^-O
M#2">/@$%9_BDZ<&6W)]6ZO-GTD]7_C]@<\,5UKP0U:\->%@9%%&UD;?DUHX
M0?J(*?H'_P!UW_$]Y7! 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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ME8Q%/ICM^1D?VS4)\7?E=[S&09*_]Q!7\3F+NFP7LU8<\3[1KT]]GZ[QG)C
M_P#I)@OI/3<*S7]5PV* X=6JL;(?G*?M//\ :Y!-H@(@(@(@(@(@(@(@(@(@
M(@(@(@(@(@(@(@X[N.(@VGJ7A-;R+WG&P8=^0D@:XM$TAE,0#E8OXF.FG^SL
M7_QDJ"G7]6Q.B[YIMG 1OJPY.S)3MU@\ECQQR"NXH"("("("("("("("(./;
M"-KVS=,CKV)S\V(I8JM ^U/!SY9); [VA8?XIMR_G3SG_J_]X@FM R.Q4<_F
M]3SF0-^:E#%9K7'??D@E^#UTU 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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M!DF1EU>4F&-I*"?PV/.J]3X,-1OW'XV]A9+#Z]B=\X9-')QWL+UUM 1 1 1
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M@(@(@(@(@(@(@(@I.]:+-L4M#(XW)OQV7HAPKVFCD=KO>QZH7U,ZZ?[=T?\
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M$!$!$!$!$!$!$!$!$!$%:VS=,#J5.*SE)GCRN[888F]\LA^36J@?_7 ZA_\
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MUJ_T3H_UU1_OKIJ B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B"O9O2\'F,U0RM_P!HEDJ=
MABK^8BN7QDN:]T?N+@2K"@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@YCON'VBIL6+VW6ZC+EJM4?4LTR>#- X]_V56?XT>IO\V%[_P!)$&?"
MU]VV_9\+E\]A/HBAB2^6"L\DRS3O'')7;4!$!$!$!$!$!$!$!$%"ZD:]G;WT
M'FL"(WY/#V7S0PO]TK)1VO8J0.IW4YGV3TQN_P!G>@PO?O\ U!NXJKEM;.&Q
M52[':L&4GOF,7J&-!7>D!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!&O:[GM<#P>#P4!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$'/MWW+)82YC<1A,6+^8O!SXH7GB-D;/>]ZK/
MT_U]_P!DL'_\:?WJ"5UO?=K9L=3!;A@8*$]UCS2GKN[HI"SWL][EU) 1 1 1
M 1 1 1 1 1!4-ZW%^L4:8J43<R%Z<04JP_UWJC_3_7WX:E@_[93^]09J/4#>
M\3E\;6W/7*M2I>G$$-JJ\N#)7>X/Y<]=A0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0<)M-W(]4= MY
M^>O$RQ+DA7QU<ES*[8J_O>_XO/*Z3L>WC$9"AB:&+GR64ML=)'5B>V/B)GH9
M)'O]&M04?5LU8RG5W+R6L;8H3PZY'%/6F():\3\^CF^C@05V5!RGK!)9AQ>$
M,YN,PIR+1F75>>\5_P!?9ZABKE+6NGU]]&YTZS=*CEH)HW\-LR?EH1]]DL3R
M20@G\OL.RQ=7L90AQ5J6H,6_B(68VL>'O =9X)_U%.V=_NS9/(T=>UBWEQCY
M#%<G9-%!$R7XQL,GWWA N]4\)6U&#8VUK+X3=94G@([9H)>>'M>WYM2OU!MQ
M9'%ULYK%S%09*414K,LL<C72.]6QRAAYC<Y!2J.P9/&=3NHU;&X&UE+,QQKF
MQ1R,A8QD=?U+WR*_8SJ3AK.M9?-7H)Z Q<[X+]>4 R13,_U @CF=2;U7V&SF
MM2OXS&6Y61PW9)8I PR?<,\;#S&"MS,[^_';+)K=# 6\AD/9([$;(GL8US7$
M@E[W\!@""1U'<H\\_*TY\9/CLCC96,N5)2'EOD'+"',]""MS9M/UK9HZL68H
M&R*Q<8AY98NTO_\ +<U!P_2^F6D9/9=ZIW,29(*&1CBJL]IG'8PL_4]=3R.U
MQX6_3U? 8&QDK=>FP^S1RB-D$#/L,,LLJ#;P&^8V]!FFWZLV+MXEO?D*U@@F
M)G'<) YOHYBK_P#&G=&/&;?IN2;@3P?;^^(R"(^Z4P<]W8@MU7<:-K9XL(V$
M\3XQM^I:YYCGB)X(:M6??\36R6S03L>RK@ZT4MRW[V=\HY$31\7(( =3KE:&
MID<OJ-_'X>P]C67Y)8GE@E]&.FB:>6 JUT=HKR[;D-<?6='/!3BMQ2EP+9XG
MGM);_1*#WA=C@RN;S^.@K/[,7+%#)9Y'8^5[>YS&_K9\5-H"("("("("("("
M("("("("("("("("(.9S_P N5/\ X2=_U*Z8@YAU%:&[5TT_KI_]Q=/0$0$0
M$0$0$0$0$0$0<SW?^4CI?_Y^3_P6KIB#F76K_16@?EFJ/]]=-0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0<VW+^4SI=_3R_P#TP6EL%V#5^J%7/Y7F/%W<)[ +?!+()V3>3A_R#D&G
MK&?QN?ZOY6YC>7U1K;(V3=I:V?ML>KV+J6 V/$9RG8LXV9TD<-F2N\N86'R1
M>\>J"L[KL67UBQAK[*1LX;R2,RQCB,DT+2/L2 #_ %1\5R'><ITUV6C&S4J[
M+&RRS1&A)0KOAF8\/!+Y7<-077.Y2K@^JNK6\O8$4<^!DJ"<M)8^P91Z*@8F
MM@\!D]GQVR[7G,+8&5L681!:?!!9@E/(E9P#RY R<-'']-ADZF/RGAL[77N!
MMU_EL6N'C\I[@1Y.%=-PVC"[N=;PNO63<L'+UK=@L8X>R00'E[Y>?NE!/Z=P
M.IO5(_\ CQ'_ $Y7,LQA;^8P/5B"C"^6:+963^%GWY&Q=KG!J#'E)=&S>-J4
M:NR[5F[-Z2)GT2;SB\'D$F8/80T,73\=&&]9LNWY:Q6_QD&35OY5NI/_ ).(
M_P  KI*#F'3K_3'J;_6\/^&M!^6I:=U/V6[G'^S4LW5I&I<>#X@^JPL=$7(*
MY<I6=YR/4'*X2*1U*? LQU.<@L;;F8?(2SE25CJ1K4_3I^(B,CLQ)BC0&)$3
M_.+!B\786(,F?Q%W5=.T3.O83;UIM=MP,]2:TS!%.P**LZEF,GT8S4HA>_+9
MJ;Z6GB'O?W2B41C\&!! W[6CY7"058-EVS+6[ACB^A/;7F3OY'+9 ]G #%T7
MJ2'ZP=7V^")[_HAWLMQO/)?5L-[/7\'(+-TVP\^)U"D;@YO7W/OW3\3-9/>>
M5<T!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$',[!XZY4OUZDX#]I73$',>HQ!VS
MIHWX_33_ .XNG("("("("("("("("(.9[P>.H_2\_#SY/_!:NF(.7=9FANJX
M]OQ=FZ/]]=10$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$<UKVEKF@@^\$<A        X 1 1D449<6
M1M:7>\@ <H!:T\<@'@H^..3M[V-=P>1R.>"@KN[ZQ-LV*J4X;+(3#D:UDN<"
M01 [DA6)K(VEQ:P N/+B!QR4!$!L<;7.>UC0YWO('J40$0$>QDC2U[0YI]X(
MY"     . GCC\G?V-[^..[CUX0$0!'&'N>&-#G>\\>I5+VS5,[LN1JU9\G7C
MP ?#+:JB(F>=T3N_L+O<&%!=$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$04G>M
M%FV*6AD<;DWX[+T0X5[31R.UWO8]4+ZF==/]NZ/_ "G]V@G]7Z>9VMG(,[M6
M?.4OUHW,JM8.(H>]=40$0$0$0$0$0$0$0$05?>=,@VC&5XA;DJ6ZDPGIVX_O
M12!<S.E=<@>&[Y2(^!+#_P#(()#$=-]KM9>A>W'9QDF491-6JQ B/R#W/>NR
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("(.-C?MCR6_ZC4AQUFAA+DET V&ADMP
MP0EW/:?5C NHYS9,#K=:.UF+\=9DC^R($%SWN^36,!<Y!^Z]M>O['%-)B;[)
MQ"0)6\.9(PGX/8\!P4D@YMU,R6?@R.G8[$9=^/.2R3X)9F1LE/';\GJ"VF#J
M+IF%LY]N[?245,L=-3LTHHVRL+@#P]B#HN3WK6<32QMG)WQ7-V!LL$'8^65P
M(Y]&1@E;6&W/6,Y0NWL;DV305 38/:]CHN 3]MCP'!!NMV+#.P1S@N-..%<S
M^T=KN/$!R7<<<JFW=DN2;_IU2E=)QN0QEJPY@:.)>&AS'(+=G9IJN S%J%_9
M+#1GDC=\G,82"N2ZEA>H.PZWB<N_J+;A-NN)3&*,#@U!<Y69+$RZE1O[BY\[
M[LK9#)5:#D/>X1_8]&=JE,]O^HZ_<%/)95D=GL#S"R.29[6?-XB#NT(*[O\
MMKXM(@S.OY-A$UVHV.Q%P\%CY0UP5JSVX:SK)KQY7(MADGY,408^61X'Q#(P
MX\(*MI.VNV+<-V97R3;>+K,QAH]H'#/-"XR+H2 B B B B B B B B B B B
M B B B B B B B B#FN\;'L\6:Q6LZNV!N3N0/L26)ARR"!AX[E!' =?/CN>
M(_9F?ND&SA,_O^O[3B\+M]BG=@RG>VI<@8&=DK!SV. #5UY 1 1 1 1 1 1
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M1P?4?8M@;._$:M1MB$@2&++QGM+O_I$$]]8>H7^PD'_NL?[M/K#U"_V$@_\
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ML_X42N" B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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MT ??[BY0.W=1!8Z8W\Y@&7F2O)@+PP"6G(#P[S H.HZUD9<EA:5J6E;JO=&
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M(H8G(9:_#$V2Q%38TB!C_=Y'/+0"4'IG4;!/U7); V&WXL>XLN53&&689&D
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MPY:SD(,'%*ZM$6&!\7D]!$TD?E4%*T3J;/!H5+*9^IE)>;WAFON9&8W>T3O
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MM)#1^*#YC^GSE]%LY#(;\(9;%6<18'&QPPD2'D"#MX,A4OARR1G0?X@16_\
MU; @OV<_E@T[^J;ZLF_96U@M,S>2K4V6IH*_+87M[V>K@"7#XAO/)0?.G4*_
M%8T*5TW423+VK$4#F8^H(60 !X<3(R($AC%U]_8_K-AGC@CZIR.:?QG09=3#
M!U4ZG'Y,P_\ @%<BR5*U8T39IX//XZ74*S:LF$<O;!&>'.""?S+=<R9P5/\
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MM-QD+Y8,?U*GN6V,'),$3QWH.S6M^U2U?UZCBW5LS9N6VEC('MD-9@!)L/\
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M59I00R><N#&(.E:%K+]6U:EBI)A+."^6Q(/<99#RY6M 1 1 1 1 1 1 1 1
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M4GREV18;'@,S![H>?@UR#=UB7?*D^/Q\^IXFABXQV$U[7<8V@?!G"TH8^IV
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M8^A%1MU759YWN#!4A(#/L1-]_P!E!;L7CJV*QE''5F\058&0QC]3!QR5^9?
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M4[&L]F?$UT/:SW#L(XX'"C;>NP6=DQ68>8P:->:.-HB'>3-Z>K_S0/<U!)D
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MJ>KY>RRUDL)0M3L' EF@8]RD;&-QMNHVK:HUI:[2TMADC:]@[/5OV2./1 1
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MIV(-D>WLJ"V8.UWI"7]G?SQQ[T'BEM.O7\-5S$&1B-"P_LAG?S&'O[S&&@/
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M4 ;STP_K.;^Z%U= 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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M<L;,]U)K.<!-]99Y>SX]CUU=!R7J"Z-_4'IG6C(,K;\\CF?$,#%UI 1 1 1
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M.$EQ5.IWMEE9',27S2%B#4I3=4:&M5M8K:Z&78(&5(LP+,1K-B8 P3=I^UR
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M]F<L2POB?WGELCB_E[>$'N#1MNJ]*L)B1C _)XK-"W[/YHP)V1SND^R]6^3
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MFDJP Q->@Z%L6OZ?B[UVW6,=+)V,'=B95@XB98B8SDN<P#U+%SW&>F,Z&?\
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MO07O2S],[9MNTO',8F&*QY^'@JG\HX?J>]8NK %J73,39>1C[^>ABN#G@2-
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M8>9HD'!'9,?<\\KZ;:YKVM<T\@CD%!\U' WL3ALR)]6Q6T82S/:G?E:<[/;
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MQ8J76*F%GK13Y/*"J7SQ^1K0X* S.=ZD:9#5R>9M8C(XWVJ*&RR"%\,S!*>
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M')'%3Q6&4\H\35Y7=W"">I^R;!U98_*UFO;!K4%FA6F'(89W_;> ?BO$HQF
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M89.S#;W_ #(P>J1Y;*5:M>&[9N6!'6K!X+V,C!#T%1UFD)H.K^-R-NABF/?
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M*U<?+6A<S[I;&@OZI'\6FKQQY^%CKH@RP<;-83GP@O<'ES&_ E!8<SJ^+S.
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MC+SPWO<&]Q^0Y7I!^5K=.P7B"S%*YAX?V/#NW\>$DG@C(#Y6-/R) 0?K)8Y
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MV\KAM4-S"5Y9&^TFR&3SMB/#WP1*YZ3LWUJU?&YOV3V;VH2'P]_?V]DA9[^
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MZN:%7+2.CIS"RV61KP.X,F8!Z$JEZUF=EJ[=U#J8/ ,OO^F/+++-8%>)@[.
MP'@DO*"^5^IV).HY#/7*D]>2C8=5M4?1\S+32&^$+3.^[)BGX^?9-59C\=<G
M9"+$5L3NK/E^X)VAH0>,KO\ GX]IR^NX35#D;5%D$I>;386&.5G>>2\+I;FR
MN@<&D1R.9P#]X-<1_9SP@^;-XP&C:GKC\=:E-O:K7$U;($&.P^Q)(>V4R\\,
M"[CDX-OEUBA7QMVG%DGQPLM6YFF1C!V?;DC:/O.Y]R"C]&ZTM"EN=62W)9?!
MM5V)T\OWY2QC 7N76D%;W+4YMFI4*!O&"D+D<EZ(<\V86>^'D$< KFV4PV!P
M?4G3JFK5(ZETF5V2BK>D?L7'OF"#)JFO8/=;6W9K8*3+SW9>Q0JME]1!6K<-
M C6#6<3EMHTC)ZR<O+$S%[%/CIYCR9)J=9X/BY0-HP&O8#;-&JZK1BIYA^29
MYF5OC0 /F,ZA-JEU_+=4,\S+:YD<VS'8RI7BJTX72ECG\S.>>"U!UCIL_29,
M-8?JU0U8?:7"U6>'-EBG X(D:\G@JYH"("("("("("("("("("("("("("("
M("("("("("("("("("("("("("("("("("("("("("("("("(-*YK^O6IG2V
M<-0FD/ODDKQO<?[2$@P.!HS>6IB*,$O''?% QC@/Q:$&ZB B B B B B B B
M B B B B B"E;ATPU#:YV6LC6ECLM ;YX'^-Y"IA_@]:&/?9RO[0$'4M=UG!
MZQCA1Q51L,7/)^+G'YN/Q*ED!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!<\R4$QZP8"81/,3<%::7@$M!,B"JZ=LM+0:.1U[/U[L,\%^Q)
M4>RM),VY%*XO:8RP%5NS@\S%HGM5O'30SY7=H\G[*6\OACGE' >$'TBN4[/=
M;A^JVNY.W!8]DFQ$M-LT<3I&B9\P(![4$ETU@GAR&_F6%[._:+3F%P([F\!<
MDGUG*7]!EECH6ICC]TL7I:L?+)I8 \AWB02<-/1<OE<)5P6,SF4F-V.2?VBS
M<BAI,C]3)(9N07A?1B#YQ-&[_$3M%?V6;S.OV"(^P]YYMA63>V:M+EL7'M&$
MMP5ACV&IG*IE+V2_&%_A'+4%7CQ.U9[2-NJTY\ED:%>[4FPC[X(L660$/E;]
ML D?!BZ0>I\>5EQ=+7<;:L9&>Q&VU#8K2Q-IQ?Z[I7$ <A!0ILA6N9_8X=TR
M.PQ3QY"1F.QE,6&0351]PL]G'VW.5<J8^['TNSE/Z+LUY6;@QXJO:YSV,,D9
M"#ZJ7SQNN)R,&Z7=:IAPI;A+5FE</=%[,>;7_,P()OJ;KU:'9M9S5NG>DPT%
M62G:]A=(V2M\62<0^O8M?5Z.NV]LBNZUB<I;CHTYW-RERS9$39I&E@AC9/\
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MB=\-9A'D[/G(NM4+\5_'T[L;)&,LP1S,9(WM>!(T. </@4'ZB B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B J;AM1R%?9+.>S&<.2LB%
M]>D/ V!E>%[NX@!OO<?BY!<D0$0$0$0$0$0<T=H6UU*UO&X_>)H<7.Z3B.6J
M)[,3)/>R.8N71<#A:.!PU'%4FD5ZL(C9W'DGCXG]909D0$0$0$0$0$0$0$0%
MYQV)IXYUY\#7=]NRZQ.][BYSGN ;[S\    @](@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@Y76V7J5GLKL(P$6
MNMH8_)RT6ONBQY'OA [C^273\6_+C&UQEO9/;^T^?V7O\///IV>3U095Q;<,
M_P!6]7QXOS6M<EA?;B@8QD,_?S*> @Z+K</4!ER4[#;PTM;PGQBG'*QXDY^)
MD4K!L6N2WSCV9K'ON \>S"Q&9>?Z /*#?6AD,_K^)?&S)YBA3<\<L98G9$3_
M &/(0;[LGC6U(K9O5Q6D+0R<R-$;NX\#AW/!Y6E0S>"NVY:M7+TI[,7/?!%.
MQ\C./FUIY09KV?P5 3^V9>C7\)8)?-.QG89!RT.[B..5[CRF+]@%\7JQJEO=
M[1Y6^+M^??SQP@\4LQA[5BS!6R52::O_ )>*.9CWQ?TP#R%AQVPZ[D++ZU',
MT+5AGWHH;$<CQ_8TDH-NM<IV3,VO9BE,,ACE#'AQ8\>]KN/<4COT'BSV6X#[
M.>)^)&GQ$#GA_P":4&+&[!@<L^5F-R]*VZ/[X@G9*6_B&$K.@T;6U:Q3N>QV
M<]C8;//'@DM1LD_Y25N6[M&E6?8MVH8(&#ETLKPQ@_%SD%*^NPM;M@<7C;5*
MUCKM"S,^:)PE^W"1P ]I5AUJ_D)\3+8RMS'2R,L3 RTW]T(C:[T!)]S@/O(-
MS&9_7LG))#C<Q1MR,^^R"=DKF_B&$K8CMTY9IX([$3Y8"T31M>"Z/O'([P/4
M<H/(RF)CAM3/R%5K*S^R=YE:&PN_->>?LE8V;%K[WV6-S- NKR".=HG9S&]Q
MX#7^OH24'BGGM?LWI*-;,49K;.>^O'.Q\C>/?RP'E:%"_<CS&QB]>Q8H5! Z
M ,D_+0-,9=(;7/HWYM0;YV;7/;(J7TWC_:I0#'![1'Y'!PY!:WGD\K-=R>*Q
M=?VC(7ZU6'GCR3R-B9S^+B$&2EE<3<+&4\A5G)B$H$4K9"8R>.\=I]RJ^^;7
M%J&KWLN61231AH@KOD#/*]S@U!&Y/=/9MITVK6M4GXW*1Y%\]CN#@!4B#@6/
M!X5VQF;PF4C>[&Y.G;9&>'FO,R4-/Z^PE!KS[%KM"XRE:S5"&T_CB"2Q&R0\
M_)I/*W4$!N.P,UO5\KERT%T$)\##_KS/^RQO]KBHSIYM&3SM')5<S!##EL;=
M?7N11 AGS8\ D^A""R6<]@*#9GW<Q0KB)X9(99V,[7D<AKN3Z%9_I/&-I,N"
M_6]F>!Q8\K?%PX\#A_/'J4&.MG]?FOOH0YBC)=9SWUV3L=*WCYL!Y6TRU4?9
MDJML1.FC:'/A#P7M#O<7-]X!0?L5RI--8ABLQ/E@($S&O!=&7#D!X'NY4=7V
MC5Y;@HPY[&R6R[CP,LQF3GY=H/*"&EV3(-ZD5M>#8O8WX)]TG@^3RB;QK;WW
M.W=?U#,Y:DV,SU8 ^,2#EG/< @CNFVV7-HUOVK(1QQ7Z]F:M<C8.&MDC*JV.
MZA96YU5FUN&&#Z*C$\?F[3Y'SUV O /R!*#I5W/:_C;$=>_F:%6=_P!R*:=D
M;W?@'$+?DFABA=-)*QD;6]SGN(#0/F24&'&9[!Y8R#&Y:E<,?W_9YV2]OX]A
M*J&%WNCEL_L^(KS4F.Q_B;6?YPXV"Z,O>[\&()W!9B3Z#QDV8R.,=<G8_E]6
M4>"4L))\)<?4 *2QN>P>6,HQN6I6S']\03,E[/Q["4&*SG<#C[<52YEZ,%F3
MCQPRSL9([GY-<02MJI:JVHS)7L13,#BTNC<'@.:>".1\0@_52\EM=S"5=PO9
M"YBGPT6\T((Y>)>X1%_BGY]SWD>@"!TYS&=S.$^D\KE<9:\\<4C(J3>/9B]O
M>8I#R?M*X6<KAZ!D%O)5('1Q"5XEF8SLC)[0\]Q'#>?3E QN3Q>0K"S0O5[4
M)/'D@D;*WGY<M)6E'L.NG(_1YS5 W>>/9?:(_+S\NSGE!OW;U+'UGV+=J&O"
MW[TLSQ&P?B7+QC,AC,G7%BA>KVH>>.^"5LK>?Q:2@P5MBUR:\['P9JA)<:2'
M5V6(W2@C_P  /*R9+-87$,C.1RE.FUYX:ZQ,R(._#O(09J]RC+4%N&U#)7+"
M_P [7@Q]H^(</3A8,?L>O9222+'YFA:?']]D$[)7#\0PE!BO[%KN(D9'DLS0
MJ2.'+&3V(XG$?@\A;AOXZ*K'9=<@;!(6ADQD:&.+_1O#N>#S\$&A2V#7;=@5
MZ^:H33=[F")EB-[R]GJ1P#SR%O2VZD,L$,UB*.29Q$,;GAKI"!R0T'WD(/:I
M^V[G4U>S@()75N_(9&*!_EE#/#"_[TR"S6<SA<=4CN7LG3K02 &.6:9D;' C
MD<.<0"MFG<I7J[+%.S#/ _[LL3P]COP+4"S9JU('SV9XX8F#E\DC@QC1\R2O
M&-SF%RS7NQN4IW&L/#S7F9*&_CV$H-6UL>N4+3*ES-4*\[N.V&6Q&R0\_)KB
MJ[M6Q7\-DM1@JB$LR66;5G[P21&6D\M03N'MY2?+9Z*U:Q\D$,T3:L==Y=-&
MTMY(L#X.)]RRT=@UZW<?4K9FA-:;SS!'8C?(WCYM!Y05^YL]O#P;A>R-O%R5
ML>WOIPQ3=LOI&7>*?GW/>?NJ9U78X,_KN,R<<D!DGK1/F9$\/$4KV![HS\BW
ME!(7\KB<3 )\ED*U2,G@/GE;$WG\7$)C\IC<C6]HH7JUJ+G@202-E;S^+"4%
M0VW=\;BL!GIL;E,=-DZ-5\@JF9DCP6_GL:>5:(,U3@P=/)9*W6JLDK1/DEE>
M(HPY[0>.7H*O4W%]_?VX:E8ISXU^N&^R>(B3F46/#Z/:2.U15[?[6 U3 W,K
M9Q%J_>O,KO=5GXK=CI2TRL)]2&!!;H\C<FV.I'4O8N3&2XTS!@EYM/D[^!(P
M#T,7"D9]EURM>%"?-T(K9( KOL1ME_Y2>4&U8NTJKHFV+4,3I"X1A[PTN[1R
M>.??P%AQN>P>6,HQN6I6S']\03,E[/Q["4&G<V76L;.V#(9O'U9C[HI[$<;_
M /T<5 ;ILEW!TM>L4/ \7\Y3IO+AWCPV.>2WA!<5%G9]7A=7$N>QK#/SX0ZS
M$/+P2T]OKZ\$()*>]1IB/VFW!%Y"0SR/#.X@<D#E:E?/8%^.?DH\O1?3:>#9
M$[#$TCX%X/"#-B\MA\E7=8H9&I:A;]Z2"9DK&_B6DK)!D<9-2-V&]6DK!KB;
M#9&NB ;[SW \<!!$?2ERQL.,;4OXQ^,GI22%@EYLR/Y^R^( \&-;5K/Z[0MQ
MU;V9H5[+^.R"6=D;SS\FN*#?N7J5&NZS;M0P0-^]+*\,8.?F7+%BLIB<K"9L
M=D:MN)IX+H)6R@']982@CMJL9.E@;4^-LX^O::8NR2^\LKCEX![R%)V<KAZ!
MD%O)5('1Q"5XEF8SLC)[0\]Q'#>?3E QN3Q>0K"S0O5[4)/'D@D;*WGY<M)5
M5WO;8M2P$F1+89)3)''#"^0,[R]X:2/F&\\E!IW]R;5V_6J4-ND[%WJ5V>:S
MW@@>SCT+7@\ *YXK+8C+1/FQV2JVXV.X+J\K)0#^LL)0>+&R:[6OMH3YJA%;
M/ %=]B-LIY^32>5M(,=_)XG$0BQDLA5J1D\"2>5L3>?D"\A>AFL.: R R=0T
M_A9\S/#ZGC[_ #P@6+56I ^S:GBAA9]Z21P8QH/IZDK'D<[@L3'$_(96E49)
M_DS/,R(._ O(0>A?H"E[<ZY *G8'^<R-\?;\^[GCA:T>?U]^0&.;F*!M_HPL
M,,W_ "<\H*T_>,?%OT.LNFJ@'&F<S&<<^<RB-M<#\]6K)7J^-QMN]9D9'%!$
MYY+WA@/'N')^90<NFZFV;6I:MF*(I";(9BI5MP=WE\#)W$%IX(X<NI4=AP.1
MLRUJ.7HV9XOOQ0SLD>W\0TDA!BR&<P>*\?TGE:5,/^Y[1.R+O_#O(6TZ_CX:
M;;<ERNVNX-(G,C1&>\\#AQ/'J@5,UAKKK;:N3J3FJ2+ CF8\Q$?!_!^RM?&Y
M_7\G))#C<O1MR1_?9!.R5S?Q#24&TM&UM6L4[GL=G/8V&SSQX)+4;)/^4E!N
M7,ICZ?8+-VO"7M>YOED:SEL8[G$<^\ >I6HW-X-V-&2&6I>P_I0G9X?^?GA!
MLXK)8O)P>T8^_6MQ<\>2"5LK0?ERTE9$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$'&\)TPT7
M,8BW=K9J_=%BU8FCNLM/B$,KG>I8QA#5:>D>:R>9T>A9R$YGF9)-!YS[YFPO
M+ ]!>US#K;_H=6_K>E_B(+%U0OWJ&@;)9I.>R=E0AKV^]H>0TD*E;%IFGU.D
M]F2M0JQNJX@6JUQC0)O.QG>R02#UY<4'5-5MV[NL8&U<Y]IGQM:6;^F^,%RX
M[":62V+:)L#I#<V\WC!=OY&>)D+)8AP880]KR6-0<]9&#T;SU69S(8HMN\/$
M3R8X6>=G(C)73^I6 PFOX+7[^&Q]>I>HY:FRD^%@8]_>[M,9(]7!P09<3@\-
MD^L.[SWZL,\M:ICO!'* \#OBX<_@JC9V"''4.M.(H,#,;!%1FBA9]R*:=O,C
M6()[<L!B,#TZQ4>/J15!D9\;5R5N,!LLD$AY>9'J3ZK:]@\#IT&4P^-K4LCC
M;=0T)(&"-Y>90PL0;.2R<&B[]FKMC[./S6)?<'^^4&\O:/UO8N>YO'9:CH>H
M03P"6QL6PLN92)\AA;.^SS(V![T%DOX;8HL[J=V/5\%@)*^2BC\T-]C3/ _T
M?7#0QG>2%WJU-#6JV)YI.R..)SWO_-:T<DH/FD58+>B91^'T"L<7)5M3_2^5
MLQ^TR#U<9N&M<_E;N+9'F9^CV,RP\] X::QX9/5D\\$0#0[Y]B"USX/#8KK/
M@),?5AKOLX>VZ:*(!C26>@?P%SBL3-HFO8V9[F4<CO+ZU[@\!T)F<>PH.B]2
ML)A\##J^5P]&M2R$&;J05S7C$1D9*>'0D-]X*EM-+6]2>J ^4V*_Z<H.79I[
M7Z1UI+#R/K$?\2-6GJ1JN!PW31\>-H0UGS3XUDTT30)9")1PY[D&]O\ K6 P
M/U"LXG&5J<T.ST(&R0QACS%)R'-<5%W_ /.'7W^JJO\ T+T&EG-2UVKT*BNQ
M8RN+HQ-.W[7V#S^=_8\O[U9*M:KG^J44.:B9993UJO/2@F <POF=]N4-*#WJ
M^)Q.*ZQ[-!C88X8WX2"5\,8X8R1\BD^N5:O+TSSLLD+'OA\!B>0"6$SL!+4$
M)NFN86WOO2_%24(/8>,H\U@P"(]D395FM4*F!ZLP.Q%&&L;&L67RPPL#&2/B
M?RTEK4%!T;%Y?+:8;#M(Q&6&1,\EK(V;H;/*\O()/,9+"U=OZ9LR<.CX:#(7
M8+,\,;X_/!,)V.C8\AG#VH*3U-OY+*;7K&O8O%G)&H\9:[5;,R$.9$>V(%[U
M%ULOG\/U2H93+:Z_$5,]"VA,#:BL-?9C]8G\Q();5-<PF4ZB]1K61H06WPW*
MS(1.P2-8'P\N(#ESO*0,J=+.J%"O]BO4VU\59GPB8+$/#6H+_P!1=6U_ 8G4
MY\7C:]6Q4S]!D<\3 R4@NX/+E/X/^6#<1\\3005(7\15R/6JQDIYV40^DR=U
M<\2\.A[.UBIN^4[D'3MTT&@T<-4JBJZO<DL1F[]]H! B9]\H.NO//6K'?\(/
M_P"I4IU>_DVV;_=1_?""A09F'1,[DK<WI3RVMQ7XF_ W*488]@_6\+5UK"SX
M;>.GM>SZVY<+?LVS\3/8/E>@@M#JYW,8C*9"32,3F)K]ZQ[7:N6PV;D.X\7#
MF.+ U:>0BS\&H:1@+'LEZ";/RQ>!ET/AEBB^U%6DF:@N4V'V&+:]2OMUK"8%
M\-T0O?!>8#9@?Z/A# QG>I+5\7C(MRZJ/CHUF/@=6$)$308Q)6)=V(*#1QU7
M)ZIT6I6H^^":_.)&?![?4EI71\EB,7A^K6CG&4(*?M='(QSM@8(A(V*,.;R&
M(-3IKK^"V'7LYD<SCZUN_>REQEY\[ ]["Q_ CY/JT-"E^A[(6:*&0R%\;<E<
M#'_-HE0=/7S]>JU;,?7/SP1R>-@DC[V@]CVU#PX(.P:!1IU-,UWV:K##Y<94
MDE\; SO>Z%O+W<*@Y/"8S,=<(F9&K'9B@U5L[(I0'L,@LE@)""N7^=;SG5QN
M$B%5K,'6LLCA'8QDIC(,C0%"U];REGIU#!%I.#CA?CV3MR[\@QDK7EG>+)>8
MT%M$$F;W?0\;L)@N1PZT;G;R)8)[G(87_)Z]]0Z> U?%[C;P,_LF7LXB(RTH
M"&,\)F$1L!C4%7R6LYAVE5Z]?3,#C60PPRULL,DQDD3QP1,9"P*S9K"Y^79H
M,W2I8//61AJ\5S%V)6>2 _?[X>>0 ]!&UZN$S>B[=@J$/U;MC),]JJ79AX(Y
MY"'B-I]WCDX6>K(,5L^K?671:^*L^UBK0R6,D9X'RS M$;V,09J0IY3+;--@
M-&CS0FR,L=O)9.>)D?E9Z&.(%CW&)JH3&/DZ&VJQ>&AFR>)GB<2U@-D>C$'5
M-^TW%8#6H,QKN*KU;.$MP7P(6!AECA]) _\ %BV\+9@V[J/-EX3WX_"8V**H
M[X.LWFB5[Q^#$'45RKJICJ$^2Z?F:I!*7[)6A>7L#B8R'$L*#!C,7C,OU8VF
M+)U()H\3CZ$6,KR,!BCBF9W/<QBV-5J5L/U4VK%8R-L5"3&5K<M>/TCBLN/'
MH/AW!!+]4,)/FL9B8*UR@RS%DXIX:=YW$%TQ@_D7!5#7[L-+=ZT>5TKZ%SEG
M'V(ZCZLK'U+;81WN!$:#/TLUC6\[H,=_*4*UVYE)+,E^Q,P/D+_*X*CX.U9L
M8+I>V6=TT<&VS05I7'DO@B+@Q!L;+?NT:/6R>G(YCS<QT9>WX,E 8]=4RFE]
M/:&%Q$LT=?'0T)Z[ZUZ#MBE#^0&\R<$GO04>6M7L'KF)X62!D0> \!W#V4W$
M%=-Z=UZE30]9%:"*(S8NI++V,#>][H6\O*"G[3/C+._B*GK$N>R]7&@.AFFC
MCIU8Y#R'?E0?ME<_J6,OAK?5XP4*N-LLPU>8U:3^^*%YC/VP>&_;06/9=.U*
M+HJ9X:%5KXL3#9BMA@$KI7 'DO\ CWK?%2KE]_TK&Y2)DU&OJ@N5X)1S&^T2
M&$D'T)#4&WCL+B,1UKO#'010"?4WS311 -8'FTQJYM5ITY^C73E\U6*1XS\3
M Y[ 2&/MR<M0=&S_ #C>IG-"!C#6T:VZO&QH#062\M ":-IVHY/IC3FOT:L[
M[].2>[<E:'S&5_)<\R'U!8@H55LNQZST9BS(=,)K\\<H>3S+%%RT!WXM:NB9
M+$8O#]6M'.,H04_:Z.1CG; P1"1L48<WD,05O$,IY>#-3X#1*^3IW+M@S9?+
M6(V^5W/#BT=CW]@5=Q<LDO2/I@7O+N-MK-'X"S*@^H5P[I-J&J7^GLTU['UI
MWW)[@M22-!>P,E<T %!3((WY[1^DM;)E\T4N?=7)/OE@8Y[ "K]F,!@?XRM6
MP+L;6BQ$="U>CI,C#();?/;R6>XD!!NW\?1P75O41AZ\5;Z3HWF9&&$!C'L@
M9WQO<UJYCL$>/I;K?UJ"_-#JES)UGY?QLXBKVI>3[/W_  9*0.Y!U7)Q,J]6
MM9C@B8QD6NVVQ1M'  :X  +F6@T<WF-7GO2:1B<N_)3V'V[MJX&3/?WD$$&,
MEG""6@UW.7=-TJN<GA+M_'7K#ZU&S:;/7O1,YX8"W[[H@K5I=RC!O%BM?U!^
M!S=G&_=@E8^I9BB?]\"/@=Z"6ZX?R9YO^G4_ZEBB<GA,9F.N$3,C5CLQ0:JV
M=D4H#V&062P$A!N:?1J8OJCO-*A RO5?3H3^",!L8D(/) 7OKA6K3:'9DE@C
M>^*Y4['.:"6=T[ 4$7MNNX6YU,T#&S4(#293OO%4, B)8 X L6.W5@U[JEE#
MAJD5?RZ7-9=!"P,8^>*;ACN @H^HX7+9+0P\Z1A\@R_%-+8R=B\T3R/<3R]Q
M,9+2U=XZ>G(Q:7@X\A;@LV60%CYH91,QX8XAI#QZ.]$'*LN,QDNKF=8S7J68
M^CL?5%2"Y8$3(F3 /?(QI:\$DK9P6H7[U_><1=I8W&TLI083CJUML_L]GX3!
M@ [.4$;6S%G<<7HNIV039;;><XSY1XH\%K__ #')39F\IU"WBT-7Q^9EJVHZ
ML8NV1'[-"&^@8QS'^CT&E/CLIC- ZHU;$-&K6Y9+!0K6A9%1TGWV'CCL4OOF
MKX#$=+:%ZCCJ\-VH_'31VVL G\KY&<O+T%EFQ>-?USB+J%8GZJ^T<F-O^6;;
MX$O]-=*V&O5L:_E89H(Y8S5EY8]H<TEK>0>"@^;;6(QTW1_I[![-&P7<W0;9
M+ &.D[R]O)(5_P!QP&$PFT].+.*QM:G*<N:Q,$8BYB?&>6GM053$LS>4W/>[
MHU3&YF6'*.J!]VR&&""+T8QC'L?P'*&S>.RN-Z7[[3G%.O ,O5?6IUK0LBF9
M)V%\2"W]4<!CM=UC"XW!XJO!#D<S1J70P^#VF,<D,FD"U<OA-BBOZS;BU7 X
M"6GDH1'9BOQL,D9]'5^.QG?WA!WZU-#6JV)YI.R..)SWO_-:T<DKYI%6"WHF
M4?A] K'%R5;4_P!+Y6S'[3(/5QFX:US^4&8T*^;J]#*F0'GAE@G\K'>YXC@:
M>'*3W'&F+J'K&"QFN4+5"MC)[E?&2/%:L9WR$.?QP02$$SK>+SE+J-#<DQ&)
MPL5G'/9:I5KK'F?L/+)A$ Q=E0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0<_M]*\$Z:^:N4S
M%&M=D<^U1J6O%7E<_P!_+>"1RK'?U'#V=>J82+STZ==T9A;5D\3@(SR!R@G5
M&;%K&.V/&LH7S*(FV(I^8G!I[XCR/>"@DK->O:K35K$39(98W,DC<.6N:X<$
M$+GL?2/7A'%4ER69GQD4@?'BI;9=4'!Y [>.2U!T)K0T!K0  .  J/8Z:X@7
M\C;J9;,T67YC-;J5+7B@ED?]YQ''()04W>M!H8;I]D\7@Z=J2&WF*U@U1S+V
M<R,#@Q7.ATWPE2_2N37\I>%)W=2@N63-#6=\#&$%2^IK\QU/W&Y+/E<>6UJ
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MU['LV=VQ<R^VNQPH\<CQ^(2>7W?/E!C9K&)BS66R[@]\V1K15[$;R'1F.(<
M!JI_\4.NB$T_I3-?17?W_17MA]D^?'''/""R['IN%S<&/$GGJST#_P!BM5'^
M":OZ<$,(^"U\/H.!Q<>4,[K61FR$7BN6+TGGEEBXX\?/  :@A(^D>O!D%6;)
MYFSC89 ^/%S6R^H.T\@=O'):%-YW0L7E\G%E8KV1QM]L A-BA,(7OB^#'\AP
M*#!%T[U>' Y+#2PSV8[[_+<GGE+YY9?@]S_F%AH=.,53OT;US+YG)NHN[ZD=
M^UYHX7_![0 WER#&>E^&;;OR5<KF:=>[.Z:U1K6C%7D>_P"\> .1RO8Z9ZS!
MKMG!1&TRC+D!=$8D',;PX.#6'C[@X03&Y9^I@\,\SXNY>%@.@;7K0F8O<YIX
M:X#W J*Z6:H_5M,QU&>+LMR<SVA\I9/_ )$<!!N:=AKN'@S3;$DO%K+V+,+9
M)?*YD3P&@<_V<@+:VK4\7LM"O4NRV8G5[++,$]:3Q2Q2LY <UR"/RG3W%Y&;
M'VAD<I5R%2JVL,C6G[+,L8^$KB"'K>UW4\3KK+?LAGEGM2"2W;L2&6>=P]Q>
M\H-W9M7Q6RT&5+XE'BF;-!-"\QS0RL]SXW? J(PFA8W%Y5F6GR.4R5Z.(Q0S
MWY_,86/]XC #0$$3=Z78)\]YU7*9BA!=D,EJE4M>*O*Y_O);P>.5.SZ7KWAU
MZ"*!\$6&L-GIQQ'AH<T<?;YY)0;$6FX-D^QR21/F;FBTW8I2"PAK.SAJJ]3I
MA@JUB@9<GF+M:C()*E&U:\M:%S/NEK> 3VH+5!I^'BGV67B5_P!-\"ZQSOLD
M",Q<-7K5-6JZOC3CZM^_8@#^8Q;F\IB;P (X_0<,"")SNB8S(YCZ9AR.3QU]
MT(AEFHSB(RQCU D#@X%,+H&NX*_D+=869)+M406Q/*9A/Z\E\A?R2\H("ST?
MUN2E+0?DLR<<>?%CC;YK0D_%@5ESNE8;*U,7%));@L8X 4[E:7Q6(1QV^CT&
M# ]/,-@\S-F8KE^Q>FINK3SVIO*Z1KGA_)6&7ISKGU.JZMWVQ4K2>2"42\3Q
MO[S('!X""6H:;CJ>6H91UN[9MU<8: EL2B0R1%_?S(>.2]5F?I/KX;:@@R>8
MJX^P]SY<7!;+*CB_WCMXY *"T7-2PDLFO/;$Z$8:3OI11$-8/L]G#EM9#7L?
M<SN'S<QE%K',G;7 < PBPWM=W!!4XNE."A-F"#)YF''3RN?+C([995/?[QP!
MW!I6]!TWUZ#"XO#QOM"I0RC<A6'>.6RM>7AON^YR4%O7 ^G?32"]J+#?N9R@
M;$]D7:44[H(YQY2 9&.'Q:@[%;TW"6&:_&(G0Q8:PR:E%$0UH+&]H#DVG4\3
ML4=0VC/#9JR&2I;K2&*>!Q]Y8]!H8;1L7A;=K(>VY"[DIX/";]R833LC_-9Z
M!K0E?0=9JZO>UXP/FJW'2/LOE=WS2R2'DRN?^>@V*FGXRED</D/:;DUG'4'T
MX7S2!Q=$[XOX Y*A;?2W"36;\M/*9C'0W7F2U4IV?%!*YWO)80>"4&_D^GVM
M6L+B\5%#-3CQS@^C-5D,4T#OB6O3":3C</DI<FZ]D<A??#X1;O3>:1D7//8S
M@- "":V36,=LF$LXB^91!.8R\Q.#7_DWB0<$@_$(=>Q[-G=L7,OMKL<*/'(\
M?B$GE]WSY0>:^ Q]38<GG(C+[5=@AAEY<"SMA]W:%FV; 8S8\+:Q.1#S7G#>
M>QW:\%A#P6GY@A!$T]*QM*Y@KTE_(6K.+@GA@FLS"5[VV/?Y#QZK?EU_'/V9
MFP<R^ULQYI>\>,Q%_D]WSY05&?I/KW%N*OD\S3H6GE\^-K6NRJ\O]X[>"0"N
M@4*%/'4J]2K R&O!&V.*-HX#6M' ""N['I&(S5^MDS:O4,C#&8F7:,WAF,9]
M>QW((+5DUW4L3K@NOJNL3V;<@?:MV9#-/.6^[O<@RXK2L%BMCS&?JQ/%S(@"
M?D@L'S[!\.XCDJ.SNA8G)9<Y:"]DL;??$(YK%"?PF5@]PD!#@4"+IYK=?6,E
M@6BQX+Y<ZW.9.ZQ,]QY+WO=SR5+9[5<5FM>^@[CYA5XA'+' /_($.:@T\UIN
M+RF>QF=-R_5NU&"-KZLWB$L0?W^*4?%BL<L;)8WQO:"Q[2UP/Q!]"$%#H]+,
M!3QU;'-O922I7R,%ZM%+8[Q"^ DM8SD>C%;LSKF/S%O#6;1E#\;;%F#L< "\
M#C[2"NYK0,3?R\V6K9')XR]/&&69J$_A\X;[O("' H_IMK(U2UKH98;4L3MG
ML2B3F>:4/#^][W \N)""R;!@\5G<38QF2JB:M,/5O)!!!Y#@1[B%4J'3?$5<
MC1O6\IE\FZD>ZHR_9\T<+_@Y@ ""\S0Q30R0RL#XY&%KVGW%KAP05SR+I/K\
M%0T'Y3-28OU+,8^X?9A\>.  2$$Y2T+"U!JP9+:=] B84BYX]1,WM(>MW9M/
MQ.R"F^TZQ!:J/+ZMRK(8IX2??V.0:6!TG$X*_9R(M7KV1GB$3[MV;S3"(>O8
MT@  *SH"(,-S(XW'1>6[=KUHN>/)-(V-O/XN(4?]==-_VGQ'[9"@E*-ZA>@$
MU*W!8B/NDBD;(T_VM7I 1 1 1 1 1 49:V+6Z$YAO9S'5Y1[XIK,<;A_8XH$
M.X:C(]D46QXI[R>&M;;B)*DT!$!$!$!$!$ D $D@ *&=MVGQ.+';+B6O!X<#
M;B!"#>H[)KN0F$%'-8^Q)QSV0V(Y'<?@TE;: B B B B B B B B B B B B
M B B B B B B B B B B B B B B B O,E_'UIX:\UR".>7TCC?(UKW_ -$$
M\E!X^E,0V>2!^1JB6/[\1E9W-^'VARLJ#\FFAAC,DTC(V#WN<0T#GT]Y7Z@(
M@(@(@(@(@(9H1*(?(SR%O<&<CN[?=SP@(@7,A0HL:^W<@@:X\-,LC6 GY#N1
M 1 1 1 7FG>Q]LRBK<@G,9X>(I&O[#\CP@])'-#+W^.5C^QQ:[M(/#A[P>/B
M@(@+\^F</SQ])5.?EYF( ((!!Y!2*6&:-LD,C'L/N<T@M/X$(/U$!$!$!+%R
MI5#38LQ1!WW>]X;SQ\N4&M%E\/S_ )SJ<_ >5BV1-"93")&&0-#BSD=P!^)"
M B DDT,(:99&,#G!K>X@<N/N Y0$0$0>#D\5 ]T<N0JLD:>'-=*T$+W%-#,P
M/BD8]A]SFD$("("("("(#IH6R1QND8'OY[&$@%W'OX"("&:$2MB,C!(X$AG(
M[B!\0$!$!+%FM68'SSQQ-YX[GN#1_P#90&N:]H<UP+2.00>00OQEFLZ9\#9X
MG2M'+HPX%P_$($T\$$9DFE9&P>]SW!H']I2*2.6-LD;VO8X<M<T\@_@0@>V4
MS.:PLQ>;C_)]X[__ $7Z@\R9'&UGF*:]7CD'O:^1K2/["5^P6*]AG?!-'(WY
ML<'#_P"P@1S0RM<8I&/ <6DM(/!'O'HOU 1 2*>"8O$4S'ECNUX:X'M(^!X]
MQ0$0$0$0?DLT,+"^61C&C@%SB /7\5^H"("("(,<E_'U7]EBY7B?QSVOD:T\
M?@5ZK6:UEI=!/'*![RQP</\ ["#TB B B B!)-#"&>21C YP:WN('+C[@.?B
MB B B!%-#,SOBE8]O)'<T@CD(@,FB>Z1C)&.<P@/:""6D_-$!$!$!$'%;FNT
M-VZI;%4S8?/2PM.FVO5[R&%]EG>7E6K^)CII_L[%_P#&2H*SA,%2TSJI5Q6'
M[XL=E<5+-)5+RYC)83]X+LR B B B B B#1V*[+B];S=Z'CRUL?8G9_2CC+@
MN0:/THTW*:MB\KF:)OWK]=EJ>Q-*_DNF^T@LUGHGTWF@EC9@Q$YS2!(R63EJ
MS='K]RWI<45N=TSZ=RQ4$KO>YD+^&H.@H@(@(@(@(@YQUALVAKF-QT%A\/TK
MF:E":1AX<(IN249T7Z:0Q1L.!8\@ %QEDY*"H;_TRU37M7NYW!4S0R&-[+$,
MT4C_ (.7<L=;-K%X^R\#NFK12$?K>T%!D1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 51W;</JC3Q5GZ,DN&YDHJ8BC>&O!E:X@M^9]$$71W
MG88-CQ.(V+6FT!E!+['-%:%@=\0[C')P DF];#D[^5@U?6F7ZV.G=7GM3VA7
M;).S[T<(X<@I?4'=[6=Z39>]C*<L!$XJ9%CYO'-3>R5@<Q=QPUC(V,;7ER-)
ME.R0[R0,E\S6\.('#^&\\A!0;&ZY^SF\QC==UV&]]%N8RU+/;%?F1X[NR-O#
MELV^H,M?7]<RDF"LPR9+*UZ#ZM@F&2 S.+2]!,;#LIPF3UJE['Y1E+_LW?W]
MOCX;W=W'!Y7&,*S/W^I>Y7Y]-H7;U1]'L$UT?]C(A)9XG&,_?05?5Q0J=/9\
MWF-.J6Q/?#3<-HMGL/DM^YY:WD!A"[UF]NR,.?;@,%AAD<@RL+%@R3"""O&X
M\-[W<'EQ0579MRK6]$V3ZP:I)Y<;:K0W,<^<MCD+Y6=CXYF*U9W<,A!GFX#
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M6LA:B#S-<E;),]SBXGL:&M Y]S0!Z!!Z1 1 1 1 1 1 1 1 1 1 1 1 1 1
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MUQY2;*\XJYQ4L3M?6DMU^0&&=IX[U>NRUA]NZ6XROE,@^M/7RCYVS6'R>4B
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MIL6)-V"":!S)Y()J\P ?%-$>',=PHG,;BZEF?H7%X6UE+[(!/-%"^.)D,9/
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MAEG)YFG<@QPX-@5ZKV>\?GD!7S&,NWNH[,U]&W(*DVJQ1 SQ&,LE]J<\QO\
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M&OXF#&4?)X(G2N;WN[G<RO,A_P#LN0;*("T\UA,?ECC#:[^:%^*Y &.X_*Q
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MFCKSWJT4\@_)0R2M:^0_^%I/)05+6=PR.<Q6IY$U*<,6298=:#I^'1"('CQ
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MC$X@??66EM^R5,KAZFQ8.M3ARI,=62"P9C%,&]XAF!:WU*##8W/9[MC,OUW
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M5F!AEHF,F7N#/>T(,>N7*U;5>J#IIF,$6>SADY/NY5:PF*Q^5O\ 2""_69/
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M,1CGY%\VS\-QYE,%)MP,[RQQ((\0^+ M;'5[E'J;/#9IX>E-+JUDRUL:7=G
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M+N2Y4'.=,,+%/@[6!Q%2M-6SM.U._P!W$$+BYX8@N.4TC4\SD&9'(X6M/::
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M.:75O#7*<=NKKVR2U'@EMB/'/?$0#P2'-5F@WK7;-7 6JUE\\.7LFO5>QO\
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MSJ%#J;6K9&W<&*&.-!]MYGEB-\=AY<]*4VQX[)8.?&0;G8D=<ACR0R32^O+
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M+:UK&5=BR=;"6)'/EQD?C[.'GES&2%I>QA70H*\%>"*"&,,BBC:QC![FM:.
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M,0T\?9V/)V</5E8^'&R>/LXC/+&/D#0][&H-RSHSV9?*7<;L61Q\>2>)+M>
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M.QM:K-=GM/B8&F><\RR?K>57]DTS%9[,X#*6I)6S8N8R1L9QVR>K7ALGZ@6
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M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$'X' D@$<CWA?J B B B B B B B
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MIND$;XK#0X%CC^IS4!V\[2_*5\''@<?'EQ3]IL13W^R(-,A8UL1#"7D@+H.
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M#Z<J)V3-08' 93+3?<J5GR<?G.]S6_BXH.5:!6R.H['0QN3F>[ZQXWVUQ?\
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M.ZW%2QM^>*&.:.UYI:[Y_2/SL[0@V\ALFX-MY1F)U>)]:B>'SW;!J^T$#D^
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MQY+6$%J"$_C'SXQ#=DDU<-U\\/\ +[3S;$!/ G,7:NG69K Q\DV/BCGE,7=
MQ[_&R0GU'+@'< H/GGIQD9,%KN)S,^#KNM9O-Q47WA9+IIO:+$@+Y 6^G8NV
MW=B-?;<1@?90YMRG8L>;OX[/ 0..WCX\H.(:DYWT)T4_7;O?X<B[IL^Q5=;P
MMG(S1/E\98QD4?WY))'!C&-_$E! T]KV6K=BBV'7&TZTU::<6JTYM1P>%O>Y
MEC[#>Q0!ZC["S#LV6750, [A_D]IYMBN3P)S%P@D,GN^:9LK\'@<!'D)10AN
MB9]D0Q^*0D+5AWS:\B_/OQ>IPS0XB_9JS.DM]CIS7/!$ [$&_9ZB-M5M<& Q
MQOW<Q7?/7ADD\+(8H_OOF=PY8']1+U&ILT65PK:^4Q%#VTUV3]\-F'X/CDX0
M9JVY;;+ASD7:=(?:7UQC88IP]\@GY^W/PWB%K1ZDI0V[8H\\_ 93!TXKTN/E
MM4C!;,D4IB_U)"6 L05'2]VR^,Z?1W\K3=:GGR<M:@&V"^:W8FLO'82\ ,X5
MZQVVYR'/4,/L6&@I27XY74IJ]CSQ/=$.Y\3^6L(> @G=LV:OK6)-V2O)8D?-
M'!6K1^CYIY3VL8"57:>X9ZIF\9C-CP<%+Z2+VTYZ]GVAGE8.XQ2<M;PY!BU#
M==@V:WY&:ZR#&,GL036G607>2%Q [&<>K5N[9ME[ Y' 4*6(]NL922>*)GE\
M08Z)@=RX\'[*!B=QR!R.6Q.9Q'L^2ITO;61U7FRRS![N8?1IYY''"@)M[VC%
MQ8O(9;5X:N-NVH8>/:^;<'G/#721%@02,^Z['8VW+X'$:W'9&-EJBS9EM"%H
M99C#U1M?WG8L+JVQY;)XT661;#+" VT9).9)Q$8V\L]T?^H@O]#<<_'LF+P^
M=P$-(9..=]*2&UY^'0-[W1RCM;P>%'G?MBNPY+)X76H[>(I32L=,^UXIK'@/
M$CH&=I0+W42X^Y@J>O849%^6Q9NUWOG$ : 1R)%X?OFR6LGDZ&+U^G/8QD<1
MN02WO'*Z5\8D+(&AA[@/<'E!$[)F,L=YT.W1PTLERSBKW%.=X@\3GAA/F/KP
M&+8R^XNNZMO-//X!HLXB"/VNI':/BGCG'>PLE !""7L;EFQL#-<PN AGF;BH
M+8FFLF*&-C^6\/(8XJRZIM!SU6\+%,T[U"VZK=K%XD#)&\'EKAQW-<#R"@@L
MSMN:J[4S7,3@F7+3\8RZ)9;'AB8TRNC/?]DIC]]OV<#E[+M<LORF.OFC-CJ[
M_+W3>G!:_C[G#N24"EM^PP[-B\'GL-4JNR44[JLM6T9^# WO<QX<QBKLO4[8
M7XS,Y6MJL;\=BKL\-R1UOM>\0/X)A;V()FEO>8&4P++VO"MCLRXLHS^T!\P/
M89&>:/@ =X6,[]L5V')9/"ZU';Q%*:5CIGVO%-8\!XD= SM*#H&(RU+*8FED
M:;^Z&U R:,D<'M>.1RJ=U3:6].=G=\?8B@CZ&ZY^@< <UKK*F.R4D-:O8;9\
MDL4D@_)B=G X[U+4]\A.%VB]?JBK+A+%F*S"']_/A'<QS20/20(+7B+UJYB<
M?<MU16GGK,D?7[N_Q%XY[2>!SPN>97>=OIT,EF&:DQF+IODY]JLFO;ECB/!D
M9$6(++0VR.WLM+$05?R5G C*,L%WKP9 P,+5SWJ!N67GU3?8,?6\#\59BK/L
M-G+'^.1@>9&<! RN2V2#?]6?%AH9<E-@;;#6%G\@S\J#WOE+588.I I8C9)<
MWBW5KN%GBAGK02>83.L &'Q'@??Y0;$.Z;'0R.(AV37H:-;)SBO7G@M>?Q3O
M'+(I@6MX+E'5-US>8GV""'6&'%X^W?I7;3[?87&N#]QH:@S8?-9N'4->M8/7
MJ(QQQ<<I%G(NB\ _-Y,;RX +!C>IEU^JG-W-?,9GO,IXJ"*?O-Y\AX:6E[&<
M,*"<H;?FJV<HXG8\/!1?>BE?3G@L^>)QA'>^-_+6%K@%S[;]SV#-Z!G\A3UP
M#!SU9XH;)L<62S[@G\7'W$'<<+Q]#8PG]#A_N!<T'438;F/N9W%ZPRS@Z[I>
M)C:[+,\4)X?+%'VH*MND\^U[5HD46)J9#$VZEJW6AFLNB;/S$PETH##P8U4X
M((AB>I&>SVK5+1@R$\#W"]()!V/B:*S"&#B-OP<@[IE-LS+\_:PFOX:&[8IP
M12W9I['@AB\W)9&.&O)>X+1FZ@7_ &+"P0ZY8&;R4T\4>/G?XA'[-_E9'2<>
ML0^!" -]R%.+8ZV8PS*^3Q>)DR+88I_)#9@8#ZL?P"/4<%2NH;)GL[6-V]@F
M4:<\$4U)WM EDD9(.?MM ':@M"("("("("("("("("("("("("("("("("("
M("("("("("("("\9&&W+C;L=2<0V7UY&P2D!PCD+2&N(/(/!0<CBI[YL=_3Z
MV9P)IC#W66[MYT\3VV)86%@\38_SUOX^#;=0N[%5I:V_*U;^2GO4YHK$478^
MQZNBF$A' !0:F"T7.8JWT],K&3&C:RMG)RL< R-]V)W :#P2.3PM_$:QG*_3
M+8\-+3XO68\N(8>]A[C9+S&@Q#"[)C<YH=^'#NM,JX48^ZUDT;75W/#.7GD\
M. X5NW_7;FPZQ:I4I&,MMDAGK%_W#+ \2 .05"]#M6UV]=K7M;?BJM#)P7[<
MLT\4ID?7Y+8H1&3R"5KC1,G)O^1DL0-.OR"U<9]MIYN7(6UI&]J"/U;1]IJ:
M5N4&4@!RES&/QU-@>P\P5JQAA]>>!WDJS9W6\U;TK4L=!4[[5.UB7V(^]@[&
MUBWR(*AD-%%#9-ALV=$BV&#(VC:K3MDB9)"]X^U%()2/LJ;KZ9FH*.AL&*HP
M/IYHW+L-/AD,#',>/3O/+D&YO.%LY++ W],@SN,-8"!\#V0W*\OQ!<][.6%3
M?3_%YO$:TRIE'O$OM$SXH7S>=U>![N60F3_6+0@JNXX"UD<U>.2T6/,P%K/H
M^Y3F96LQ<#U9,]SV%9<-J^TU+O367)/-J3&5,FR_8,H<6&PT")OJ>7H&RZ+E
ML]E-\9VB*#)XFC#4G+AP9J[B_@@+QEX]TVVGB\-D-;..C;<KS9&V^>*1A%=P
M>1 &$DEY"#8@K;AK^=VR*CKQO0Y:X+56V)XXXXGOC#")@X\@-(49@=0V&CC.
MET,]+A^)L6G7AY8SXP]CPU!C@QF\8/5\OJ-'7O;&/]L90R L1,A$-HN=^5#R
M'![>]=1UFK:HZQ@*-EG9-6QM6&9G(/$D<8:X<A!Q,=/GXB?,U)>GU;./FMS3
M4+_EB8.V8\AE@/(([%,Y;3\W!]5H;6"^DL36Q[X[6,QLPK1,MO=W>0,>]G>Q
M!'5.G&;LT]_I#"U</!E8*#\=%'(Q[(WTR7!DG8NATLOO>1O8F&7 ?1,$+^_(
MS2S0S"4!O'B@#"3ZGXE!"8[5<]#T=OX!]+C)25<@QD'D8>3/-(]GVN>%T[$P
MSP8G'UWCL?%5B8_X\.:P CT0<!R^G;!D#*&::RGL7M/+,]1LLK5N._GS%@?W
MJP;1J5VR_J//>LP4JUVMB#3O3R,;$9J?)^W\AWH-+9LIME[):#!DM?BQS!L=
M1SS[5'.Z9[&N/,89[HPK]JF#RE"#=FVJW8;^=NV:OVVGOBEC8UKD&YH&+O8?
M2\#C[\/BLUZH9+'W!W#@?FTD+GF S6R8[8=_9CM<?DXGYMW88YXXBR;PL])/
M(1]A!'6^EU^MBM2L38NKFIZ#[;\C0+PP3"Z[R$PE_ YC*FL-J%H0[3/3TVEA
MH[.'FJ4X.6&W*^0>I>YCBQK$%EFQ&>@Z<8/&0XJE<M5J%&*YC[7:YDS(F 2Q
M _=#_D52,/H5RU?S,=+"6M>Q%S#V:D]66R)A+//Z"1D;'O#0Q!MVJ.^Y73H=
M-FUP5Y#!#4L90V(W5A!%P#*QH/>7$!7;7L'>QFX[==DKEE.U7Q;*CR]I[_9H
MGL>@Y]8U#;HM>97]@GE@^L]RW>H066PRVJDKR6</#EFP6GY&MN#,G2U"+$XY
M^&M5>SS1.G\KR'!\W#C]Y!(Z_J.PTQTJ$]+L^B(;PO\ Y2,^$RP%C%H3Z]/+
MU9?C(GM.+?)!G[,7YEF,&  _TW</0=B%[)_3,U5^+[:(JA[+WF:>^4G@Q>+W
MC@>O<JCONO9'9)=>P[:I.)?>\^5D[PT>* =S(N.0X][D%;VGI;0J8^#(ZGC>
MS-4+<-FJ#8?Q)V.^U&3*_@ A:6R:CLV2I]3C#C#WY@8LTHS+%R\P1,$@0=G7
M(ZVI;"SHG)KCJ/&4]@EB%?R1_?=*7 =_/""0^CMEUG:+V8I85^3JY2C3CLPP
MRQLF@GJ,+ >)" 6$*"FTO:+E"WD)Z+&W\CM%"_+49*PBO6K$  O) <X!!/QU
MMIU;8=CEQ^!?E:>6LMM1.CGCB=#.6!CV2^0C[!5*/3G89=2UMU_#5KE_&92]
M/9QKY6=EF&U(XD,>@G\'J,INY2U3T>GA(/HN>"$/+#;FGE'SC>6L8I^MA-CJ
M=,<3BHL92GO04:T=BA:[7QRAG'DBY!+>4$#INK7J>W19#':[9P&,%65MRK+9
M;(RS,_[A9&Q[PT,5UWG#Y++Q:T*5?R>R[%0M3 N:WMAA?R]WVD X;)'J7#F/
M!_V$:Y)4,W<W_+&RV0,X5#N:=M#<9FIH*#7VHMY^FJE<RL'M,$?8@FJM7;LQ
MO>'SEG G'4J^-MP 2S122B23@@O:PJCW]/V"Z^,PZ<S&;"+32_.TK+(:G DY
M,O8U_+N1\"$'2:5#-XWJ3G+AQ;I<;E:E0"VR5@$#JK'CA[">3RI#?*&1NTZ+
M(<!3S%,3DW:,W:)7,(X#X'/(:'-*#E\.C;"=;WBMCL/8H4K]*.+'8B:TV5PE
M'WW\EY;&"K/%'FL%M^4MXBA!E3>QU$7J3+<4-BM+786,?Q)[XWA!3<)BMASV
M!SY%2)]O^,%MF=D4@[&,@,1?VN?QR&+KN<PV2M;QIF2@@[JM&+)"S)W-'89X
MV!B"?QE[*68K+K^+]A>RS)'$SS-F\D3?NR\L]W?\E6,WALG/U U/*PU^:=.I
M?9/+W-'8Z9H#!P@R:)B,CAZF>9?K^)UG/W[4([FN[HIG\L=]E5S><#E;VS8^
MS/A;68P;*#HS0KV&P]ELOY\KVN>P/'"#WTYUS*X'*[7-9P=?&5;LE22G!!(Q
M[&-8PL+/L?$*2V''YW';E3V?&8QV1C.+=0MU8Y&1RM8)/*R2/O(!00.5P^]Y
MFO6S,E."*YCLS'<H8ITC.?9V,['QOE;R/(]2D-;8=BV[ Y?(81^*I8=EET;)
MY8Y)IY[#/'[HB0&-""L7L-DL)T'RV/R,'ALQ5KA?'R'\"2RYX]6*3M0[;M46
MN8Z]@/8*U2Y6N7;AGC>R;V;[360!GKP\H-G'P;;J%W8JM+6WY6K?R4]ZG-%8
MBB['V/5T4PD(X *U,%HN<Q5SIZZ5C)C2LY6SDY6. 9')=C/ :"@;7KV3M[A:
MM9+7;.=Q3ZD+*,$=ID45>4??\L;WL![E 0:-M4&A[5C1A:\-J;869"G4@E9X
M3$'1/\;#\. Q!9,MJ^9V7-9.W;H/H09#3S0)?(QYAM&=S^PAA6ADZF\9_5:^
MHW-<]C+V007<D;$3X/%"02^$ EY+^$%YP&'OX_<-VOSU^RK>DH&H_N:>\0UP
MQZKVOOS6EZE2CMXGR33Y]\3XO.QI9%=M$-E!'=W?>'V4'3+W_<;7_DO_ +J^
M>=<?N.;Z68S7(, &QW*0A&4,[/ RL\^KBS[_ 'H+5E^GN1R-K=:0 BJ7\)0J
MTIW.!!DJ\GU 4)CM,DGL8>%G3/'8Z>*>)UZ_,^.6$,C]Y@$;^XN<@SV]4R\V
M<V%^6U%^;GGO2/QEN:RSV*&N?N,?$YWIV?'AI6>EJ^Q4M#U;$W]6J92*H9V9
M''R.B,W!>>R6!Y=VH(Z'IOFK^M[;0AIOQ=*V^K)BL9;L>T"*2N>]Y=P7AK9%
M(X;43+F<))!TUH8?V6PR:Y;G?'+P8_4"L(GH.K[;7RMG 78<95IV;):.*UL<
MPS,Y^U&?Q"Y=JNKW:FWTLCC-9LZ[09!.,A!):9)':>\<,#(HWO [$$;C-=SN
MOX?IS-X*QS6,%^(XN6S'&^S%/R7B)_)!>Q9 _8LYO6TLMXME6P_2WP051,R5
MP\LA[!(\?9#G(+/E]8SECICKF&BI\WJL>($T/>P=IK%AD72I6%\4C.>.YI'_
M *H.(X#6=N&(T+'V\&Z!V#S ,\GGB>U\(8\>5G!5WRVL7\EO%FTZ(C'SZI9Q
MSYPYOI+-,#QP@Y33T"[5Q,&(=TWQLN3B[8OI>5\;JCV \>=P#A(OHV"%D,$4
M30T-8QK0 .!PT<(.,PZ=L];IMK-1E!IRF(S#+YIF5@\HBLOD# \$CDARG*5;
M:\OOV%SMO /H4*V/M0<2SQ/E#Y"T\N#"@AM=TW9*6+Z70V*'8_$V;3[X\L9\
M0D8\!7_?,!<SVN25L>Z,6X+,%JL'^C'25WAX:4$(^7=-H>:%G"OPV-?2LQ7S
M-)%-),Z:,L#(?&3P&D\ERJTE+?IM)9I3]<#)1490?E#8C-7P- 9Y0.>_DM07
M7#:W>QV\W+@@/L P-.G#,7-Y<^![N1PJ'JN9VRI]=J^,ULWQ+LV4%:=L\<;8
MY#)[IP]!OU=*SVHC3K^+JC)R8S&RT;U9CQ&][)W"4OA+^!Z/6/*:SM&PLW#,
M3XGV.>U@#B\=1=-&92.3(7RN![ 24%@W'";%:U37JE*":5M>:J<E2AG$$MB!
MC.'Q->J]KFHWJN]8;+TM.9B,8RG:AE!FB=8+W@$/FX<4$0-$V6]H[<%:P<?G
MP^;-ZL)IF&#(L=+(\Q^A)9RUZL&LZJ/K+CKM;0*>#K562.FFF+)+#Y2. V#P
MO( 073?\!DLUB*9QGC-W'Y&M?K1R'M9))7=SV$JMRP;-M&?UN:[@),31Q-@V
MY//-%))-.&%C6,$1/V0@G^GF)R.$UPT[]?Q3^WW)>SN:_P"Q+,Y[3RPE5OJ!
M8R5/;^GDV.IBU9;/D2("\1][17Y> XH!PVX9K)[!L J?1%MV!?C<5#)(Q\H<
MYQE,TACY#50+6BY>WAJ#*>A/ARE>>I+<O7+D4LTQB>"\0.+W(.RX#$9"CN.\
M9">OV5K\M U']S3WB&N&/7-Y=6VY^"V+!C!N/=LHOUK(GB[)H7VA*?0D$%H0
M=+V##9*YN6D9""#OK4);YM2=S1V":N6,7((.GDN'AR.-?T[JYB<SS.H9,RQ!
MA9*>6^T!Y#@6(.B8G5,I0VK6;/L=9M6GKTU6=U?AD+)WR-=V,8XEW"@MPUR[
MDLODCD-%CRO=Q]&Y"E.RK/&./N3N<]KN6E!)835]HJ9C0[&2?[4<?A[<%ZT9
M >)9>WL'J>7+4V74=ANR=437H]XRU#'14/RC!Y7P,<'H-1U_.8GJ9<-+"OR
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M@H@(@(@(@(@(@(@(@(@(@(@(@(@*I3_RH8S_ (:N_P#4P(+:B B B B B B
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M@(@(@(@(@(@(@(@(@(@(@(@(@(@)F/\ -.1_W67^X4'(>A?^CV0_\VC_ -!
MNO("("("("("("("("("("("J.]_?T__ (EJ?W'H+<B B B B B B B B B
MB B B B JE/_ "H8S_AJ[_U,""VH@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@*@=4/\ ):7_ ,88K^^4%_1 1 1
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M97_J7(+DJAU)_P P4_Z[Q7_5QH+>B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B F8_P TY'_=9?[A0<AZ%_Z/9#_S
M:/\ T$"Z\@(@(@(@(@(@(@(@(@(@(@*H[W]_3_\ B6I_<>@MR("("("("("(
M"("("("("("("("J4_\ *AC/^&KO_4P(+:B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B J!U0_P EI?\ QABO[Y07
M]$!$!$!$!$!$!$!$!$!$!$!4WIO_ )JS7_$65_ZER"Y*H=2?\P4_Z[Q7_5QH
M+>B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B F8_S3D?]UE_N%!R'H7_H]D/_ #:/_00+KR B B B B B B B B B
M B JCO?W]/\ ^):G]QZ"W(@(@(@(@(@(@(@(@(@(@(@(@(@*I3_RH8S_ (:N
M_P#4P(+:B B B B B B B B B B B B B B B B B B B B B B B B B B
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M@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@*@=4/\
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M5/WB!]<-I_F]RW[14_>)]<-I_F]RW[14_>('UPVG^;W+?M%3]XJAMU_<<ZW
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M1%5[W$@L''/(5FDEBB;W2/:P<\<N( 0:.;ERU;$6K&*I1V[C TP5WR")KR7
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M;%2D@OY+'1G#S32&3LK-]34!/N<U=(V_^5#I;_\ CG_I@@Z.B B B B B B
MB B B"@=9_Y,ME_\F'_&8K_BO\UT/]VB_NA!\XX:UC6ZCU*L6,K9H8NWM-D0
M3U1S*\.<.6P_TU$9VICL;-JN1PFBY#!&/-4XA?G>R%\C)#P8WQA[B[N07W'Z
MY@6=9MBL_1L1D@QD%V/YBQ(\]SUSS5:@V;"39C+Z'DLW<R,LSCD&68FA@#RT
M,@Y>"P,0=\Z</V*/3L?%GXY!>A+XR9'![WQM=]ASBTE6] 1 1 1 1 1 1 1
M1 1!S#+ZU4SVS9/(ZQM4V+SE1L=?(>./RQO^+!+&]>,/L.XX7;<5@-J;0MC)
M1S^P9&JTL=W0-[WLE8@YJ;=J/7=AH0V)(&97J=/0LS,/#F03D%ZL6_Z'K&O'
M3;>'J"D[ZR8Z"2-CSQ.TOY!>/BX(-Z+5L1L75K=V96 V*T%7&O%9SB(G/,7
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MX^8AD[VE=)0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0%S#H=_H#!_O\
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*!$!$!$!$!$'_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
